id	sid	tid	token	lemma	pos
ctmj-186	1	1	ctmj	ctmj	NOUN
ctmj-186	1	2	|	|	ADV
ctmj-186	1	3	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-186	1	4	chinese	chinese	ADJ
ctmj-186	1	5	traditional	traditional	ADJ
ctmj-186	1	6	medicine	medicine	NOUN
ctmj-186	1	7	journal	journal	NOUN
ctmj-186	1	8	|	|	ADV
ctmj-186	1	9	2025	2025	NUM
ctmj-186	1	10	|	|	ADV
ctmj-186	1	11	vol	vol	NOUN
ctmj-186	1	12	8	8	NUM
ctmj-186	1	13	|issue	|issue	NOUN
ctmj-186	1	14	1	1	NUM
ctmj-186	1	15	22	22	NUM
ctmj-186	1	16	abstract	abstract	NOUN
ctmj-186	1	17	:	:	PUNCT
ctmj-186	1	18	purpose	purpose	NOUN
ctmj-186	1	19	:	:	PUNCT
ctmj-186	1	20	using	use	VERB
ctmj-186	1	21	transcriptome	transcriptome	ADJ
ctmj-186	1	22	analysis	analysis	NOUN
ctmj-186	1	23	,	,	PUNCT
ctmj-186	1	24	we	we	PRON
ctmj-186	1	25	want	want	VERB
ctmj-186	1	26	to	to	PART
ctmj-186	1	27	learn	learn	VERB
ctmj-186	1	28	how	how	SCONJ
ctmj-186	1	29	compound	compound	NOUN
ctmj-186	1	30	danshen	danshen	ADJ
ctmj-186	1	31	dripping	dripping	ADJ
ctmj-186	1	32	pills	pill	NOUN
ctmj-186	1	33	(	(	PUNCT
ctmj-186	1	34	cddp	cddp	PROPN
ctmj-186	1	35	)	)	PUNCT
ctmj-186	1	36	affect	affect	VERB
ctmj-186	1	37	diffuse	diffuse	ADJ
ctmj-186	1	38	intravascular	intravascular	ADJ
ctmj-186	1	39	coagulation	coagulation	NOUN
ctmj-186	1	40	(	(	PUNCT
ctmj-186	1	41	dic	dic	ADJ
ctmj-186	1	42	)	)	PUNCT
ctmj-186	1	43	and	and	CCONJ
ctmj-186	1	44	what	what	PRON
ctmj-186	1	45	mechanisms	mechanism	NOUN
ctmj-186	1	46	cddp	cddp	NOUN
ctmj-186	1	47	may	may	AUX
ctmj-186	1	48	work	work	VERB
ctmj-186	1	49	by	by	ADP
ctmj-186	1	50	.	.	PUNCT
ctmj-186	2	1	research	research	NOUN
ctmj-186	2	2	tools	tool	NOUN
ctmj-186	2	3	and	and	CCONJ
ctmj-186	2	4	procedures	procedure	NOUN
ctmj-186	2	5	:	:	PUNCT
ctmj-186	2	6	we	we	PRON
ctmj-186	2	7	carried	carry	VERB
ctmj-186	2	8	out	out	ADP
ctmj-186	2	9	dic	dic	PROPN
ctmj-186	2	10	animal	animal	NOUN
ctmj-186	2	11	models	model	NOUN
ctmj-186	2	12	with	with	ADP
ctmj-186	2	13	various	various	ADJ
ctmj-186	2	14	inducers	inducer	NOUN
ctmj-186	2	15	and	and	CCONJ
ctmj-186	2	16	studied	study	VERB
ctmj-186	2	17	the	the	DET
ctmj-186	2	18	impact	impact	NOUN
ctmj-186	2	19	of	of	ADP
ctmj-186	2	20	cddp	cddp	NOUN
ctmj-186	2	21	on	on	ADP
ctmj-186	2	22	many	many	ADJ
ctmj-186	2	23	parameters	parameter	NOUN
ctmj-186	2	24	,	,	PUNCT
ctmj-186	2	25	including	include	VERB
ctmj-186	2	26	survival	survival	NOUN
ctmj-186	2	27	rate	rate	NOUN
ctmj-186	2	28	,	,	PUNCT
ctmj-186	2	29	blood	blood	NOUN
ctmj-186	2	30	flow	flow	NOUN
ctmj-186	2	31	to	to	ADP
ctmj-186	2	32	the	the	DET
ctmj-186	2	33	hepatic	hepatic	ADJ
ctmj-186	2	34	and	and	CCONJ
ctmj-186	2	35	gastric	gastric	ADJ
ctmj-186	2	36	fundi	fundi	NOUN
ctmj-186	2	37	,	,	PUNCT
ctmj-186	2	38	aberrant	aberrant	ADJ
ctmj-186	2	39	prothrombin	prothrombin	ADJ
ctmj-186	2	40	time	time	NOUN
ctmj-186	2	41	(	(	PUNCT
ctmj-186	2	42	pt	pt	NOUN
ctmj-186	2	43	)	)	PUNCT
ctmj-186	2	44	,	,	PUNCT
ctmj-186	2	45	fibrinogen	fibrinogen	NOUN
ctmj-186	2	46	(	(	PUNCT
ctmj-186	2	47	fib	fib	ADJ
ctmj-186	2	48	)	)	PUNCT
ctmj-186	2	49	concentration	concentration	NOUN
ctmj-186	2	50	,	,	PUNCT
ctmj-186	2	51	inflammatory	inflammatory	ADJ
ctmj-186	2	52	factors	factor	NOUN
ctmj-186	2	53	,	,	PUNCT
ctmj-186	2	54	and	and	CCONJ
ctmj-186	2	55	the	the	DET
ctmj-186	2	56	damage	damage	NOUN
ctmj-186	2	57	index	index	NOUN
ctmj-186	2	58	for	for	ADP
ctmj-186	2	59	the	the	DET
ctmj-186	2	60	liver	liver	NOUN
ctmj-186	2	61	and	and	CCONJ
ctmj-186	2	62	kidneys	kidney	NOUN
ctmj-186	2	63	.	.	PUNCT
ctmj-186	3	1	after	after	ADP
ctmj-186	3	2	that	that	PRON
ctmj-186	3	3	,	,	PUNCT
ctmj-186	3	4	confirmation	confirmation	NOUN
ctmj-186	3	5	of	of	ADP
ctmj-186	3	6	the	the	DET
ctmj-186	3	7	primary	primary	ADJ
ctmj-186	3	8	target	target	NOUN
ctmj-186	3	9	genes	gene	NOUN
ctmj-186	3	10	was	be	AUX
ctmj-186	3	11	done	do	VERB
ctmj-186	3	12	using	use	VERB
ctmj-186	3	13	whole	whole	ADJ
ctmj-186	3	14	-	-	PUNCT
ctmj-186	3	15	blood	blood	NOUN
ctmj-186	3	16	transcriptome	transcriptome	NOUN
ctmj-186	3	17	sequencing	sequencing	NOUN
ctmj-186	3	18	.	.	PUNCT
ctmj-186	4	1	the	the	DET
ctmj-186	4	2	results	result	NOUN
ctmj-186	4	3	showed	show	VERB
ctmj-186	4	4	that	that	SCONJ
ctmj-186	4	5	cddp	cddp	NOUN
ctmj-186	4	6	increased	increase	VERB
ctmj-186	4	7	the	the	DET
ctmj-186	4	8	efficiency	efficiency	NOUN
ctmj-186	4	9	of	of	ADP
ctmj-186	4	10	glutamic	glutamic	ADJ
ctmj-186	4	11	pyruvic	pyruvic	ADJ
ctmj-186	4	12	transaminase	transaminase	NOUN
ctmj-186	4	13	and	and	CCONJ
ctmj-186	4	14	glutamic	glutamic	ADJ
ctmj-186	4	15	oxaloacetic	oxaloacetic	ADJ
ctmj-186	4	16	transaminase	transaminase	NOUN
ctmj-186	4	17	,	,	PUNCT
ctmj-186	4	18	improved	improve	VERB
ctmj-186	4	19	blood	blood	NOUN
ctmj-186	4	20	flow	flow	NOUN
ctmj-186	4	21	in	in	ADP
ctmj-186	4	22	the	the	DET
ctmj-186	4	23	stomach	stomach	NOUN
ctmj-186	4	24	and	and	CCONJ
ctmj-186	4	25	liver	liver	NOUN
ctmj-186	4	26	,	,	PUNCT
ctmj-186	4	27	increased	increase	VERB
ctmj-186	4	28	pt	pt	NOUN
ctmj-186	4	29	and	and	CCONJ
ctmj-186	4	30	fib	fib	ADJ
ctmj-186	4	31	values	value	NOUN
ctmj-186	4	32	,	,	PUNCT
ctmj-186	4	33	decreased	decrease	VERB
ctmj-186	4	34	the	the	DET
ctmj-186	4	35	elevated	elevated	ADJ
ctmj-186	4	36	serum	serum	NOUN
ctmj-186	4	37	levels	level	NOUN
ctmj-186	4	38	of	of	ADP
ctmj-186	4	39	interleukin-10	interleukin-10	PROPN
ctmj-186	4	40	and	and	CCONJ
ctmj-186	4	41	tumor	tumor	NOUN
ctmj-186	4	42	necrosis	necrosis	NOUN
ctmj-186	4	43	factor	factor	NOUN
ctmj-186	4	44	-	-	PUNCT
ctmj-186	4	45	alpha	alpha	NOUN
ctmj-186	4	46	,	,	PUNCT
ctmj-186	4	47	and	and	CCONJ
ctmj-186	4	48	increased	increase	VERB
ctmj-186	4	49	blood	blood	NOUN
ctmj-186	4	50	urea	urea	NOUN
ctmj-186	4	51	nitrogen	nitrogen	NOUN
ctmj-186	4	52	and	and	CCONJ
ctmj-186	4	53	creatinine	creatinine	NOUN
ctmj-186	4	54	.	.	PUNCT
ctmj-186	5	1	additionally	additionally	ADV
ctmj-186	5	2	,	,	PUNCT
ctmj-186	5	3	it	it	PRON
ctmj-186	5	4	improved	improve	VERB
ctmj-186	5	5	the	the	DET
ctmj-186	5	6	survival	survival	NOUN
ctmj-186	5	7	rate	rate	NOUN
ctmj-186	5	8	of	of	ADP
ctmj-186	5	9	the	the	DET
ctmj-186	5	10	animals	animal	NOUN
ctmj-186	5	11	used	use	VERB
ctmj-186	5	12	in	in	ADP
ctmj-186	5	13	the	the	DET
ctmj-186	5	14	study	study	NOUN
ctmj-186	5	15	.	.	PUNCT
ctmj-186	6	1	according	accord	VERB
ctmj-186	6	2	to	to	ADP
ctmj-186	6	3	research	research	NOUN
ctmj-186	6	4	using	use	VERB
ctmj-186	6	5	whole	whole	ADJ
ctmj-186	6	6	-	-	PUNCT
ctmj-186	6	7	blood	blood	NOUN
ctmj-186	6	8	transcriptome	transcriptome	NOUN
ctmj-186	6	9	sequencing	sequencing	NOUN
ctmj-186	6	10	,	,	PUNCT
ctmj-186	6	11	cddp	cddp	PROPN
ctmj-186	6	12	may	may	AUX
ctmj-186	6	13	control	control	VERB
ctmj-186	6	14	inflammatory	inflammatory	ADJ
ctmj-186	6	15	response	response	NOUN
ctmj-186	6	16	in	in	ADP
ctmj-186	6	17	the	the	DET
ctmj-186	6	18	immune	immune	ADJ
ctmj-186	6	19	system	system	NOUN
ctmj-186	6	20	,	,	PUNCT
ctmj-186	6	21	oxidative	oxidative	ADJ
ctmj-186	6	22	stress	stress	NOUN
ctmj-186	6	23	,	,	PUNCT
ctmj-186	6	24	activation	activation	NOUN
ctmj-186	6	25	and	and	CCONJ
ctmj-186	6	26	aggregation	aggregation	NOUN
ctmj-186	6	27	of	of	ADP
ctmj-186	6	28	platelets	platelet	NOUN
ctmj-186	6	29	,	,	PUNCT
ctmj-186	6	30	and	and	CCONJ
ctmj-186	6	31	cell	cell	NOUN
ctmj-186	6	32	death	death	NOUN
ctmj-186	6	33	in	in	ADP
ctmj-186	6	34	dic	dic	PROPN
ctmj-186	6	35	.	.	PUNCT
ctmj-186	7	1	the	the	DET
ctmj-186	7	2	model	model	NOUN
ctmj-186	7	3	animals	animal	NOUN
ctmj-186	7	4	'	'	PART
ctmj-186	7	5	aberrant	aberrant	ADJ
ctmj-186	7	6	expression	expression	NOUN
ctmj-186	7	7	of	of	ADP
ctmj-186	7	8	sqstml	sqstml	NOUN
ctmj-186	7	9	,	,	PUNCT
ctmj-186	7	10	ctsd	ctsd	VERB
ctmj-186	7	11	,	,	PUNCT
ctmj-186	7	12	mylk2	mylk2	ADJ
ctmj-186	7	13	,	,	PUNCT
ctmj-186	7	14	and	and	CCONJ
ctmj-186	7	15	nfkbib	nfkbib	NOUN
ctmj-186	7	16	was	be	AUX
ctmj-186	7	17	further	far	ADV
ctmj-186	7	18	enhanced	enhance	VERB
ctmj-186	7	19	by	by	ADP
ctmj-186	7	20	cddp	cddp	PROPN
ctmj-186	7	21	,	,	PUNCT
ctmj-186	7	22	as	as	SCONJ
ctmj-186	7	23	demonstrated	demonstrate	VERB
ctmj-186	7	24	by	by	ADP
ctmj-186	7	25	quantitative	quantitative	ADJ
ctmj-186	7	26	polymerase	polymerase	NOUN
ctmj-186	7	27	chain	chain	NOUN
ctmj-186	7	28	reaction	reaction	NOUN
ctmj-186	7	29	(	(	PUNCT
ctmj-186	7	30	qpcr	qpcr	ADJ
ctmj-186	7	31	)	)	PUNCT
ctmj-186	7	32	.	.	PUNCT
ctmj-186	8	1	results	result	NOUN
ctmj-186	8	2	:	:	PUNCT
ctmj-186	8	3	cddp	cddp	NOUN
ctmj-186	8	4	protects	protect	VERB
ctmj-186	8	5	primary	primary	ADJ
ctmj-186	8	6	organs	organ	NOUN
ctmj-186	8	7	in	in	ADP
ctmj-186	8	8	dic	dic	ADJ
ctmj-186	8	9	models	model	NOUN
ctmj-186	8	10	by	by	ADP
ctmj-186	8	11	reducing	reduce	VERB
ctmj-186	8	12	inflammatory	inflammatory	ADJ
ctmj-186	8	13	factor	factor	NOUN
ctmj-186	8	14	expression	expression	NOUN
ctmj-186	8	15	,	,	PUNCT
ctmj-186	8	16	increasing	increase	VERB
ctmj-186	8	17	organ	organ	NOUN
ctmj-186	8	18	blood	blood	NOUN
ctmj-186	8	19	flow	flow	NOUN
ctmj-186	8	20	,	,	PUNCT
ctmj-186	8	21	and	and	CCONJ
ctmj-186	8	22	correcting	correct	VERB
ctmj-186	8	23	coagulation	coagulation	NOUN
ctmj-186	8	24	anomalies	anomaly	NOUN
ctmj-186	8	25	.	.	PUNCT
ctmj-186	9	1	not	not	PART
ctmj-186	9	2	only	only	ADV
ctmj-186	9	3	that	that	PRON
ctmj-186	9	4	,	,	PUNCT
ctmj-186	9	5	but	but	CCONJ
ctmj-186	9	6	cddp	cddp	PROPN
ctmj-186	9	7	enhanced	enhance	VERB
ctmj-186	9	8	the	the	DET
ctmj-186	9	9	outcome	outcome	NOUN
ctmj-186	9	10	of	of	ADP
ctmj-186	9	11	dic	dic	PROPN
ctmj-186	9	12	animal	animal	NOUN
ctmj-186	9	13	models	model	NOUN
ctmj-186	9	14	by	by	ADP
ctmj-186	9	15	boosting	boost	VERB
ctmj-186	9	16	the	the	DET
ctmj-186	9	17	expression	expression	NOUN
ctmj-186	9	18	of	of	ADP
ctmj-186	9	19	important	important	ADJ
ctmj-186	9	20	genes	gene	NOUN
ctmj-186	9	21	associated	associate	VERB
ctmj-186	9	22	with	with	ADP
ctmj-186	9	23	the	the	DET
ctmj-186	9	24	illness	illness	NOUN
ctmj-186	9	25	,	,	PUNCT
ctmj-186	9	26	namely	namely	ADV
ctmj-186	9	27	sqstml	sqstml	NOUN
ctmj-186	9	28	and	and	CCONJ
ctmj-186	9	29	nfkbib	nfkbib	NOUN
ctmj-186	9	30	.	.	PUNCT
ctmj-186	10	1	keywords	keyword	NOUN
ctmj-186	10	2	:	:	PUNCT
ctmj-186	10	3	various	various	ADJ
ctmj-186	10	4	terms	term	NOUN
ctmj-186	10	5	such	such	ADJ
ctmj-186	10	6	as	as	ADP
ctmj-186	10	7	microcirculation	microcirculation	NOUN
ctmj-186	10	8	,	,	PUNCT
ctmj-186	10	9	disseminated	disseminate	VERB
ctmj-186	10	10	intravascular	intravascular	ADJ
ctmj-186	10	11	coagulation	coagulation	NOUN
ctmj-186	10	12	,	,	PUNCT
ctmj-186	10	13	the	the	DET
ctmj-186	10	14	sqstml	sqstml	NOUN
ctmj-186	10	15	gene	gene	NOUN
ctmj-186	10	16	,	,	PUNCT
ctmj-186	10	17	transcriptomics	transcriptomic	NOUN
ctmj-186	10	18	,	,	PUNCT
ctmj-186	10	19	and	and	CCONJ
ctmj-186	10	20	compound	compound	VERB
ctmj-186	10	21	danshen	danshen	PROPN
ctmj-186	10	22	dripping	dripping	ADJ
ctmj-186	10	23	tablet	tablet	NOUN
ctmj-186	10	24	are	be	AUX
ctmj-186	10	25	used	use	VERB
ctmj-186	10	26	.	.	PUNCT
ctmj-186	11	1	chinese	chinese	ADJ
ctmj-186	11	2	traditional	traditional	ADJ
ctmj-186	11	3	medical	medical	ADJ
ctmj-186	11	4	journal	journal	PROPN
ctmj-186	11	5	a	a	DET
ctmj-186	11	6	disseminated	disseminate	VERB
ctmj-186	11	7	intravascular	intravascular	ADJ
ctmj-186	11	8	coagulation	coagulation	NOUN
ctmj-186	11	9	animal	animal	NOUN
ctmj-186	11	10	model	model	NOUN
ctmj-186	11	11	:	:	PUNCT
ctmj-186	11	12	how	how	SCONJ
ctmj-186	11	13	compound	compound	ADJ
ctmj-186	11	14	danshen	danshen	ADJ
ctmj-186	11	15	dripping	dripping	ADJ
ctmj-186	11	16	pills	pill	NOUN
ctmj-186	11	17	work	work	VERB
ctmj-186	11	18	and	and	CCONJ
ctmj-186	11	19	what	what	PRON
ctmj-186	11	20	they	they	PRON
ctmj-186	11	21	do	do	VERB
ctmj-186	11	22	kiran	kiran	PROPN
ctmj-186	11	23	kumar	kumar	PROPN
ctmj-186	11	24	reddy	reddy	PROPN
ctmj-186	11	25	and	and	CCONJ
ctmj-186	11	26	varun	varun	PROPN
ctmj-186	11	27	1,2	1,2	NUM
ctmj-186	11	28	academy	academy	NOUN
ctmj-186	11	29	of	of	ADP
ctmj-186	11	30	acupuncture	acupuncture	NOUN
ctmj-186	11	31	and	and	CCONJ
ctmj-186	11	32	moxibustion	moxibustion	NOUN
ctmj-186	11	33	,	,	PUNCT
ctmj-186	11	34	fujian	fujian	PROPN
ctmj-186	11	35	university	university	PROPN
ctmj-186	11	36	of	of	ADP
ctmj-186	11	37	traditional	traditional	ADJ
ctmj-186	11	38	chinese	chinese	ADJ
ctmj-186	11	39	medicine	medicine	NOUN
ctmj-186	11	40	,	,	PUNCT
ctmj-186	11	41	fuzhou	fuzhou	PROPN
ctmj-186	11	42	,	,	PUNCT
ctmj-186	11	43	fujian	fujian	PROPN
ctmj-186	11	44	350122	350122	NUM
ctmj-186	11	45	,	,	PUNCT
ctmj-186	11	46	china	china	PROPN
ctmj-186	11	47	received	receive	VERB
ctmj-186	11	48	on	on	ADP
ctmj-186	11	49	:	:	PUNCT
ctmj-186	11	50	21	21	NUM
ctmj-186	11	51	oct	oct	PROPN
ctmj-186	11	52	2024	2024	NUM
ctmj-186	11	53	revised	revise	VERB
ctmj-186	11	54	on	on	ADP
ctmj-186	11	55	:	:	PUNCT
ctmj-186	11	56	20	20	NUM
ctmj-186	11	57	nov	nov	NOUN
ctmj-186	11	58	2024	2024	NUM
ctmj-186	11	59	accepted	accept	VERB
ctmj-186	11	60	date	date	NOUN
ctmj-186	11	61	:	:	PUNCT
ctmj-186	11	62	25	25	NUM
ctmj-186	11	63	dec	dec	PROPN
ctmj-186	11	64	2024	2024	NUM
ctmj-186	11	65	published	publish	VERB
ctmj-186	11	66	on	on	ADP
ctmj-186	11	67	:	:	PUNCT
ctmj-186	11	68	17	17	NUM
ctmj-186	11	69	feb	feb	NOUN
ctmj-186	11	70	2025	2025	NUM
ctmj-186	11	71	introduction	introduction	NOUN
ctmj-186	11	72	microthrombuses	microthrombuse	NOUN
ctmj-186	11	73	develop	develop	VERB
ctmj-186	11	74	all	all	ADV
ctmj-186	11	75	over	over	ADP
ctmj-186	11	76	the	the	DET
ctmj-186	11	77	place	place	NOUN
ctmj-186	11	78	and	and	CCONJ
ctmj-186	11	79	systemic	systemic	ADJ
ctmj-186	11	80	coagulation	coagulation	NOUN
ctmj-186	11	81	is	be	AUX
ctmj-186	11	82	activated	activate	VERB
ctmj-186	11	83	in	in	ADP
ctmj-186	11	84	disseminated	disseminate	VERB
ctmj-186	11	85	intravascular	intravascular	ADJ
ctmj-186	11	86	coagulation	coagulation	NOUN
ctmj-186	11	87	(	(	PUNCT
ctmj-186	11	88	dic	dic	ADJ
ctmj-186	11	89	)	)	PUNCT
ctmj-186	11	90	,	,	PUNCT
ctmj-186	11	91	a	a	DET
ctmj-186	11	92	condition	condition	NOUN
ctmj-186	11	93	of	of	ADP
ctmj-186	11	94	acquired	acquire	VERB
ctmj-186	11	95	coagulation	coagulation	NOUN
ctmj-186	11	96	dysfunction	dysfunction	NOUN
ctmj-186	11	97	.	.	PUNCT
ctmj-186	12	1	[	[	X
ctmj-186	12	2	1	1	X
ctmj-186	12	3	]	]	PUNCT
ctmj-186	12	4	one	one	NUM
ctmj-186	12	5	of	of	ADP
ctmj-186	12	6	the	the	DET
ctmj-186	12	7	most	most	ADV
ctmj-186	12	8	dangerous	dangerous	ADJ
ctmj-186	12	9	outcomes	outcome	NOUN
ctmj-186	12	10	for	for	ADP
ctmj-186	12	11	patients	patient	NOUN
ctmj-186	12	12	suffering	suffer	VERB
ctmj-186	12	13	from	from	ADP
ctmj-186	12	14	sepsis	sepsis	NOUN
ctmj-186	12	15	,	,	PUNCT
ctmj-186	12	16	tumors	tumor	NOUN
ctmj-186	12	17	,	,	PUNCT
ctmj-186	12	18	acute	acute	NOUN
ctmj-186	12	19	leukemia	leukemia	NOUN
ctmj-186	12	20	,	,	PUNCT
ctmj-186	12	21	placental	placental	ADJ
ctmj-186	12	22	abruption	abruption	NOUN
ctmj-186	12	23	,	,	PUNCT
ctmj-186	12	24	or	or	CCONJ
ctmj-186	12	25	trauma	trauma	NOUN
ctmj-186	12	26	,	,	PUNCT
ctmj-186	12	27	it	it	PRON
ctmj-186	12	28	happens	happen	VERB
ctmj-186	12	29	as	as	ADP
ctmj-186	12	30	a	a	DET
ctmj-186	12	31	response	response	NOUN
ctmj-186	12	32	to	to	ADP
ctmj-186	12	33	several	several	ADJ
ctmj-186	12	34	disorders	disorder	NOUN
ctmj-186	12	35	.	.	PUNCT
ctmj-186	13	1	due	due	ADP
ctmj-186	13	2	to	to	ADP
ctmj-186	13	3	its	its	PRON
ctmj-186	13	4	high	high	ADJ
ctmj-186	13	5	death	death	NOUN
ctmj-186	13	6	rates	rate	NOUN
ctmj-186	13	7	and	and	CCONJ
ctmj-186	13	8	vulnerability	vulnerability	NOUN
ctmj-186	13	9	to	to	ADP
ctmj-186	13	10	organ	organ	NOUN
ctmj-186	13	11	failure	failure	NOUN
ctmj-186	13	12	,	,	PUNCT
ctmj-186	13	13	dic	dic	PROPN
ctmj-186	13	14	is	be	AUX
ctmj-186	13	15	difficult	difficult	ADJ
ctmj-186	13	16	to	to	PART
ctmj-186	13	17	detect	detect	VERB
ctmj-186	13	18	and	and	CCONJ
ctmj-186	13	19	has	have	VERB
ctmj-186	13	20	a	a	DET
ctmj-186	13	21	bad	bad	ADJ
ctmj-186	13	22	prognosis	prognosis	NOUN
ctmj-186	13	23	when	when	SCONJ
ctmj-186	13	24	treated	treat	VERB
ctmj-186	13	25	.	.	PUNCT
ctmj-186	14	1	[	[	X
ctmj-186	14	2	2	2	X
ctmj-186	14	3	]	]	PUNCT
ctmj-186	14	4	in	in	ADP
ctmj-186	14	5	the	the	DET
ctmj-186	14	6	coagulation	coagulation	NOUN
ctmj-186	14	7	system	system	NOUN
ctmj-186	14	8	becomes	becomes	AUX
ctmj-186	14	9	activated	activated	ADJ
ctmj-186	14	10	and	and	CCONJ
ctmj-186	14	11	microvascular	microvascular	ADJ
ctmj-186	14	12	system	system	NOUN
ctmj-186	14	13	gets	get	AUX
ctmj-186	14	14	damaged	damage	VERB
ctmj-186	14	15	when	when	SCONJ
ctmj-186	14	16	pathogenic	pathogenic	ADJ
ctmj-186	14	17	agents	agent	NOUN
ctmj-186	14	18	do	do	VERB
ctmj-186	14	19	this	this	PRON
ctmj-186	14	20	.	.	PUNCT
ctmj-186	15	1	the	the	DET
ctmj-186	15	2	third	third	ADJ
ctmj-186	15	3	furthermore	furthermore	ADV
ctmj-186	15	4	,	,	PUNCT
ctmj-186	15	5	coagulation	coagulation	NOUN
ctmj-186	15	6	factors	factor	NOUN
ctmj-186	15	7	have	have	VERB
ctmj-186	15	8	a	a	DET
ctmj-186	15	9	role	role	NOUN
ctmj-186	15	10	in	in	ADP
ctmj-186	15	11	the	the	DET
ctmj-186	15	12	breakdown	breakdown	NOUN
ctmj-186	15	13	and	and	CCONJ
ctmj-186	15	14	consumption	consumption	NOUN
ctmj-186	15	15	of	of	ADP
ctmj-186	15	16	platelets	platelet	NOUN
ctmj-186	15	17	and	and	CCONJ
ctmj-186	15	18	coagulation	coagulation	NOUN
ctmj-186	15	19	factors	factor	NOUN
ctmj-186	15	20	leading	lead	VERB
ctmj-186	15	21	to	to	ADP
ctmj-186	15	22	hemorrhage	hemorrhage	NOUN
ctmj-186	15	23	and	and	CCONJ
ctmj-186	15	24	thrombosis	thrombosis	NOUN
ctmj-186	15	25	.	.	PUNCT
ctmj-186	16	1	according	accord	VERB
ctmj-186	16	2	to	to	ADP
ctmj-186	16	3	reports	report	NOUN
ctmj-186	16	4	,	,	PUNCT
ctmj-186	16	5	a	a	DET
ctmj-186	16	6	significant	significant	ADJ
ctmj-186	16	7	number	number	NOUN
ctmj-186	16	8	of	of	ADP
ctmj-186	16	9	patients	patient	NOUN
ctmj-186	16	10	in	in	ADP
ctmj-186	16	11	the	the	DET
ctmj-186	16	12	intensive	intensive	ADJ
ctmj-186	16	13	care	care	NOUN
ctmj-186	16	14	unit	unit	NOUN
ctmj-186	16	15	(	(	PUNCT
ctmj-186	16	16	icu	icu	PROPN
ctmj-186	16	17	)	)	PUNCT
ctmj-186	16	18	have	have	VERB
ctmj-186	16	19	signs	sign	NOUN
ctmj-186	16	20	of	of	ADP
ctmj-186	16	21	dic	dic	NOUN
ctmj-186	16	22	,	,	PUNCT
ctmj-186	16	23	which	which	PRON
ctmj-186	16	24	may	may	AUX
ctmj-186	16	25	lead	lead	VERB
ctmj-186	16	26	to	to	ADP
ctmj-186	16	27	an	an	DET
ctmj-186	16	28	increased	increase	VERB
ctmj-186	16	29	death	death	NOUN
ctmj-186	16	30	rate	rate	NOUN
ctmj-186	16	31	.	.	PUNCT
ctmj-186	17	1	the	the	DET
ctmj-186	17	2	most	most	ADV
ctmj-186	17	3	common	common	ADJ
ctmj-186	17	4	cause	cause	NOUN
ctmj-186	17	5	of	of	ADP
ctmj-186	17	6	dic	dic	PROPN
ctmj-186	17	7	is	be	AUX
ctmj-186	17	8	infection	infection	NOUN
ctmj-186	17	9	.	.	PUNCT
ctmj-186	18	1	[	[	X
ctmj-186	18	2	6	6	NUM
ctmj-186	18	3	]	]	PUNCT
ctmj-186	18	4	the	the	DET
ctmj-186	18	5	new	new	ADJ
ctmj-186	18	6	coronavirus	coronavirus	NOUN
ctmj-186	18	7	causes	cause	VERB
ctmj-186	18	8	the	the	DET
ctmj-186	18	9	acute	acute	ADJ
ctmj-186	18	10	infectious	infectious	ADJ
ctmj-186	18	11	illness	illness	NOUN
ctmj-186	18	12	known	know	VERB
ctmj-186	18	13	as	as	ADP
ctmj-186	18	14	coronavirus	coronavirus	NOUN
ctmj-186	18	15	disease	disease	NOUN
ctmj-186	18	16	2019	2019	NUM
ctmj-186	18	17	(	(	PUNCT
ctmj-186	18	18	covid-19	covid-19	PROPN
ctmj-186	18	19	)	)	PUNCT
ctmj-186	18	20	,	,	PUNCT
ctmj-186	18	21	which	which	PRON
ctmj-186	18	22	impacts	impact	VERB
ctmj-186	18	23	several	several	ADJ
ctmj-186	18	24	organs	organ	NOUN
ctmj-186	18	25	and	and	CCONJ
ctmj-186	18	26	systems	system	NOUN
ctmj-186	18	27	.	.	PUNCT
ctmj-186	19	1	those	those	DET
ctmj-186	19	2	two	two	NUM
ctmj-186	19	3	in	in	ADP
ctmj-186	19	4	addition	addition	NOUN
ctmj-186	19	5	,	,	PUNCT
ctmj-186	19	6	a	a	DET
ctmj-186	19	7	number	number	NOUN
ctmj-186	19	8	of	of	ADP
ctmj-186	19	9	mechanisms	mechanism	NOUN
ctmj-186	19	10	,	,	PUNCT
ctmj-186	19	11	including	include	VERB
ctmj-186	19	12	inflammation	inflammation	NOUN
ctmj-186	19	13	,	,	PUNCT
ctmj-186	19	14	immunology	immunology	NOUN
ctmj-186	19	15	,	,	PUNCT
ctmj-186	19	16	cell	cell	VERB
ctmj-186	19	17	the	the	DET
ctmj-186	19	18	establishment	establishment	NOUN
ctmj-186	19	19	of	of	ADP
ctmj-186	19	20	a	a	DET
ctmj-186	19	21	clotting	clot	VERB
ctmj-186	19	22	-	-	PUNCT
ctmj-186	19	23	inflammation	inflammation	NOUN
ctmj-186	19	24	-	-	PUNCT
ctmj-186	19	25	immune	immune	ADJ
ctmj-186	19	26	network	network	NOUN
ctmj-186	19	27	,	,	PUNCT
ctmj-186	19	28	adhesion	adhesion	NOUN
ctmj-186	19	29	,	,	PUNCT
ctmj-186	19	30	and	and	CCONJ
ctmj-186	19	31	platelet	platelet	NOUN
ctmj-186	19	32	activation	activation	NOUN
ctmj-186	19	33	.	.	PUNCT
ctmj-186	20	1	[	[	X
ctmj-186	20	2	4	4	X
ctmj-186	20	3	]	]	PUNCT
ctmj-186	20	4	the	the	DET
ctmj-186	20	5	core	core	ADJ
ctmj-186	20	6	feature	feature	NOUN
ctmj-186	20	7	of	of	ADP
ctmj-186	20	8	dic	dic	PROPN
ctmj-186	20	9	is	be	AUX
ctmj-186	20	10	the	the	DET
ctmj-186	20	11	presence	presence	NOUN
ctmj-186	20	12	of	of	ADP
ctmj-186	20	13	unregulated	unregulated	ADJ
ctmj-186	20	14	ctmj	ctmj	NOUN
ctmj-186	20	15	|	|	ADV
ctmj-186	20	16	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-186	20	17	chinese	chinese	ADJ
ctmj-186	20	18	traditional	traditional	ADJ
ctmj-186	20	19	medicine	medicine	NOUN
ctmj-186	20	20	journal	journal	NOUN
ctmj-186	20	21	|	|	ADV
ctmj-186	20	22	2025	2025	NUM
ctmj-186	20	23	|	|	ADV
ctmj-186	20	24	vol	vol	NOUN
ctmj-186	20	25	8	8	NUM
ctmj-186	20	26	|issue	|issue	NOUN
ctmj-186	20	27	1	1	NUM
ctmj-186	20	28	23	23	NUM
ctmj-186	20	29	covid-19	covid-19	PROPN
ctmj-186	20	30	patients	patient	NOUN
ctmj-186	20	31	in	in	ADP
ctmj-186	20	32	critical	critical	ADJ
ctmj-186	20	33	care	care	NOUN
ctmj-186	20	34	often	often	ADV
ctmj-186	20	35	present	present	ADJ
ctmj-186	20	36	with	with	ADP
ctmj-186	20	37	abnormal	abnormal	ADJ
ctmj-186	20	38	coagulation	coagulation	NOUN
ctmj-186	20	39	function	function	NOUN
ctmj-186	20	40	.	.	PUNCT
ctmj-186	21	1	multiple	multiple	ADJ
ctmj-186	21	2	systems	system	NOUN
ctmj-186	21	3	,	,	PUNCT
ctmj-186	21	4	including	include	VERB
ctmj-186	21	5	coagulation	coagulation	NOUN
ctmj-186	21	6	,	,	PUNCT
ctmj-186	21	7	inflammation	inflammation	NOUN
ctmj-186	21	8	,	,	PUNCT
ctmj-186	21	9	and	and	CCONJ
ctmj-186	21	10	the	the	DET
ctmj-186	21	11	immune	immune	ADJ
ctmj-186	21	12	complement	complement	NOUN
ctmj-186	21	13	system	system	NOUN
ctmj-186	21	14	,	,	PUNCT
ctmj-186	21	15	are	be	AUX
ctmj-186	21	16	involved	involve	VERB
ctmj-186	21	17	in	in	ADP
ctmj-186	21	18	coagulation	coagulation	NOUN
ctmj-186	21	19	dysfunction	dysfunction	NOUN
ctmj-186	21	20	in	in	ADP
ctmj-186	21	21	covid19	covid19	NOUN
ctmj-186	21	22	individuals	individual	NOUN
ctmj-186	21	23	,	,	PUNCT
ctmj-186	21	24	according	accord	VERB
ctmj-186	21	25	to	to	ADP
ctmj-186	21	26	studies	study	NOUN
ctmj-186	21	27	.	.	PUNCT
ctmj-186	22	1	[	[	X
ctmj-186	22	2	9	9	NUM
ctmj-186	22	3	]	]	SYM
ctmj-186	22	4	infections	infection	NOUN
ctmj-186	22	5	may	may	AUX
ctmj-186	22	6	progress	progress	VERB
ctmj-186	22	7	to	to	PART
ctmj-186	22	8	dic	dic	VERB
ctmj-186	22	9	in	in	ADP
ctmj-186	22	10	critically	critically	ADV
ctmj-186	22	11	sick	sick	ADJ
ctmj-186	22	12	individuals	individual	NOUN
ctmj-186	22	13	,	,	PUNCT
ctmj-186	22	14	leading	lead	VERB
ctmj-186	22	15	to	to	ADP
ctmj-186	22	16	unfavorable	unfavorable	ADJ
ctmj-186	22	17	health	health	NOUN
ctmj-186	22	18	consequences	consequence	NOUN
ctmj-186	22	19	.	.	PUNCT
ctmj-186	23	1	depending	depend	VERB
ctmj-186	23	2	on	on	ADP
ctmj-186	23	3	the	the	DET
ctmj-186	23	4	treatment	treatment	NOUN
ctmj-186	23	5	of	of	ADP
ctmj-186	23	6	underlying	underlie	VERB
ctmj-186	23	7	conditions	condition	NOUN
ctmj-186	23	8	,	,	PUNCT
ctmj-186	23	9	heparin	heparin	ADJ
ctmj-186	23	10	or	or	CCONJ
ctmj-186	23	11	lowmolecular	lowmolecular	ADJ
ctmj-186	23	12	-	-	PUNCT
ctmj-186	23	13	weight	weight	NOUN
ctmj-186	23	14	heparin	heparin	NOUN
ctmj-186	23	15	is	be	AUX
ctmj-186	23	16	now	now	ADV
ctmj-186	23	17	recommended	recommend	VERB
ctmj-186	23	18	as	as	ADP
ctmj-186	23	19	the	the	DET
ctmj-186	23	20	firstchoice	firstchoice	ADJ
ctmj-186	23	21	medicine	medicine	NOUN
ctmj-186	23	22	for	for	ADP
ctmj-186	23	23	dic	dic	PROPN
ctmj-186	23	24	according	accord	VERB
ctmj-186	23	25	to	to	ADP
ctmj-186	23	26	worldwide	worldwide	ADJ
ctmj-186	23	27	treatment	treatment	NOUN
ctmj-186	23	28	recommendations	recommendation	NOUN
ctmj-186	23	29	.	.	PUNCT
ctmj-186	24	1	citations	citation	NOUN
ctmj-186	25	1	[	[	X
ctmj-186	25	2	10,11	10,11	NOUN
ctmj-186	25	3	]	]	PUNCT
ctmj-186	25	4	nevertheless	nevertheless	ADV
ctmj-186	25	5	,	,	PUNCT
ctmj-186	25	6	a	a	DET
ctmj-186	25	7	number	number	NOUN
ctmj-186	25	8	of	of	ADP
ctmj-186	25	9	studies	study	NOUN
ctmj-186	25	10	have	have	AUX
ctmj-186	25	11	shown	show	VERB
ctmj-186	25	12	that	that	SCONJ
ctmj-186	25	13	heparin	heparin	NOUN
ctmj-186	25	14	has	have	VERB
ctmj-186	25	15	no	no	DET
ctmj-186	25	16	discernible	discernible	ADJ
ctmj-186	25	17	impact	impact	NOUN
ctmj-186	25	18	on	on	ADP
ctmj-186	25	19	patients	patient	NOUN
ctmj-186	25	20	'	'	PART
ctmj-186	25	21	long	long	ADJ
ctmj-186	25	22	-	-	PUNCT
ctmj-186	25	23	term	term	NOUN
ctmj-186	25	24	survival	survival	NOUN
ctmj-186	25	25	rates	rate	NOUN
ctmj-186	25	26	and	and	CCONJ
ctmj-186	25	27	carries	carry	VERB
ctmj-186	25	28	a	a	DET
ctmj-186	25	29	large	large	ADJ
ctmj-186	25	30	risk	risk	NOUN
ctmj-186	25	31	of	of	ADP
ctmj-186	25	32	severe	severe	ADJ
ctmj-186	25	33	side	side	NOUN
ctmj-186	25	34	effects	effect	NOUN
ctmj-186	25	35	including	include	VERB
ctmj-186	25	36	bleeding	bleed	VERB
ctmj-186	25	37	.	.	PUNCT
ctmj-186	26	1	consequently	consequently	ADV
ctmj-186	26	2	,	,	PUNCT
ctmj-186	26	3	the	the	DET
ctmj-186	26	4	creation	creation	NOUN
ctmj-186	26	5	of	of	ADP
ctmj-186	26	6	efficient	efficient	ADJ
ctmj-186	26	7	methods	method	NOUN
ctmj-186	26	8	for	for	ADP
ctmj-186	26	9	treating	treat	VERB
ctmj-186	26	10	dic	dic	PROPN
ctmj-186	26	11	is	be	AUX
ctmj-186	26	12	a	a	DET
ctmj-186	26	13	pressing	pressing	ADJ
ctmj-186	26	14	and	and	CCONJ
ctmj-186	26	15	unfulfilled	unfulfilled	ADJ
ctmj-186	26	16	therapeutic	therapeutic	ADJ
ctmj-186	26	17	need	need	NOUN
ctmj-186	26	18	.	.	PUNCT
ctmj-186	27	1	for	for	ADP
ctmj-186	27	2	the	the	DET
ctmj-186	27	3	treatment	treatment	NOUN
ctmj-186	27	4	of	of	ADP
ctmj-186	27	5	coronary	coronary	ADJ
ctmj-186	27	6	heart	heart	NOUN
ctmj-186	27	7	disease	disease	NOUN
ctmj-186	27	8	(	(	PUNCT
ctmj-186	27	9	chd	chd	NOUN
ctmj-186	27	10	)	)	PUNCT
ctmj-186	27	11	,	,	PUNCT
ctmj-186	27	12	the	the	DET
ctmj-186	27	13	china	china	PROPN
ctmj-186	27	14	food	food	PROPN
ctmj-186	27	15	and	and	CCONJ
ctmj-186	27	16	drug	drug	PROPN
ctmj-186	27	17	administration	administration	NOUN
ctmj-186	27	18	has	have	AUX
ctmj-186	27	19	authorized	authorize	VERB
ctmj-186	27	20	compound	compound	NOUN
ctmj-186	27	21	danshen	danshen	ADJ
ctmj-186	27	22	dripping	dripping	ADJ
ctmj-186	27	23	tablet	tablet	NOUN
ctmj-186	27	24	(	(	PUNCT
ctmj-186	27	25	cddp	cddp	PROPN
ctmj-186	27	26	)	)	PUNCT
ctmj-186	27	27	during	during	ADP
ctmj-186	27	28	the	the	DET
ctmj-186	27	29	last	last	ADJ
ctmj-186	27	30	quarter	quarter	NOUN
ctmj-186	27	31	of	of	ADP
ctmj-186	27	32	a	a	DET
ctmj-186	27	33	century	century	NOUN
ctmj-186	27	34	.	.	PUNCT
ctmj-186	28	1	many	many	ADJ
ctmj-186	28	2	studies	study	NOUN
ctmj-186	28	3	have	have	AUX
ctmj-186	28	4	shown	show	VERB
ctmj-186	28	5	that	that	SCONJ
ctmj-186	28	6	cddp	cddp	NOUN
ctmj-186	28	7	can	can	AUX
ctmj-186	28	8	alleviate	alleviate	VERB
ctmj-186	28	9	myocardial	myocardial	ADJ
ctmj-186	28	10	ischemia	ischemia	NOUN
ctmj-186	28	11	-	-	PUNCT
ctmj-186	28	12	induced	induce	VERB
ctmj-186	28	13	angina	angina	NOUN
ctmj-186	28	14	symptoms	symptom	NOUN
ctmj-186	28	15	by	by	ADP
ctmj-186	28	16	improving	improve	VERB
ctmj-186	28	17	blood	blood	NOUN
ctmj-186	28	18	circulation	circulation	NOUN
ctmj-186	28	19	,	,	PUNCT
ctmj-186	28	20	decreasing	decrease	VERB
ctmj-186	28	21	blood	blood	NOUN
ctmj-186	28	22	viscosity	viscosity	NOUN
ctmj-186	28	23	,	,	PUNCT
ctmj-186	28	24	protecting	protect	VERB
ctmj-186	28	25	endothelial	endothelial	ADJ
ctmj-186	28	26	cells	cell	NOUN
ctmj-186	28	27	,	,	PUNCT
ctmj-186	28	28	inhibiting	inhibit	VERB
ctmj-186	28	29	leukocyte	leukocyte	NOUN
ctmj-186	28	30	adhesion	adhesion	NOUN
ctmj-186	28	31	and	and	CCONJ
ctmj-186	28	32	inflammation	inflammation	NOUN
ctmj-186	28	33	,	,	PUNCT
ctmj-186	28	34	and	and	CCONJ
ctmj-186	28	35	optimizing	optimize	VERB
ctmj-186	28	36	myocardial	myocardial	ADJ
ctmj-186	28	37	energy	energy	NOUN
ctmj-186	28	38	metabolism	metabolism	NOUN
ctmj-186	28	39	.	.	PUNCT
ctmj-186	29	1	[	[	X
ctmj-186	29	2	12	12	NUM
ctmj-186	29	3	]	]	X
ctmj-186	29	4	moreover	moreover	ADV
ctmj-186	29	5	,	,	PUNCT
ctmj-186	29	6	prior	prior	ADJ
ctmj-186	29	7	research	research	NOUN
ctmj-186	29	8	has	have	AUX
ctmj-186	29	9	shown	show	VERB
ctmj-186	29	10	that	that	SCONJ
ctmj-186	29	11	cddp	cddp	NOUN
ctmj-186	29	12	has	have	VERB
ctmj-186	29	13	pharmacological	pharmacological	ADJ
ctmj-186	29	14	actions	action	NOUN
ctmj-186	29	15	such	such	ADJ
ctmj-186	29	16	enhancing	enhance	VERB
ctmj-186	29	17	microcirculation	microcirculation	NOUN
ctmj-186	29	18	,	,	PUNCT
ctmj-186	29	19	preventing	prevent	VERB
ctmj-186	29	20	platelet	platelet	NOUN
ctmj-186	29	21	adhesion	adhesion	NOUN
ctmj-186	29	22	and	and	CCONJ
ctmj-186	29	23	aggregation	aggregation	NOUN
ctmj-186	29	24	,	,	PUNCT
ctmj-186	29	25	acting	act	VERB
ctmj-186	29	26	as	as	ADP
ctmj-186	29	27	an	an	DET
ctmj-186	29	28	antioxidant	antioxidant	ADJ
ctmj-186	29	29	and	and	CCONJ
ctmj-186	29	30	anti	anti	ADJ
ctmj-186	29	31	-	-	ADJ
ctmj-186	29	32	inflammatory	inflammatory	ADJ
ctmj-186	29	33	,	,	PUNCT
ctmj-186	29	34	and	and	CCONJ
ctmj-186	29	35	safeguarding	safeguard	VERB
ctmj-186	29	36	endothelial	endothelial	ADJ
ctmj-186	29	37	functions	function	NOUN
ctmj-186	29	38	.	.	PUNCT
ctmj-186	30	1	[	[	X
ctmj-186	30	2	13	13	NUM
ctmj-186	30	3	]	]	SYM
ctmj-186	30	4	myocardial	myocardial	ADJ
ctmj-186	30	5	ischemia	ischemia	NOUN
ctmj-186	30	6	and	and	CCONJ
ctmj-186	30	7	dic	dic	PROPN
ctmj-186	30	8	have	have	VERB
ctmj-186	30	9	similar	similar	ADJ
ctmj-186	30	10	clinical	clinical	ADJ
ctmj-186	30	11	and	and	CCONJ
ctmj-186	30	12	physiological	physiological	ADJ
ctmj-186	30	13	processes	process	NOUN
ctmj-186	30	14	,	,	PUNCT
ctmj-186	30	15	such	such	ADJ
ctmj-186	30	16	as	as	ADP
ctmj-186	30	17	inflammation	inflammation	NOUN
ctmj-186	30	18	,	,	PUNCT
ctmj-186	30	19	impaired	impaired	ADJ
ctmj-186	30	20	coagulation	coagulation	NOUN
ctmj-186	30	21	function	function	NOUN
ctmj-186	30	22	,	,	PUNCT
ctmj-186	30	23	and	and	CCONJ
ctmj-186	30	24	platelet	platelet	NOUN
ctmj-186	30	25	activation	activation	NOUN
ctmj-186	30	26	.	.	PUNCT
ctmj-186	31	1	this	this	PRON
ctmj-186	31	2	suggests	suggest	VERB
ctmj-186	31	3	that	that	SCONJ
ctmj-186	31	4	the	the	DET
ctmj-186	31	5	regulatory	regulatory	ADJ
ctmj-186	31	6	mechanism	mechanism	NOUN
ctmj-186	31	7	by	by	ADP
ctmj-186	31	8	which	which	PRON
ctmj-186	31	9	cddp	cddp	PROPN
ctmj-186	31	10	protects	protect	VERB
ctmj-186	31	11	against	against	ADP
ctmj-186	31	12	dic	dic	PROPN
ctmj-186	31	13	and	and	CCONJ
ctmj-186	31	14	chd	chd	PROPN
ctmj-186	31	15	is	be	AUX
ctmj-186	31	16	similar	similar	ADJ
ctmj-186	31	17	as	as	ADV
ctmj-186	31	18	well	well	ADV
ctmj-186	31	19	.	.	PUNCT
ctmj-186	32	1	thus	thus	ADV
ctmj-186	32	2	,	,	PUNCT
ctmj-186	32	3	the	the	DET
ctmj-186	32	4	purpose	purpose	NOUN
ctmj-186	32	5	of	of	ADP
ctmj-186	32	6	this	this	DET
ctmj-186	32	7	study	study	NOUN
ctmj-186	32	8	was	be	AUX
ctmj-186	32	9	to	to	PART
ctmj-186	32	10	examine	examine	VERB
ctmj-186	32	11	the	the	DET
ctmj-186	32	12	effectiveness	effectiveness	NOUN
ctmj-186	32	13	of	of	ADP
ctmj-186	32	14	cddp	cddp	NOUN
ctmj-186	32	15	in	in	ADP
ctmj-186	32	16	treating	treat	VERB
ctmj-186	32	17	dic	dic	NOUN
ctmj-186	32	18	in	in	ADP
ctmj-186	32	19	two	two	NUM
ctmj-186	32	20	separate	separate	ADJ
ctmj-186	32	21	animal	animal	NOUN
ctmj-186	32	22	models	model	NOUN
ctmj-186	32	23	and	and	CCONJ
ctmj-186	32	24	to	to	PART
ctmj-186	32	25	investigate	investigate	VERB
ctmj-186	32	26	,	,	PUNCT
ctmj-186	32	27	using	use	VERB
ctmj-186	32	28	transcriptomics	transcriptomic	NOUN
ctmj-186	32	29	as	as	ADP
ctmj-186	32	30	a	a	DET
ctmj-186	32	31	starting	starting	NOUN
ctmj-186	32	32	point	point	NOUN
ctmj-186	32	33	,	,	PUNCT
ctmj-186	32	34	the	the	DET
ctmj-186	32	35	potential	potential	ADJ
ctmj-186	32	36	mechanism	mechanism	NOUN
ctmj-186	32	37	of	of	ADP
ctmj-186	32	38	cddp	cddp	PROPN
ctmj-186	32	39	's	's	PART
ctmj-186	32	40	treatment	treatment	NOUN
ctmj-186	32	41	of	of	ADP
ctmj-186	32	42	dic	dic	PROPN
ctmj-186	32	43	.	.	PUNCT
ctmj-186	33	1	the	the	DET
ctmj-186	33	2	ultimate	ultimate	ADJ
ctmj-186	33	3	goal	goal	NOUN
ctmj-186	33	4	is	be	AUX
ctmj-186	33	5	to	to	PART
ctmj-186	33	6	provide	provide	VERB
ctmj-186	33	7	evidence	evidence	NOUN
ctmj-186	33	8	supporting	support	VERB
ctmj-186	33	9	cddp	cddp	NOUN
ctmj-186	33	10	's	's	PART
ctmj-186	33	11	use	use	NOUN
ctmj-186	33	12	in	in	ADP
ctmj-186	33	13	treating	treat	VERB
ctmj-186	33	14	dic	dic	PROPN
ctmj-186	33	15	and	and	CCONJ
ctmj-186	33	16	to	to	PART
ctmj-186	33	17	provide	provide	VERB
ctmj-186	33	18	a	a	DET
ctmj-186	33	19	safe	safe	ADJ
ctmj-186	33	20	and	and	CCONJ
ctmj-186	33	21	effective	effective	ADJ
ctmj-186	33	22	option	option	NOUN
ctmj-186	33	23	for	for	ADP
ctmj-186	33	24	patients	patient	NOUN
ctmj-186	33	25	suffering	suffer	VERB
ctmj-186	33	26	from	from	ADP
ctmj-186	33	27	clinical	clinical	ADJ
ctmj-186	33	28	dic	dic	PROPN
ctmj-186	33	29	.	.	PUNCT
ctmj-186	33	30	materials	material	NOUN
ctmj-186	33	31	and	and	CCONJ
ctmj-186	33	32	methods	method	NOUN
ctmj-186	33	33	animals	animal	NOUN
ctmj-186	33	34	specific	specific	ADJ
ctmj-186	33	35	pathogen‑free	pathogen‑free	PROPN
ctmj-186	33	36	(	(	PUNCT
ctmj-186	33	37	spf	spf	ADJ
ctmj-186	33	38	)	)	PUNCT
ctmj-186	33	39	male	male	NOUN
ctmj-186	33	40	kunming	kunming	NOUN
ctmj-186	33	41	mice	mouse	NOUN
ctmj-186	33	42	,	,	PUNCT
ctmj-186	33	43	weighing	weigh	VERB
ctmj-186	33	44	20	20	NUM
ctmj-186	33	45	±	±	NUM
ctmj-186	33	46	2	2	NUM
ctmj-186	33	47	g	g	NOUN
ctmj-186	33	48	,	,	PUNCT
ctmj-186	33	49	were	be	AUX
ctmj-186	33	50	purchased	purchase	VERB
ctmj-186	33	51	from	from	ADP
ctmj-186	33	52	the	the	DET
ctmj-186	33	53	beijing	beijing	PROPN
ctmj-186	33	54	weitong	weitong	PROPN
ctmj-186	33	55	lihua	lihua	PROPN
ctmj-186	33	56	experimental	experimental	PROPN
ctmj-186	33	57	animal	animal	PROPN
ctmj-186	33	58	technology	technology	PROPN
ctmj-186	33	59	co.	co.	PROPN
ctmj-186	33	60	,	,	PUNCT
ctmj-186	33	61	ltd	ltd	PROPN
ctmj-186	33	62	.	.	PROPN
ctmj-186	33	63	(	(	PUNCT
ctmj-186	33	64	animal	animal	NOUN
ctmj-186	33	65	certificate	certificate	NOUN
ctmj-186	33	66	number	number	NOUN
ctmj-186	33	67	:	:	PUNCT
ctmj-186	33	68	110011110698978	110011110698978	NUM
ctmj-186	33	69	)	)	PUNCT
ctmj-186	33	70	.	.	PUNCT
ctmj-186	34	1	spf	spf	ADJ
ctmj-186	34	2	male	male	ADJ
ctmj-186	34	3	sprague	sprague	NOUN
ctmj-186	34	4	–	–	PUNCT
ctmj-186	34	5	dawley	dawley	NOUN
ctmj-186	34	6	rats	rat	NOUN
ctmj-186	34	7	,	,	PUNCT
ctmj-186	34	8	weighing	weigh	VERB
ctmj-186	34	9	200	200	NUM
ctmj-186	34	10	±	±	NUM
ctmj-186	34	11	20	20	NUM
ctmj-186	34	12	g	g	NOUN
ctmj-186	34	13	,	,	PUNCT
ctmj-186	34	14	were	be	AUX
ctmj-186	34	15	purchased	purchase	VERB
ctmj-186	34	16	from	from	ADP
ctmj-186	34	17	the	the	DET
ctmj-186	34	18	beijing	beijing	PROPN
ctmj-186	34	19	vital	vital	PROPN
ctmj-186	34	20	river	river	PROPN
ctmj-186	34	21	laboratory	laboratory	NOUN
ctmj-186	34	22	animal	animal	NOUN
ctmj-186	34	23	technology	technology	PROPN
ctmj-186	34	24	co.	co.	PROPN
ctmj-186	34	25	,	,	PUNCT
ctmj-186	34	26	ltd	ltd	PROPN
ctmj-186	34	27	(	(	PUNCT
ctmj-186	34	28	animal	animal	NOUN
ctmj-186	34	29	certificate	certificate	NOUN
ctmj-186	34	30	number	number	NOUN
ctmj-186	34	31	:	:	PUNCT
ctmj-186	34	32	110011211104397472	110011211104397472	NUM
ctmj-186	34	33	)	)	PUNCT
ctmj-186	34	34	.	.	PUNCT
ctmj-186	35	1	the	the	DET
ctmj-186	35	2	animals	animal	NOUN
ctmj-186	35	3	were	be	AUX
ctmj-186	35	4	fed	feed	VERB
ctmj-186	35	5	using	use	VERB
ctmj-186	35	6	the	the	DET
ctmj-186	35	7	tianjin	tianjin	NOUN
ctmj-186	35	8	tasly	tasly	ADV
ctmj-186	35	9	proud	proud	ADJ
ctmj-186	35	10	pharmaceutical	pharmaceutical	PROPN
ctmj-186	35	11	co.	co.	PROPN
ctmj-186	35	12	,	,	PUNCT
ctmj-186	35	13	ltd	ltd	PROPN
ctmj-186	35	14	.	.	PROPN
ctmj-186	35	15	animal	animal	NOUN
ctmj-186	35	16	barrier	barrier	NOUN
ctmj-186	35	17	system	system	NOUN
ctmj-186	35	18	(	(	PUNCT
ctmj-186	35	19	facility	facility	NOUN
ctmj-186	35	20	license	license	NOUN
ctmj-186	35	21	:	:	PUNCT
ctmj-186	35	22	syxk	syxk	NOUN
ctmj-186	35	23	(	(	PUNCT
ctmj-186	35	24	tianjin	tianjin	PROPN
ctmj-186	35	25	)	)	PUNCT
ctmj-186	35	26	2017	2017	NUM
ctmj-186	35	27	-	-	SYM
ctmj-186	35	28	0006	0006	NUM
ctmj-186	35	29	)	)	PUNCT
ctmj-186	35	30	.	.	PUNCT
ctmj-186	36	1	they	they	PRON
ctmj-186	36	2	were	be	AUX
ctmj-186	36	3	adapted	adapt	VERB
ctmj-186	36	4	to	to	ADP
ctmj-186	36	5	feeding	feed	VERB
ctmj-186	36	6	for	for	ADP
ctmj-186	36	7	3	3	NUM
ctmj-186	36	8	days	day	NOUN
ctmj-186	36	9	,	,	PUNCT
ctmj-186	36	10	during	during	ADP
ctmj-186	36	11	which	which	PRON
ctmj-186	36	12	their	their	PRON
ctmj-186	36	13	weight	weight	NOUN
ctmj-186	36	14	,	,	PUNCT
ctmj-186	36	15	head	head	NOUN
ctmj-186	36	16	,	,	PUNCT
ctmj-186	36	17	and	and	CCONJ
ctmj-186	36	18	torso	torso	NOUN
ctmj-186	36	19	conditions	condition	NOUN
ctmj-186	36	20	,	,	PUNCT
ctmj-186	36	21	and	and	CCONJ
ctmj-186	36	22	activity	activity	NOUN
ctmj-186	36	23	levels	level	NOUN
ctmj-186	36	24	were	be	AUX
ctmj-186	36	25	monitored	monitor	VERB
ctmj-186	36	26	.	.	PUNCT
ctmj-186	37	1	the	the	DET
ctmj-186	37	2	present	present	ADJ
ctmj-186	37	3	study	study	NOUN
ctmj-186	37	4	was	be	AUX
ctmj-186	37	5	approved	approve	VERB
ctmj-186	37	6	by	by	ADP
ctmj-186	37	7	the	the	DET
ctmj-186	37	8	committee	committee	NOUN
ctmj-186	37	9	on	on	ADP
ctmj-186	37	10	animal	animal	NOUN
ctmj-186	37	11	experimentation	experimentation	NOUN
ctmj-186	37	12	of	of	ADP
ctmj-186	37	13	the	the	DET
ctmj-186	37	14	tasly	tasly	ADV
ctmj-186	37	15	academy	academy	NOUN
ctmj-186	37	16	(	(	PUNCT
ctmj-186	37	17	ethics	ethic	NOUN
ctmj-186	37	18	approval	approval	PROPN
ctmj-186	37	19	code	code	PROPN
ctmj-186	37	20	:	:	PUNCT
ctmj-186	37	21	tsl‑iacuc‑2020‑19	tsl‑iacuc‑2020‑19	NOUN
ctmj-186	37	22	,	,	PUNCT
ctmj-186	37	23	tsl‑	tsl‑	PUNCT
ctmj-186	37	24	iacuc‑2020‑20	iacuc‑2020‑20	X
ctmj-186	37	25	)	)	PUNCT
ctmj-186	37	26	.	.	PUNCT
ctmj-186	38	1	apparatus	apparatus	NOUN
ctmj-186	38	2	and	and	CCONJ
ctmj-186	38	3	reagents	reagent	NOUN
ctmj-186	38	4	the	the	DET
ctmj-186	38	5	tool	tool	NOUN
ctmj-186	38	6	the	the	DET
ctmj-186	38	7	following	follow	VERB
ctmj-186	38	8	instruments	instrument	NOUN
ctmj-186	38	9	were	be	AUX
ctmj-186	38	10	used	use	VERB
ctmj-186	38	11	:	:	PUNCT
ctmj-186	38	12	a	a	DET
ctmj-186	38	13	laser	laser	NOUN
ctmj-186	38	14	speckle	speckle	NOUN
ctmj-186	38	15	blood	blood	NOUN
ctmj-186	38	16	flow	flow	NOUN
ctmj-186	38	17	imaging	imaging	NOUN
ctmj-186	38	18	system	system	NOUN
ctmj-186	38	19	(	(	PUNCT
ctmj-186	38	20	moorflpi-2	moorflpi-2	PROPN
ctmj-186	38	21	)	)	PUNCT
ctmj-186	38	22	,	,	PUNCT
ctmj-186	38	23	a	a	DET
ctmj-186	38	24	semiautomatic	semiautomatic	ADJ
ctmj-186	38	25	coagulation	coagulation	NOUN
ctmj-186	38	26	analyzer	analyzer	NOUN
ctmj-186	38	27	(	(	PUNCT
ctmj-186	38	28	siddhi	siddhi	NOUN
ctmj-186	38	29	scientific	scientific	ADJ
ctmj-186	38	30	instruments	instrument	NOUN
ctmj-186	38	31	,	,	PUNCT
ctmj-186	38	32	lg	lg	NOUN
ctmj-186	38	33	-	-	NOUN
ctmj-186	38	34	paber	paber	NOUN
ctmj-186	38	35	-	-	PUNCT
ctmj-186	38	36	i	i	PROPN
ctmj-186	38	37	)	)	PUNCT
ctmj-186	38	38	,	,	PUNCT
ctmj-186	38	39	a	a	DET
ctmj-186	38	40	microplate	microplate	NOUN
ctmj-186	38	41	reader	reader	NOUN
ctmj-186	38	42	(	(	PUNCT
ctmj-186	38	43	tecan	tecan	ADJ
ctmj-186	38	44	,	,	PUNCT
ctmj-186	38	45	infinite	infinite	ADJ
ctmj-186	38	46	m200	m200	PROPN
ctmj-186	38	47	)	)	PUNCT
ctmj-186	38	48	,	,	PUNCT
ctmj-186	38	49	an	an	DET
ctmj-186	38	50	automatic	automatic	ADJ
ctmj-186	38	51	biochemical	biochemical	ADJ
ctmj-186	38	52	analyzer	analyzer	NOUN
ctmj-186	38	53	(	(	PUNCT
ctmj-186	38	54	hitachi	hitachi	PROPN
ctmj-186	38	55	7020	7020	NUM
ctmj-186	38	56	)	)	PUNCT
ctmj-186	38	57	,	,	PUNCT
ctmj-186	38	58	a	a	DET
ctmj-186	38	59	fragment	fragment	ADJ
ctmj-186	38	60	analyze	analyze	NOUN
ctmj-186	38	61	biological	biological	ADJ
ctmj-186	38	62	analyzer	analyzer	NOUN
ctmj-186	38	63	(	(	PUNCT
ctmj-186	38	64	thermo	thermo	NOUN
ctmj-186	38	65	,	,	PUNCT
ctmj-186	38	66	fsv2	fsv2	PROPN
ctmj-186	38	67	-	-	PUNCT
ctmj-186	38	68	ce	ce	PROPN
ctmj-186	38	69	)	)	PUNCT
ctmj-186	38	70	,	,	PUNCT
ctmj-186	38	71	a	a	DET
ctmj-186	38	72	gene	gene	NOUN
ctmj-186	38	73	sequencing	sequence	VERB
ctmj-186	38	74	instrument	instrument	NOUN
ctmj-186	38	75	(	(	PUNCT
ctmj-186	38	76	shenzhen	shenzhen	PROPN
ctmj-186	38	77	huada	huada	PROPN
ctmj-186	38	78	,	,	PUNCT
ctmj-186	38	79	dnbseq	dnbseq	NOUN
ctmj-186	38	80	-	-	PUNCT
ctmj-186	38	81	t7	t7	NOUN
ctmj-186	38	82	)	)	PUNCT
ctmj-186	38	83	,	,	PUNCT
ctmj-186	38	84	a	a	DET
ctmj-186	38	85	qpcr	qpcr	ADJ
ctmj-186	38	86	instrument	instrument	NOUN
ctmj-186	38	87	(	(	PUNCT
ctmj-186	38	88	analytik	analytik	PROPN
ctmj-186	38	89	jena	jena	PROPN
ctmj-186	38	90	,	,	PUNCT
ctmj-186	38	91	qtower3	qtower3	NOUN
ctmj-186	38	92	g	g	NOUN
ctmj-186	38	93	)	)	PUNCT
ctmj-186	38	94	,	,	PUNCT
ctmj-186	38	95	and	and	CCONJ
ctmj-186	38	96	a	a	DET
ctmj-186	38	97	chemiluminescence	chemiluminescence	NOUN
ctmj-186	38	98	imager	imager	NOUN
ctmj-186	38	99	(	(	PUNCT
ctmj-186	38	100	shanghai	shanghai	PROPN
ctmj-186	38	101	qianxiang	qianxiang	PROPN
ctmj-186	38	102	,	,	PUNCT
ctmj-186	38	103	chemiscope6200	chemiscope6200	PROPN
ctmj-186	38	104	)	)	PUNCT
ctmj-186	38	105	.	.	PUNCT
ctmj-186	39	1	chemicals	chemical	NOUN
ctmj-186	39	2	and	and	CCONJ
ctmj-186	39	3	substances	substance	NOUN
ctmj-186	39	4	the	the	DET
ctmj-186	39	5	drug	drug	NOUN
ctmj-186	39	6	and	and	CCONJ
ctmj-186	39	7	reagents	reagent	NOUN
ctmj-186	39	8	used	use	VERB
ctmj-186	39	9	were	be	AUX
ctmj-186	39	10	:	:	PUNCT
ctmj-186	39	11	cddp	cddp	PROPN
ctmj-186	39	12	(	(	PUNCT
ctmj-186	39	13	tasly	tasly	ADV
ctmj-186	39	14	,	,	PUNCT
ctmj-186	39	15	190117	190117	NUM
ctmj-186	39	16	)	)	PUNCT
ctmj-186	39	17	,	,	PUNCT
ctmj-186	39	18	nadroparin	nadroparin	ADJ
ctmj-186	39	19	calcium	calcium	NOUN
ctmj-186	39	20	injection	injection	NOUN
ctmj-186	39	21	(	(	PUNCT
ctmj-186	39	22	aspen	aspen	NOUN
ctmj-186	39	23	,	,	PUNCT
ctmj-186	39	24	5325b	5325b	NUM
ctmj-186	39	25	)	)	PUNCT
ctmj-186	39	26	,	,	PUNCT
ctmj-186	39	27	high	high	ADJ
ctmj-186	39	28	molecular	molecular	ADJ
ctmj-186	39	29	dextran	dextran	NOUN
ctmj-186	39	30	(	(	PUNCT
ctmj-186	39	31	h20m10b88790	h20m10b88790	NOUN
ctmj-186	39	32	)	)	PUNCT
ctmj-186	39	33	,	,	PUNCT
ctmj-186	39	34	ulcerose	ulcerose	VERB
ctmj-186	39	35	(	(	PUNCT
ctmj-186	39	36	t20100310	t20100310	ADJ
ctmj-186	39	37	)	)	PUNCT
ctmj-186	39	38	,	,	PUNCT
ctmj-186	39	39	sodium	sodium	NOUN
ctmj-186	39	40	chloride	chloride	NOUN
ctmj-186	39	41	injection	injection	NOUN
ctmj-186	39	42	(	(	PUNCT
ctmj-186	39	43	2012174c	2012174c	NUM
ctmj-186	39	44	)	)	PUNCT
ctmj-186	39	45	,	,	PUNCT
ctmj-186	39	46	lipopolysaccharide	lipopolysaccharide	PROPN
ctmj-186	39	47	(	(	PUNCT
ctmj-186	39	48	lps	lps	PROPN
ctmj-186	39	49	;	;	PUNCT
ctmj-186	39	50	sigma	sigma	PROPN
ctmj-186	39	51	,	,	PUNCT
ctmj-186	39	52	0000081275	0000081275	NUM
ctmj-186	39	53	)	)	PUNCT
ctmj-186	39	54	,	,	PUNCT
ctmj-186	39	55	prothrombin	prothrombin	NOUN
ctmj-186	39	56	time	time	NOUN
ctmj-186	39	57	detection	detection	NOUN
ctmj-186	39	58	kit	kit	NOUN
ctmj-186	39	59	(	(	PUNCT
ctmj-186	39	60	taizhou	taizhou	PROPN
ctmj-186	39	61	zhongqin	zhongqin	PROPN
ctmj-186	39	62	,	,	PUNCT
ctmj-186	39	63	sty20101	sty20101	PROPN
ctmj-186	39	64	-	-	PUNCT
ctmj-186	39	65	41	41	NUM
ctmj-186	39	66	-	-	PUNCT
ctmj-186	39	67	9	9	NUM
ctmj-186	39	68	)	)	PUNCT
ctmj-186	39	69	,	,	PUNCT
ctmj-186	39	70	and	and	CCONJ
ctmj-186	39	71	fibrinogen	fibrinogen	NOUN
ctmj-186	39	72	(	(	PUNCT
ctmj-186	39	73	fib	fib	NOUN
ctmj-186	39	74	)	)	PUNCT
ctmj-186	39	75	determination	determination	NOUN
ctmj-186	39	76	kit	kit	NOUN
ctmj-186	39	77	(	(	PUNCT
ctmj-186	39	78	taizhou	taizhou	PROPN
ctmj-186	39	79	zhongqin	zhongqin	PROPN
ctmj-186	39	80	,	,	PUNCT
ctmj-186	39	81	sty20401	sty20401	NOUN
ctmj-186	39	82	-	-	PUNCT
ctmj-186	39	83	39	39	NUM
ctmj-186	39	84	-	-	SYM
ctmj-186	39	85	5	5	NUM
ctmj-186	39	86	)	)	PUNCT
ctmj-186	39	87	.	.	PUNCT
ctmj-186	40	1	rat	rat	NOUN
ctmj-186	40	2	interleukin-10	interleukin-10	PROPN
ctmj-186	40	3	(	(	PUNCT
ctmj-186	40	4	il-10	il-10	PRON
ctmj-186	40	5	)	)	PUNCT
ctmj-186	40	6	enzyme	enzyme	NOUN
ctmj-186	40	7	-	-	PUNCT
ctmj-186	40	8	linked	link	VERB
ctmj-186	40	9	immunosorbent	immunosorbent	NOUN
ctmj-186	40	10	assay	assay	PROPN
ctmj-186	40	11	(	(	PUNCT
ctmj-186	40	12	elisa	elisa	NOUN
ctmj-186	40	13	)	)	PUNCT
ctmj-186	40	14	kit	kit	NOUN
ctmj-186	40	15	(	(	PUNCT
ctmj-186	40	16	shanghai	shanghai	PROPN
ctmj-186	40	17	enzyme	enzyme	NOUN
ctmj-186	40	18	-	-	PUNCT
ctmj-186	40	19	linked	link	VERB
ctmj-186	40	20	,	,	PUNCT
ctmj-186	40	21	nov	nov	PROPN
ctmj-186	40	22	2020	2020	NUM
ctmj-186	40	23	)	)	PUNCT
ctmj-186	40	24	,	,	PUNCT
ctmj-186	40	25	rat	rat	NOUN
ctmj-186	40	26	tumour	tumour	NOUN
ctmj-186	40	27	necrosis	necrosis	NOUN
ctmj-186	40	28	factoralpha	factoralpha	NOUN
ctmj-186	40	29	(	(	PUNCT
ctmj-186	40	30	tnf-	tnf-	NOUN
ctmj-186	40	31	)	)	PUNCT
ctmj-186	40	32	elisa	elisa	NOUN
ctmj-186	40	33	kit	kit	NOUN
ctmj-186	40	34	(	(	PUNCT
ctmj-186	40	35	shanghai	shanghai	PROPN
ctmj-186	40	36	enzyme	enzyme	NOUN
ctmj-186	40	37	-	-	PUNCT
ctmj-186	40	38	linked	link	VERB
ctmj-186	40	39	,	,	PUNCT
ctmj-186	40	40	nov	nov	PROPN
ctmj-186	40	41	2020	2020	NUM
ctmj-186	40	42	)	)	PUNCT
ctmj-186	40	43	,	,	PUNCT
ctmj-186	40	44	glutamic	glutamic	ADJ
ctmj-186	40	45	pyruvic	pyruvic	ADJ
ctmj-186	40	46	transaminase	transaminase	NOUN
ctmj-186	40	47	(	(	PUNCT
ctmj-186	40	48	gpt	gpt	NOUN
ctmj-186	40	49	)	)	PUNCT
ctmj-186	40	50	test	test	NOUN
ctmj-186	40	51	kit	kit	NOUN
ctmj-186	40	52	(	(	PUNCT
ctmj-186	40	53	nanjing	nanjing	PROPN
ctmj-186	40	54	jiancheng	jiancheng	PROPN
ctmj-186	40	55	,	,	PUNCT
ctmj-186	40	56	20210305	20210305	NUM
ctmj-186	40	57	)	)	PUNCT
ctmj-186	40	58	,	,	PUNCT
ctmj-186	40	59	glutamic	glutamic	ADJ
ctmj-186	40	60	oxaloacetic	oxaloacetic	ADJ
ctmj-186	40	61	transaminase	transaminase	NOUN
ctmj-186	40	62	(	(	PUNCT
ctmj-186	40	63	got	got	NOUN
ctmj-186	40	64	)	)	PUNCT
ctmj-186	40	65	test	test	NOUN
ctmj-186	40	66	kit	kit	NOUN
ctmj-186	40	67	(	(	PUNCT
ctmj-186	40	68	nanjing	nanjing	PROPN
ctmj-186	40	69	jiancheng	jiancheng	PROPN
ctmj-186	40	70	,	,	PUNCT
ctmj-186	40	71	20210304	20210304	NUM
ctmj-186	40	72	)	)	PUNCT
ctmj-186	40	73	,	,	PUNCT
ctmj-186	40	74	creatinine	creatinine	NOUN
ctmj-186	40	75	(	(	PUNCT
ctmj-186	40	76	cr	cr	NOUN
ctmj-186	40	77	)	)	PUNCT
ctmj-186	40	78	test	test	NOUN
ctmj-186	40	79	kit	kit	NOUN
ctmj-186	40	80	(	(	PUNCT
ctmj-186	40	81	nanjing	nanjing	PROPN
ctmj-186	40	82	jiancheng	jiancheng	PROPN
ctmj-186	40	83	,	,	PUNCT
ctmj-186	40	84	20210304	20210304	NUM
ctmj-186	40	85	)	)	PUNCT
ctmj-186	40	86	,	,	PUNCT
ctmj-186	40	87	transzol	transzol	VERB
ctmj-186	40	88	(	(	PUNCT
ctmj-186	40	89	beijing	beijing	PROPN
ctmj-186	40	90	transgen	transgen	PROPN
ctmj-186	40	91	et111	et111	PROPN
ctmj-186	40	92	-	-	PROPN
ctmj-186	40	93	01	01	NUM
ctmj-186	40	94	)	)	PUNCT
ctmj-186	40	95	,	,	PUNCT
ctmj-186	40	96	reverse	reverse	VERB
ctmj-186	40	97	transcription	transcription	NOUN
ctmj-186	40	98	kit	kit	NOUN
ctmj-186	40	99	(	(	PUNCT
ctmj-186	40	100	takara	takara	PROPN
ctmj-186	40	101	,	,	PUNCT
ctmj-186	40	102	rr047a	rr047a	PROPN
ctmj-186	40	103	)	)	PUNCT
ctmj-186	40	104	.	.	PUNCT
ctmj-186	41	1	research	research	NOUN
ctmj-186	41	2	techniques	technique	NOUN
ctmj-186	41	3	how	how	SCONJ
ctmj-186	41	4	the	the	DET
ctmj-186	41	5	danshen	danshen	ADJ
ctmj-186	41	6	dripping	dripping	ADJ
ctmj-186	41	7	tablet	tablet	NOUN
ctmj-186	41	8	composition	composition	NOUN
ctmj-186	41	9	affects	affect	VERB
ctmj-186	41	10	the	the	DET
ctmj-186	41	11	survival	survival	NOUN
ctmj-186	41	12	rate	rate	NOUN
ctmj-186	41	13	of	of	ADP
ctmj-186	41	14	rats	rat	NOUN
ctmj-186	41	15	stimulated	stimulate	VERB
ctmj-186	41	16	with	with	ADP
ctmj-186	41	17	lipopolysaccharide	lipopolysaccharide	ADJ
ctmj-186	41	18	?	?	PUNCT
ctmj-186	42	1	intraperitoneal	intraperitoneal	ADJ
ctmj-186	42	2	injection	injection	NOUN
ctmj-186	42	3	of	of	ADP
ctmj-186	42	4	lps	lps	PROPN
ctmj-186	42	5	into	into	ADP
ctmj-186	42	6	rats	rat	NOUN
ctmj-186	42	7	allowed	allow	VERB
ctmj-186	42	8	researchers	researcher	NOUN
ctmj-186	42	9	to	to	PART
ctmj-186	42	10	reproduce	reproduce	VERB
ctmj-186	42	11	the	the	DET
ctmj-186	42	12	mouse	mouse	NOUN
ctmj-186	42	13	model	model	NOUN
ctmj-186	42	14	of	of	ADP
ctmj-186	42	15	dic	dic	PROPN
ctmj-186	42	16	.	.	PUNCT
ctmj-186	43	1	there	there	PRON
ctmj-186	43	2	were	be	VERB
ctmj-186	43	3	three	three	NUM
ctmj-186	43	4	sets	set	NOUN
ctmj-186	43	5	of	of	ADP
ctmj-186	43	6	animals	animal	NOUN
ctmj-186	43	7	used	use	VERB
ctmj-186	43	8	as	as	ADP
ctmj-186	43	9	models	model	NOUN
ctmj-186	43	10	:	:	PUNCT
ctmj-186	43	11	those	those	PRON
ctmj-186	43	12	given	give	VERB
ctmj-186	43	13	cddp	cddp	NOUN
ctmj-186	43	14	-	-	PUNCT
ctmj-186	43	15	h	h	PROPN
ctmj-186	43	16	(	(	PUNCT
ctmj-186	43	17	1660	1660	NUM
ctmj-186	43	18	mg	mg	PROPN
ctmj-186	43	19	/	/	SYM
ctmj-186	43	20	kg	kg	PROPN
ctmj-186	43	21	)	)	PUNCT
ctmj-186	43	22	,	,	PUNCT
ctmj-186	43	23	those	those	PRON
ctmj-186	43	24	given	give	VERB
ctmj-186	43	25	cddp	cddp	NOUN
ctmj-186	43	26	-	-	PUNCT
ctmj-186	43	27	l	l	NOUN
ctmj-186	43	28	(	(	PUNCT
ctmj-186	43	29	830	830	NUM
ctmj-186	43	30	mg	mg	NUM
ctmj-186	43	31	/	/	SYM
ctmj-186	43	32	kg	kg	PROPN
ctmj-186	43	33	)	)	PUNCT
ctmj-186	43	34	,	,	PUNCT
ctmj-186	43	35	and	and	CCONJ
ctmj-186	43	36	those	those	PRON
ctmj-186	43	37	given	give	VERB
ctmj-186	43	38	nadroparin	nadroparin	ADJ
ctmj-186	43	39	calcium	calcium	NOUN
ctmj-186	43	40	(	(	PUNCT
ctmj-186	43	41	500	500	NUM
ctmj-186	43	42	iu	iu	NOUN
ctmj-186	43	43	/	/	SYM
ctmj-186	43	44	kg	kg	NOUN
ctmj-186	43	45	)	)	PUNCT
ctmj-186	43	46	.	.	PUNCT
ctmj-186	44	1	in	in	ADP
ctmj-186	44	2	order	order	NOUN
ctmj-186	44	3	to	to	PART
ctmj-186	44	4	mimic	mimic	VERB
ctmj-186	44	5	the	the	DET
ctmj-186	44	6	dic	dic	PROPN
ctmj-186	44	7	model	model	NOUN
ctmj-186	44	8	,	,	PUNCT
ctmj-186	44	9	35	35	NUM
ctmj-186	44	10	mg	mg	NUM
ctmj-186	44	11	/	/	SYM
ctmj-186	44	12	kg	kg	NOUN
ctmj-186	44	13	of	of	ADP
ctmj-186	44	14	lps	lps	PROPN
ctmj-186	44	15	was	be	AUX
ctmj-186	44	16	intraperitoneally	intraperitoneally	ADV
ctmj-186	44	17	administered	administer	VERB
ctmj-186	44	18	into	into	ADP
ctmj-186	44	19	all	all	DET
ctmj-186	44	20	groups	group	NOUN
ctmj-186	44	21	of	of	ADP
ctmj-186	44	22	mice	mouse	NOUN
ctmj-186	44	23	except	except	SCONJ
ctmj-186	44	24	the	the	DET
ctmj-186	44	25	control	control	NOUN
ctmj-186	44	26	group	group	NOUN
ctmj-186	44	27	.	.	PUNCT
ctmj-186	45	1	after	after	ADP
ctmj-186	45	2	modeling	modeling	NOUN
ctmj-186	45	3	,	,	PUNCT
ctmj-186	45	4	mice	mouse	NOUN
ctmj-186	45	5	in	in	ADP
ctmj-186	45	6	the	the	DET
ctmj-186	45	7	model	model	NOUN
ctmj-186	45	8	group	group	NOUN
ctmj-186	45	9	received	receive	VERB
ctmj-186	45	10	10	10	NUM
ctmj-186	45	11	ml	ml	NOUN
ctmj-186	45	12	/	/	SYM
ctmj-186	45	13	kg	kg	NOUN
ctmj-186	45	14	of	of	ADP
ctmj-186	45	15	pure	pure	ADJ
ctmj-186	45	16	water	water	NOUN
ctmj-186	45	17	;	;	PUNCT
ctmj-186	45	18	mice	mouse	NOUN
ctmj-186	45	19	in	in	ADP
ctmj-186	45	20	the	the	DET
ctmj-186	45	21	cddp	cddp	PROPN
ctmj-186	45	22	group	group	NOUN
ctmj-186	45	23	received	receive	VERB
ctmj-186	45	24	the	the	DET
ctmj-186	45	25	indicated	indicate	VERB
ctmj-186	45	26	doses	dose	NOUN
ctmj-186	45	27	of	of	ADP
ctmj-186	45	28	cddp	cddp	PROPN
ctmj-186	45	29	intragastrically	intragastrically	ADV
ctmj-186	45	30	;	;	PUNCT
ctmj-186	45	31	and	and	CCONJ
ctmj-186	45	32	mice	mouse	NOUN
ctmj-186	45	33	in	in	ADP
ctmj-186	45	34	the	the	DET
ctmj-186	45	35	nadroparin	nadroparin	PROPN
ctmj-186	45	36	calcium	calcium	NOUN
ctmj-186	45	37	group	group	NOUN
ctmj-186	45	38	received	receive	VERB
ctmj-186	45	39	500	500	NUM
ctmj-186	45	40	iu	iu	NOUN
ctmj-186	45	41	/	/	SYM
ctmj-186	45	42	kg	kg	PROPN
ctmj-186	45	43	of	of	ADP
ctmj-186	45	44	nadroparin	nadroparin	ADJ
ctmj-186	45	45	calcium	calcium	NOUN
ctmj-186	45	46	subcutaneously	subcutaneously	ADV
ctmj-186	45	47	.	.	PUNCT
ctmj-186	46	1	at	at	ADP
ctmj-186	46	2	72	72	NUM
ctmj-186	46	3	hours	hour	NOUN
ctmj-186	46	4	post	post	ADJ
ctmj-186	46	5	-	-	ADJ
ctmj-186	46	6	modeling	modeling	ADJ
ctmj-186	46	7	,	,	PUNCT
ctmj-186	46	8	we	we	PRON
ctmj-186	46	9	measured	measure	VERB
ctmj-186	46	10	the	the	DET
ctmj-186	46	11	survival	survival	NOUN
ctmj-186	46	12	rate	rate	NOUN
ctmj-186	46	13	of	of	ADP
ctmj-186	46	14	each	each	DET
ctmj-186	46	15	group	group	NOUN
ctmj-186	46	16	of	of	ADP
ctmj-186	46	17	experimental	experimental	ADJ
ctmj-186	46	18	animals	animal	NOUN
ctmj-186	46	19	.	.	PUNCT
ctmj-186	47	1	effect	effect	NOUN
ctmj-186	47	2	of	of	ADP
ctmj-186	47	3	compound	compound	NOUN
ctmj-186	47	4	danshen	danshen	NOUN
ctmj-186	47	5	dripping	dripping	ADJ
ctmj-186	47	6	pill	pill	NOUN
ctmj-186	47	7	on	on	ADP
ctmj-186	47	8	dextran‑	dextran‑	NOUN
ctmj-186	47	9	induced	induce	VERB
ctmj-186	47	10	microcirculatory	microcirculatory	ADJ
ctmj-186	47	11	disturbance	disturbance	NOUN
ctmj-186	47	12	the	the	DET
ctmj-186	47	13	rat	rat	NOUN
ctmj-186	47	14	model	model	NOUN
ctmj-186	47	15	of	of	ADP
ctmj-186	47	16	dic	dic	ADJ
ctmj-186	47	17	microcirculation	microcirculation	NOUN
ctmj-186	47	18	disorder	disorder	NOUN
ctmj-186	47	19	was	be	AUX
ctmj-186	47	20	established	establish	VERB
ctmj-186	47	21	by	by	ADP
ctmj-186	47	22	injecting	inject	VERB
ctmj-186	47	23	10	10	NUM
ctmj-186	47	24	%	%	NOUN
ctmj-186	47	25	dextran	dextran	NOUN
ctmj-186	47	26	t500	t500	PROPN
ctmj-186	47	27	into	into	ADP
ctmj-186	47	28	the	the	DET
ctmj-186	47	29	tail	tail	NOUN
ctmj-186	47	30	vein	vein	NOUN
ctmj-186	47	31	.	.	PUNCT
ctmj-186	48	1	the	the	DET
ctmj-186	48	2	rats	rat	NOUN
ctmj-186	48	3	were	be	AUX
ctmj-186	48	4	divided	divide	VERB
ctmj-186	48	5	into	into	ADP
ctmj-186	48	6	the	the	DET
ctmj-186	48	7	control	control	NOUN
ctmj-186	48	8	,	,	PUNCT
ctmj-186	48	9	model	model	NOUN
ctmj-186	48	10	,	,	PUNCT
ctmj-186	48	11	cddp‑h	cddp‑h	X
ctmj-186	48	12	(	(	PUNCT
ctmj-186	48	13	830	830	NUM
ctmj-186	48	14	mg	mg	NUM
ctmj-186	48	15	/	/	SYM
ctmj-186	48	16	kg	kg	PROPN
ctmj-186	48	17	)	)	PUNCT
ctmj-186	48	18	,	,	PUNCT
ctmj-186	48	19	cddp‑l	cddp‑l	ADP
ctmj-186	48	20	(	(	PUNCT
ctmj-186	48	21	415	415	NUM
ctmj-186	48	22	mg	mg	NUM
ctmj-186	48	23	/	/	SYM
ctmj-186	48	24	kg	kg	NOUN
ctmj-186	48	25	)	)	PUNCT
ctmj-186	48	26	,	,	PUNCT
ctmj-186	48	27	and	and	CCONJ
ctmj-186	48	28	nadroparin	nadroparin	ADJ
ctmj-186	48	29	calcium	calcium	NOUN
ctmj-186	48	30	(	(	PUNCT
ctmj-186	48	31	500	500	NUM
ctmj-186	48	32	iu	iu	PROPN
ctmj-186	48	33	/	/	SYM
ctmj-186	48	34	kg	kg	NOUN
ctmj-186	48	35	)	)	PUNCT
ctmj-186	48	36	groups	group	NOUN
ctmj-186	48	37	.	.	PUNCT
ctmj-186	49	1	different	different	ADJ
ctmj-186	49	2	doses	dose	NOUN
ctmj-186	49	3	of	of	ADP
ctmj-186	49	4	cddp	cddp	PROPN
ctmj-186	49	5	were	be	AUX
ctmj-186	49	6	administered	administer	VERB
ctmj-186	49	7	by	by	ADP
ctmj-186	49	8	gavage	gavage	NOUN
ctmj-186	49	9	ctmj	ctmj	NOUN
ctmj-186	49	10	|	|	ADV
ctmj-186	49	11	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-186	49	12	chinese	chinese	ADJ
ctmj-186	49	13	traditional	traditional	ADJ
ctmj-186	49	14	medicine	medicine	NOUN
ctmj-186	49	15	journal	journal	NOUN
ctmj-186	49	16	|	|	ADV
ctmj-186	49	17	2025	2025	NUM
ctmj-186	49	18	|	|	ADV
ctmj-186	49	19	vol	vol	NOUN
ctmj-186	49	20	8	8	NUM
ctmj-186	49	21	|issue	|issue	NOUN
ctmj-186	49	22	1	1	NUM
ctmj-186	49	23	24	24	NUM
ctmj-186	49	24	1.5	1.5	NUM
ctmj-186	49	25	h	h	NOUN
ctmj-186	49	26	before	before	SCONJ
ctmj-186	49	27	the	the	DET
ctmj-186	49	28	model	model	NOUN
ctmj-186	49	29	was	be	AUX
ctmj-186	49	30	replicated	replicate	VERB
ctmj-186	49	31	.	.	PUNCT
ctmj-186	50	1	blood	blood	NOUN
ctmj-186	50	2	perfusion	perfusion	NOUN
ctmj-186	50	3	of	of	ADP
ctmj-186	50	4	the	the	DET
ctmj-186	50	5	rat	rat	NOUN
ctmj-186	50	6	liver	liver	NOUN
ctmj-186	50	7	and	and	CCONJ
ctmj-186	50	8	gastric	gastric	ADJ
ctmj-186	50	9	fundus	fundus	NOUN
ctmj-186	50	10	was	be	AUX
ctmj-186	50	11	detected	detect	VERB
ctmj-186	50	12	using	use	VERB
ctmj-186	50	13	the	the	DET
ctmj-186	50	14	moor	moor	ADJ
ctmj-186	50	15	flpi‑2	flpi‑2	PROPN
ctmj-186	50	16	laser	laser	NOUN
ctmj-186	50	17	speckle	speckle	NOUN
ctmj-186	50	18	blood	blood	NOUN
ctmj-186	50	19	flow	flow	NOUN
ctmj-186	50	20	imaging	imaging	NOUN
ctmj-186	50	21	system	system	NOUN
ctmj-186	50	22	10	10	NUM
ctmj-186	50	23	min	min	NOUN
ctmj-186	50	24	before	before	ADP
ctmj-186	50	25	dextran	dextran	NOUN
ctmj-186	50	26	t500	t500	NUM
ctmj-186	50	27	injection	injection	NOUN
ctmj-186	50	28	and	and	CCONJ
ctmj-186	50	29	5	5	NUM
ctmj-186	50	30	,	,	PUNCT
ctmj-186	50	31	15	15	NUM
ctmj-186	50	32	,	,	PUNCT
ctmj-186	50	33	and	and	CCONJ
ctmj-186	50	34	30	30	NUM
ctmj-186	50	35	min	min	NOUN
ctmj-186	50	36	after	after	ADP
ctmj-186	50	37	dextran	dextran	NOUN
ctmj-186	50	38	t500	t500	PROPN
ctmj-186	50	39	injection	injection	NOUN
ctmj-186	50	40	to	to	PART
ctmj-186	50	41	investigate	investigate	VERB
ctmj-186	50	42	the	the	DET
ctmj-186	50	43	effect	effect	NOUN
ctmj-186	50	44	of	of	ADP
ctmj-186	50	45	cddp	cddp	NOUN
ctmj-186	50	46	on	on	ADP
ctmj-186	50	47	microcirculation	microcirculation	NOUN
ctmj-186	50	48	disorder	disorder	NOUN
ctmj-186	50	49	.	.	PUNCT
ctmj-186	51	1	effect	effect	NOUN
ctmj-186	51	2	of	of	ADP
ctmj-186	51	3	compound	compound	NOUN
ctmj-186	51	4	danshen	danshen	NOUN
ctmj-186	51	5	dripping	dripping	ADJ
ctmj-186	51	6	pill	pill	NOUN
ctmj-186	51	7	on	on	ADP
ctmj-186	51	8	lipopolysaccharide‑induced	lipopolysaccharide‑induce	VERB
ctmj-186	51	9	animal	animal	NOUN
ctmj-186	51	10	model	model	NOUN
ctmj-186	51	11	the	the	DET
ctmj-186	51	12	dic	dic	PROPN
ctmj-186	51	13	model	model	NOUN
ctmj-186	51	14	was	be	AUX
ctmj-186	51	15	replicated	replicate	VERB
ctmj-186	51	16	by	by	ADP
ctmj-186	51	17	intraperitoneally	intraperitoneally	ADV
ctmj-186	51	18	injecting	inject	VERB
ctmj-186	51	19	the	the	DET
ctmj-186	51	20	rats	rat	NOUN
ctmj-186	51	21	with	with	ADP
ctmj-186	51	22	lps	lps	PROPN
ctmj-186	51	23	.	.	PUNCT
ctmj-186	52	1	the	the	DET
ctmj-186	52	2	rats	rat	NOUN
ctmj-186	52	3	were	be	AUX
ctmj-186	52	4	divided	divide	VERB
ctmj-186	52	5	into	into	ADP
ctmj-186	52	6	the	the	DET
ctmj-186	52	7	control	control	NOUN
ctmj-186	52	8	,	,	PUNCT
ctmj-186	52	9	model	model	NOUN
ctmj-186	52	10	,	,	PUNCT
ctmj-186	52	11	cddp‑h	cddp‑h	NOUN
ctmj-186	52	12	and	and	CCONJ
ctmj-186	52	13	cddp‑l	cddp‑l	NOUN
ctmj-186	52	14	,	,	PUNCT
ctmj-186	52	15	and	and	CCONJ
ctmj-186	52	16	nadroparin	nadroparin	ADJ
ctmj-186	52	17	calcium	calcium	NOUN
ctmj-186	52	18	groups	group	NOUN
ctmj-186	52	19	.	.	PUNCT
ctmj-186	53	1	except	except	SCONJ
ctmj-186	53	2	for	for	ADP
ctmj-186	53	3	the	the	DET
ctmj-186	53	4	control	control	NOUN
ctmj-186	53	5	group	group	NOUN
ctmj-186	53	6	,	,	PUNCT
ctmj-186	53	7	rats	rat	NOUN
ctmj-186	53	8	in	in	ADP
ctmj-186	53	9	all	all	DET
ctmj-186	53	10	other	other	ADJ
ctmj-186	53	11	groups	group	NOUN
ctmj-186	53	12	were	be	AUX
ctmj-186	53	13	intraperitoneally	intraperitoneally	ADV
ctmj-186	53	14	injected	inject	VERB
ctmj-186	53	15	with	with	ADP
ctmj-186	53	16	30	30	NUM
ctmj-186	53	17	mg	mg	NUM
ctmj-186	53	18	/	/	SYM
ctmj-186	53	19	kg	kg	NOUN
ctmj-186	53	20	lps	lps	PROPN
ctmj-186	53	21	to	to	PART
ctmj-186	53	22	replicate	replicate	VERB
ctmj-186	53	23	the	the	DET
ctmj-186	53	24	dic	dic	PROPN
ctmj-186	53	25	model	model	NOUN
ctmj-186	53	26	.	.	PUNCT
ctmj-186	54	1	rats	rat	NOUN
ctmj-186	54	2	in	in	ADP
ctmj-186	54	3	the	the	DET
ctmj-186	54	4	control	control	NOUN
ctmj-186	54	5	and	and	CCONJ
ctmj-186	54	6	model	model	NOUN
ctmj-186	54	7	groups	group	NOUN
ctmj-186	54	8	were	be	AUX
ctmj-186	54	9	intragastrically	intragastrically	ADV
ctmj-186	54	10	administered	administer	VERB
ctmj-186	54	11	10	10	NUM
ctmj-186	54	12	ml	ml	NOUN
ctmj-186	54	13	/	/	SYM
ctmj-186	54	14	kg	kg	NOUN
ctmj-186	54	15	of	of	ADP
ctmj-186	54	16	pure	pure	ADJ
ctmj-186	54	17	water	water	NOUN
ctmj-186	54	18	immediately	immediately	ADV
ctmj-186	54	19	after	after	ADP
ctmj-186	54	20	modeling	modeling	NOUN
ctmj-186	54	21	.	.	PUNCT
ctmj-186	55	1	rats	rat	NOUN
ctmj-186	55	2	in	in	ADP
ctmj-186	55	3	the	the	DET
ctmj-186	55	4	cddp	cddp	PROPN
ctmj-186	55	5	group	group	NOUN
ctmj-186	55	6	were	be	AUX
ctmj-186	55	7	intragastrically	intragastrically	ADV
ctmj-186	55	8	administered	administer	VERB
ctmj-186	55	9	415–835	415–835	NUM
ctmj-186	55	10	mg/	mg/	NOUN
ctmj-186	55	11	kg	kg	PROPN
ctmj-186	55	12	cddp	cddp	PROPN
ctmj-186	55	13	immediately	immediately	ADV
ctmj-186	55	14	after	after	ADP
ctmj-186	55	15	modeling	modeling	NOUN
ctmj-186	55	16	.	.	PUNCT
ctmj-186	56	1	rats	rat	NOUN
ctmj-186	56	2	in	in	ADP
ctmj-186	56	3	the	the	DET
ctmj-186	56	4	nadroparin	nadroparin	PROPN
ctmj-186	56	5	calcium	calcium	NOUN
ctmj-186	56	6	group	group	NOUN
ctmj-186	56	7	were	be	AUX
ctmj-186	56	8	subcutaneously	subcutaneously	ADV
ctmj-186	56	9	injected	inject	VERB
ctmj-186	56	10	with	with	ADP
ctmj-186	56	11	500	500	NUM
ctmj-186	56	12	iu	iu	NOUN
ctmj-186	56	13	/	/	SYM
ctmj-186	56	14	kg	kg	PROPN
ctmj-186	56	15	nadroparin	nadroparin	PROPN
ctmj-186	56	16	calcium	calcium	NOUN
ctmj-186	56	17	,	,	PUNCT
ctmj-186	56	18	immediately	immediately	ADV
ctmj-186	56	19	after	after	ADP
ctmj-186	56	20	modeling	modeling	NOUN
ctmj-186	56	21	.	.	PUNCT
ctmj-186	57	1	the	the	DET
ctmj-186	57	2	rats	rat	NOUN
ctmj-186	57	3	in	in	ADP
ctmj-186	57	4	each	each	DET
ctmj-186	57	5	group	group	NOUN
ctmj-186	57	6	were	be	AUX
ctmj-186	57	7	sacrificed	sacrifice	VERB
ctmj-186	57	8	6	6	NUM
ctmj-186	57	9	h	h	NOUN
ctmj-186	57	10	after	after	SCONJ
ctmj-186	57	11	the	the	DET
ctmj-186	57	12	model	model	NOUN
ctmj-186	57	13	was	be	AUX
ctmj-186	57	14	replicated	replicate	VERB
ctmj-186	57	15	;	;	PUNCT
ctmj-186	57	16	blood	blood	NOUN
ctmj-186	57	17	and	and	CCONJ
ctmj-186	57	18	organ	organ	NOUN
ctmj-186	57	19	tissues	tissue	NOUN
ctmj-186	57	20	were	be	AUX
ctmj-186	57	21	collected	collect	VERB
ctmj-186	57	22	from	from	ADP
ctmj-186	57	23	the	the	DET
ctmj-186	57	24	abdominal	abdominal	ADJ
ctmj-186	57	25	cavity	cavity	NOUN
ctmj-186	57	26	after	after	ADP
ctmj-186	57	27	anesthesia	anesthesia	NOUN
ctmj-186	57	28	,	,	PUNCT
ctmj-186	57	29	and	and	CCONJ
ctmj-186	57	30	the	the	DET
ctmj-186	57	31	samples	sample	NOUN
ctmj-186	57	32	were	be	AUX
ctmj-186	57	33	processed	process	VERB
ctmj-186	57	34	according	accord	VERB
ctmj-186	57	35	to	to	ADP
ctmj-186	57	36	the	the	DET
ctmj-186	57	37	instructions	instruction	NOUN
ctmj-186	57	38	.	.	PUNCT
ctmj-186	58	1	hematological	hematological	ADJ
ctmj-186	58	2	examination	examination	NOUN
ctmj-186	58	3	(	(	PUNCT
ctmj-186	58	4	prothrombin	prothrombin	NOUN
ctmj-186	58	5	time	time	NOUN
ctmj-186	59	1	[	[	X
ctmj-186	59	2	pt	pt	X
ctmj-186	59	3	]	]	X
ctmj-186	59	4	and	and	CCONJ
ctmj-186	59	5	fib	fib	ADJ
ctmj-186	59	6	)	)	PUNCT
ctmj-186	59	7	,	,	PUNCT
ctmj-186	59	8	inflammatory	inflammatory	ADJ
ctmj-186	59	9	factor	factor	NOUN
ctmj-186	59	10	detection	detection	NOUN
ctmj-186	59	11	(	(	PUNCT
ctmj-186	59	12	il‑10	il‑10	NOUN
ctmj-186	59	13	and	and	CCONJ
ctmj-186	59	14	tnf‑	tnf‑	ADJ
ctmj-186	59	15	)	)	PUNCT
ctmj-186	59	16	,	,	PUNCT
ctmj-186	59	17	and	and	CCONJ
ctmj-186	59	18	pathological	pathological	ADJ
ctmj-186	59	19	examination	examination	NOUN
ctmj-186	59	20	of	of	ADP
ctmj-186	59	21	the	the	DET
ctmj-186	59	22	liver	liver	NOUN
ctmj-186	59	23	and	and	CCONJ
ctmj-186	59	24	kidneys	kidney	NOUN
ctmj-186	59	25	were	be	AUX
ctmj-186	59	26	performed	perform	VERB
ctmj-186	59	27	.	.	PUNCT
ctmj-186	60	1	transcriptomics	transcriptomic	NOUN
ctmj-186	60	2	detection	detection	NOUN
ctmj-186	60	3	and	and	CCONJ
ctmj-186	60	4	validation	validation	NOUN
ctmj-186	60	5	the	the	DET
ctmj-186	60	6	rats	rat	NOUN
ctmj-186	60	7	in	in	ADP
ctmj-186	60	8	the	the	DET
ctmj-186	60	9	control	control	NOUN
ctmj-186	60	10	,	,	PUNCT
ctmj-186	60	11	model	model	NOUN
ctmj-186	60	12	,	,	PUNCT
ctmj-186	60	13	and	and	CCONJ
ctmj-186	60	14	cddp‑h	cddp‑h	ADJ
ctmj-186	60	15	groups	group	NOUN
ctmj-186	60	16	(	(	PUNCT
ctmj-186	60	17	n	n	NOUN
ctmj-186	60	18	=	=	SYM
ctmj-186	60	19	5	5	NUM
ctmj-186	60	20	rats	rat	NOUN
ctmj-186	60	21	in	in	ADP
ctmj-186	60	22	each	each	DET
ctmj-186	60	23	group	group	NOUN
ctmj-186	60	24	)	)	PUNCT
ctmj-186	60	25	were	be	AUX
ctmj-186	60	26	anesthetized	anesthetize	VERB
ctmj-186	60	27	with	with	ADP
ctmj-186	60	28	intraperitoneal	intraperitoneal	ADJ
ctmj-186	60	29	injection	injection	NOUN
ctmj-186	60	30	of	of	ADP
ctmj-186	60	31	20	20	NUM
ctmj-186	60	32	%	%	NOUN
ctmj-186	60	33	,	,	PUNCT
ctmj-186	60	34	4	4	NUM
ctmj-186	60	35	ml	ml	NOUN
ctmj-186	60	36	/	/	SYM
ctmj-186	60	37	kg	kg	PROPN
ctmj-186	60	38	urethane	urethane	NOUN
ctmj-186	60	39	administered	administer	VERB
ctmj-186	60	40	6	6	NUM
ctmj-186	60	41	h	h	NOUN
ctmj-186	60	42	after	after	SCONJ
ctmj-186	60	43	the	the	DET
ctmj-186	60	44	model	model	NOUN
ctmj-186	60	45	was	be	AUX
ctmj-186	60	46	replicated	replicate	VERB
ctmj-186	60	47	.	.	PUNCT
ctmj-186	61	1	blood	blood	NOUN
ctmj-186	61	2	was	be	AUX
ctmj-186	61	3	collected	collect	VERB
ctmj-186	61	4	from	from	ADP
ctmj-186	61	5	the	the	DET
ctmj-186	61	6	abdominal	abdominal	ADJ
ctmj-186	61	7	aorta	aorta	NOUN
ctmj-186	61	8	and	and	CCONJ
ctmj-186	61	9	placed	place	VERB
ctmj-186	61	10	in	in	ADP
ctmj-186	61	11	a	a	DET
ctmj-186	61	12	paxgene	paxgene	ADJ
ctmj-186	61	13	blood	blood	NOUN
ctmj-186	61	14	rna	rna	NOUN
ctmj-186	61	15	tube	tube	NOUN
ctmj-186	61	16	according	accord	VERB
ctmj-186	61	17	to	to	ADP
ctmj-186	61	18	the	the	DET
ctmj-186	61	19	instructions	instruction	NOUN
ctmj-186	61	20	provided	provide	VERB
ctmj-186	61	21	in	in	ADP
ctmj-186	61	22	the	the	DET
ctmj-186	61	23	kit	kit	NOUN
ctmj-186	61	24	.	.	PUNCT
ctmj-186	62	1	total	total	PROPN
ctmj-186	62	2	rna	rna	PROPN
ctmj-186	62	3	was	be	AUX
ctmj-186	62	4	extracted	extract	VERB
ctmj-186	62	5	,	,	PUNCT
ctmj-186	62	6	and	and	CCONJ
ctmj-186	62	7	transcriptome	transcriptome	ADJ
ctmj-186	62	8	sequencing	sequencing	NOUN
ctmj-186	62	9	was	be	AUX
ctmj-186	62	10	performed	perform	VERB
ctmj-186	62	11	.	.	PUNCT
ctmj-186	63	1	the	the	DET
ctmj-186	63	2	deseq2	deseq2	PROPN
ctmj-186	63	3	software	software	NOUN
ctmj-186	63	4	and	and	CCONJ
ctmj-186	63	5	metacore	metacore	ADJ
ctmj-186	63	6	website	website	NOUN
ctmj-186	63	7	were	be	AUX
ctmj-186	63	8	used	use	VERB
ctmj-186	63	9	to	to	PART
ctmj-186	63	10	quantify	quantify	VERB
ctmj-186	63	11	the	the	DET
ctmj-186	63	12	aforementioned	aforementioned	ADJ
ctmj-186	63	13	genes	gene	NOUN
ctmj-186	63	14	and	and	CCONJ
ctmj-186	63	15	analyze	analyze	VERB
ctmj-186	63	16	them	they	PRON
ctmj-186	63	17	based	base	VERB
ctmj-186	63	18	on	on	ADP
ctmj-186	63	19	gene	gene	NOUN
ctmj-186	63	20	expression	expression	NOUN
ctmj-186	63	21	(	(	PUNCT
ctmj-186	63	22	correlation	correlation	NOUN
ctmj-186	63	23	,	,	PUNCT
ctmj-186	63	24	principal	principal	ADJ
ctmj-186	63	25	component	component	NOUN
ctmj-186	63	26	analysis	analysis	NOUN
ctmj-186	63	27	,	,	PUNCT
ctmj-186	63	28	and	and	CCONJ
ctmj-186	63	29	differential	differential	ADJ
ctmj-186	63	30	gene	gene	NOUN
ctmj-186	63	31	screening	screening	NOUN
ctmj-186	63	32	)	)	PUNCT
ctmj-186	63	33	.	.	PUNCT
ctmj-186	64	1	gene	gene	NOUN
ctmj-186	64	2	ontology	ontology	NOUN
ctmj-186	64	3	(	(	PUNCT
ctmj-186	64	4	go	go	VERB
ctmj-186	64	5	)	)	PUNCT
ctmj-186	64	6	enrichment	enrichment	NOUN
ctmj-186	64	7	analysis	analysis	NOUN
ctmj-186	64	8	,	,	PUNCT
ctmj-186	64	9	kyoto	kyoto	PROPN
ctmj-186	64	10	encyclopedia	encyclopedia	NOUN
ctmj-186	64	11	of	of	ADP
ctmj-186	64	12	genes	gene	NOUN
ctmj-186	64	13	and	and	CCONJ
ctmj-186	64	14	genomes	genome	NOUN
ctmj-186	64	15	(	(	PUNCT
ctmj-186	64	16	kegg	kegg	NOUN
ctmj-186	64	17	)	)	PUNCT
ctmj-186	64	18	pathway	pathway	NOUN
ctmj-186	64	19	enrichment	enrichment	NOUN
ctmj-186	64	20	analysis	analysis	NOUN
ctmj-186	64	21	,	,	PUNCT
ctmj-186	64	22	and	and	CCONJ
ctmj-186	64	23	protein	protein	NOUN
ctmj-186	64	24	interaction	interaction	NOUN
ctmj-186	64	25	network	network	NOUN
ctmj-186	64	26	analysis	analysis	NOUN
ctmj-186	64	27	were	be	AUX
ctmj-186	64	28	performed	perform	VERB
ctmj-186	64	29	on	on	ADP
ctmj-186	64	30	differential	differential	ADJ
ctmj-186	64	31	gene	gene	NOUN
ctmj-186	64	32	data	datum	NOUN
ctmj-186	64	33	in	in	ADP
ctmj-186	64	34	selected	select	VERB
ctmj-186	64	35	samples	sample	NOUN
ctmj-186	64	36	.	.	PUNCT
ctmj-186	65	1	for	for	ADP
ctmj-186	65	2	qpcr	qpcr	ADV
ctmj-186	65	3	,	,	PUNCT
ctmj-186	65	4	the	the	DET
ctmj-186	65	5	rna	rna	NOUN
ctmj-186	65	6	samples	sample	NOUN
ctmj-186	65	7	from	from	ADP
ctmj-186	65	8	experimental	experimental	ADJ
ctmj-186	65	9	animals	animal	NOUN
ctmj-186	65	10	were	be	AUX
ctmj-186	65	11	reverse	reverse	NOUN
ctmj-186	65	12	-	-	PUNCT
ctmj-186	65	13	transcribed	transcribe	VERB
ctmj-186	65	14	according	accord	VERB
ctmj-186	65	15	to	to	ADP
ctmj-186	65	16	the	the	DET
ctmj-186	65	17	instructions	instruction	NOUN
ctmj-186	65	18	provided	provide	VERB
ctmj-186	65	19	in	in	ADP
ctmj-186	65	20	the	the	DET
ctmj-186	65	21	kit	kit	NOUN
ctmj-186	65	22	.	.	PUNCT
ctmj-186	66	1	the	the	DET
ctmj-186	66	2	pcr	pcr	ADJ
ctmj-186	66	3	primers	primer	NOUN
ctmj-186	66	4	were	be	AUX
ctmj-186	66	5	designed	design	VERB
ctmj-186	66	6	using	use	VERB
ctmj-186	66	7	primer	primer	NOUN
ctmj-186	66	8	5.0	5.0	NUM
ctmj-186	66	9	software	software	NOUN
ctmj-186	66	10	.	.	PUNCT
ctmj-186	67	1	quantitative	quantitative	ADJ
ctmj-186	67	2	real‑time	real‑time	NOUN
ctmj-186	67	3	(	(	PUNCT
ctmj-186	67	4	qrt)‑pcr	qrt)‑pcr	ADV
ctmj-186	67	5	was	be	AUX
ctmj-186	67	6	performed	perform	VERB
ctmj-186	67	7	using	use	VERB
ctmj-186	67	8	the	the	DET
ctmj-186	67	9	sybr	sybr	ADJ
ctmj-186	67	10	green	green	ADJ
ctmj-186	67	11	fluorescent	fluorescent	NOUN
ctmj-186	67	12	dye	dye	NOUN
ctmj-186	67	13	.	.	PUNCT
ctmj-186	68	1	the	the	DET
ctmj-186	68	2	amplification	amplification	NOUN
ctmj-186	68	3	curve	curve	NOUN
ctmj-186	68	4	was	be	AUX
ctmj-186	68	5	obtained	obtain	VERB
ctmj-186	68	6	by	by	ADP
ctmj-186	68	7	real‑time	real‑time	NOUN
ctmj-186	68	8	monitoring	monitoring	NOUN
ctmj-186	68	9	of	of	ADP
ctmj-186	68	10	the	the	DET
ctmj-186	68	11	pcr	pcr	NOUN
ctmj-186	68	12	using	use	VERB
ctmj-186	68	13	the	the	DET
ctmj-186	68	14	dissolution	dissolution	NOUN
ctmj-186	68	15	curve	curve	NOUN
ctmj-186	68	16	.	.	PUNCT
ctmj-186	69	1	the	the	DET
ctmj-186	69	2	ct	ct	NOUN
ctmj-186	69	3	-	-	PUNCT
ctmj-186	69	4	value	value	NOUN
ctmj-186	69	5	of	of	ADP
ctmj-186	69	6	the	the	DET
ctmj-186	69	7	target	target	NOUN
ctmj-186	69	8	gene	gene	NOUN
ctmj-186	69	9	was	be	AUX
ctmj-186	69	10	calculated	calculate	VERB
ctmj-186	69	11	using	use	VERB
ctmj-186	69	12	the	the	DET
ctmj-186	69	13	amplification	amplification	NOUN
ctmj-186	69	14	curve	curve	NOUN
ctmj-186	69	15	,	,	PUNCT
ctmj-186	69	16	and	and	CCONJ
ctmj-186	69	17	the	the	DET
ctmj-186	69	18	gene	gene	NOUN
ctmj-186	69	19	expression	expression	NOUN
ctmj-186	69	20	changes	change	NOUN
ctmj-186	69	21	were	be	AUX
ctmj-186	69	22	quantitatively	quantitatively	ADV
ctmj-186	69	23	calculated	calculate	VERB
ctmj-186	69	24	using	use	VERB
ctmj-186	69	25	the	the	DET
ctmj-186	69	26	2	2	NUM
ctmj-186	69	27	–	–	PUNCT
ctmj-186	69	28	δδct	δδct	NOUN
ctmj-186	69	29	formula	formula	NOUN
ctmj-186	69	30	.	.	PUNCT
ctmj-186	70	1	statistics	statistic	NOUN
ctmj-186	70	2	microsoft	microsoft	PROPN
ctmj-186	70	3	excel	excel	PROPN
ctmj-186	70	4	was	be	AUX
ctmj-186	70	5	used	use	VERB
ctmj-186	70	6	to	to	PART
ctmj-186	70	7	analyze	analyze	VERB
ctmj-186	70	8	and	and	CCONJ
ctmj-186	70	9	process	process	VERB
ctmj-186	70	10	the	the	DET
ctmj-186	70	11	data	datum	NOUN
ctmj-186	70	12	.	.	PUNCT
ctmj-186	71	1	the	the	DET
ctmj-186	71	2	experimental	experimental	ADJ
ctmj-186	71	3	data	datum	NOUN
ctmj-186	71	4	obtained	obtain	VERB
ctmj-186	71	5	from	from	ADP
ctmj-186	71	6	each	each	DET
ctmj-186	71	7	group	group	NOUN
ctmj-186	71	8	are	be	AUX
ctmj-186	71	9	expressed	express	VERB
ctmj-186	71	10	as	as	ADP
ctmj-186	71	11	mean	mean	NOUN
ctmj-186	71	12	±	±	NUM
ctmj-186	71	13	standard	standard	ADJ
ctmj-186	71	14	deviation	deviation	NOUN
ctmj-186	71	15	.	.	PUNCT
ctmj-186	72	1	the	the	DET
ctmj-186	72	2	two	two	NUM
ctmj-186	72	3	-	-	PUNCT
ctmj-186	72	4	sample	sample	NOUN
ctmj-186	72	5	equal	equal	ADJ
ctmj-186	72	6	variance	variance	NOUN
ctmj-186	72	7	t‑test	t‑test	PROPN
ctmj-186	72	8	was	be	AUX
ctmj-186	72	9	used	use	VERB
ctmj-186	72	10	to	to	PART
ctmj-186	72	11	examine	examine	VERB
ctmj-186	72	12	the	the	DET
ctmj-186	72	13	significance	significance	NOUN
ctmj-186	72	14	between	between	ADP
ctmj-186	72	15	the	the	DET
ctmj-186	72	16	groups	group	NOUN
ctmj-186	72	17	,	,	PUNCT
ctmj-186	72	18	and	and	CCONJ
ctmj-186	72	19	p	p	X
ctmj-186	72	20	<	<	X
ctmj-186	72	21	0.05	0.05	NUM
ctmj-186	72	22	was	be	AUX
ctmj-186	72	23	considered	consider	VERB
ctmj-186	72	24	statistically	statistically	ADV
ctmj-186	72	25	significant	significant	ADJ
ctmj-186	72	26	.	.	PUNCT
ctmj-186	73	1	results	result	VERB
ctmj-186	73	2	effect	effect	NOUN
ctmj-186	73	3	of	of	ADP
ctmj-186	73	4	compound	compound	NOUN
ctmj-186	73	5	danshen	danshen	NOUN
ctmj-186	73	6	dripping	dripping	ADJ
ctmj-186	73	7	pill	pill	NOUN
ctmj-186	73	8	on	on	ADP
ctmj-186	73	9	the	the	DET
ctmj-186	73	10	survival	survival	NOUN
ctmj-186	73	11	rate	rate	NOUN
ctmj-186	73	12	of	of	ADP
ctmj-186	73	13	lipopolysaccharide‑induced	lipopolysaccharide‑induce	VERB
ctmj-186	73	14	model	model	NOUN
ctmj-186	73	15	animals	animal	NOUN
ctmj-186	73	16	the	the	DET
ctmj-186	73	17	survival	survival	NOUN
ctmj-186	73	18	rates	rate	NOUN
ctmj-186	73	19	of	of	ADP
ctmj-186	73	20	rats	rat	NOUN
ctmj-186	73	21	in	in	ADP
ctmj-186	73	22	the	the	DET
ctmj-186	73	23	cddp‑l	cddp‑l	NOUN
ctmj-186	73	24	,	,	PUNCT
ctmj-186	73	25	cddp‑h	cddp‑h	ADJ
ctmj-186	73	26	,	,	PUNCT
ctmj-186	73	27	and	and	CCONJ
ctmj-186	73	28	nadroparin	nadroparin	ADJ
ctmj-186	73	29	calcium	calcium	NOUN
ctmj-186	73	30	groups	group	NOUN
ctmj-186	73	31	were	be	AUX
ctmj-186	73	32	8.35	8.35	NUM
ctmj-186	73	33	%	%	NOUN
ctmj-186	73	34	,	,	PUNCT
ctmj-186	73	35	37.5	37.5	NUM
ctmj-186	73	36	%	%	NOUN
ctmj-186	73	37	,	,	PUNCT
ctmj-186	73	38	87.5	87.5	NUM
ctmj-186	73	39	%	%	NOUN
ctmj-186	73	40	,	,	PUNCT
ctmj-186	73	41	and	and	CCONJ
ctmj-186	73	42	25	25	NUM
ctmj-186	73	43	%	%	NOUN
ctmj-186	73	44	,	,	PUNCT
ctmj-186	73	45	respectively	respectively	ADV
ctmj-186	73	46	[	[	X
ctmj-186	73	47	figure	figure	NOUN
ctmj-186	73	48	1a	1a	NOUN
ctmj-186	73	49	]	]	PUNCT
ctmj-186	73	50	.	.	PUNCT
ctmj-186	74	1	the	the	DET
ctmj-186	74	2	results	result	NOUN
ctmj-186	74	3	suggested	suggest	VERB
ctmj-186	74	4	that	that	SCONJ
ctmj-186	74	5	cddp	cddp	PROPN
ctmj-186	74	6	improved	improve	VERB
ctmj-186	74	7	the	the	DET
ctmj-186	74	8	survival	survival	NOUN
ctmj-186	74	9	rate	rate	NOUN
ctmj-186	74	10	of	of	ADP
ctmj-186	74	11	lps‑induced	lps‑induce	VERB
ctmj-186	74	12	model	model	NOUN
ctmj-186	74	13	rats	rat	NOUN
ctmj-186	74	14	in	in	ADP
ctmj-186	74	15	a	a	DET
ctmj-186	74	16	dose	dose	NOUN
ctmj-186	74	17	-	-	PUNCT
ctmj-186	74	18	dependent	dependent	ADJ
ctmj-186	74	19	manner	manner	NOUN
ctmj-186	74	20	.	.	PUNCT
ctmj-186	75	1	effect	effect	NOUN
ctmj-186	75	2	of	of	ADP
ctmj-186	75	3	compound	compound	NOUN
ctmj-186	75	4	danshen	danshen	NOUN
ctmj-186	75	5	dripping	dripping	ADJ
ctmj-186	75	6	pill	pill	NOUN
ctmj-186	75	7	on	on	ADP
ctmj-186	75	8	dextran‑	dextran‑	NOUN
ctmj-186	75	9	induced	induce	VERB
ctmj-186	75	10	microcirculatory	microcirculatory	ADJ
ctmj-186	75	11	disturbance	disturbance	NOUN
ctmj-186	75	12	preadministration	preadministration	NOUN
ctmj-186	75	13	of	of	ADP
ctmj-186	75	14	415	415	NUM
ctmj-186	75	15	mg	mg	NUM
ctmj-186	75	16	/	/	SYM
ctmj-186	75	17	kg	kg	PROPN
ctmj-186	75	18	cddp	cddp	PROPN
ctmj-186	75	19	significantly	significantly	ADV
ctmj-186	75	20	increased	increase	VERB
ctmj-186	75	21	the	the	DET
ctmj-186	75	22	5‑min	5‑min	NUM
ctmj-186	75	23	and	and	CCONJ
ctmj-186	75	24	15‑min	15‑min	NUM
ctmj-186	75	25	hepatic	hepatic	ADJ
ctmj-186	75	26	blood	blood	NOUN
ctmj-186	75	27	flow	flow	NOUN
ctmj-186	75	28	and	and	CCONJ
ctmj-186	75	29	30‑min	30‑min	DET
ctmj-186	75	30	gastric	gastric	ADJ
ctmj-186	75	31	fundus	fundus	NOUN
ctmj-186	75	32	blood	blood	NOUN
ctmj-186	75	33	flow	flow	NOUN
ctmj-186	75	34	in	in	ADP
ctmj-186	75	35	dic	dic	ADJ
ctmj-186	75	36	rats	rat	NOUN
ctmj-186	75	37	following	follow	VERB
ctmj-186	75	38	10	10	NUM
ctmj-186	75	39	%	%	NOUN
ctmj-186	75	40	dextran	dextran	NOUN
ctmj-186	75	41	t500	t500	NUM
ctmj-186	75	42	modeling	modeling	NOUN
ctmj-186	75	43	(	(	PUNCT
ctmj-186	75	44	p	p	X
ctmj-186	75	45	<	<	X
ctmj-186	75	46	0.05	0.05	NUM
ctmj-186	75	47	)	)	PUNCT
ctmj-186	75	48	.	.	PUNCT
ctmj-186	76	1	preadministration	preadministration	NOUN
ctmj-186	76	2	of	of	ADP
ctmj-186	76	3	830	830	NUM
ctmj-186	76	4	mg	mg	NUM
ctmj-186	76	5	/	/	SYM
ctmj-186	76	6	kg	kg	PROPN
ctmj-186	76	7	cddp	cddp	PROPN
ctmj-186	76	8	significantly	significantly	ADV
ctmj-186	76	9	increased	increase	VERB
ctmj-186	76	10	the	the	DET
ctmj-186	76	11	5‑min	5‑min	NUM
ctmj-186	76	12	and	and	CCONJ
ctmj-186	76	13	15‑min	15‑min	NUM
ctmj-186	76	14	hepatic	hepatic	ADJ
ctmj-186	76	15	blood	blood	NOUN
ctmj-186	76	16	flow	flow	NOUN
ctmj-186	76	17	and	and	CCONJ
ctmj-186	76	18	the	the	DET
ctmj-186	76	19	5‑min	5‑min	NOUN
ctmj-186	76	20	and	and	CCONJ
ctmj-186	76	21	30‑min	30‑min	PRON
ctmj-186	76	22	gastric	gastric	ADJ
ctmj-186	76	23	fundus	fundus	NOUN
ctmj-186	76	24	blood	blood	NOUN
ctmj-186	76	25	flow	flow	NOUN
ctmj-186	76	26	after	after	ADP
ctmj-186	76	27	modeling	modeling	NOUN
ctmj-186	76	28	in	in	ADP
ctmj-186	76	29	dic	dic	ADJ
ctmj-186	76	30	rats	rat	NOUN
ctmj-186	76	31	(	(	PUNCT
ctmj-186	76	32	p	p	X
ctmj-186	76	33	<	<	X
ctmj-186	76	34	0.05	0.05	NUM
ctmj-186	76	35	)	)	PUNCT
ctmj-186	76	36	.	.	PUNCT
ctmj-186	77	1	these	these	DET
ctmj-186	77	2	findings	finding	NOUN
ctmj-186	77	3	suggested	suggest	VERB
ctmj-186	77	4	that	that	SCONJ
ctmj-186	77	5	cddp	cddp	PROPN
ctmj-186	77	6	plays	play	VERB
ctmj-186	77	7	a	a	DET
ctmj-186	77	8	therapeutic	therapeutic	ADJ
ctmj-186	77	9	role	role	NOUN
ctmj-186	77	10	in	in	ADP
ctmj-186	77	11	dic	dic	ADJ
ctmj-186	77	12	microcirculation	microcirculation	NOUN
ctmj-186	77	13	disorder	disorder	NOUN
ctmj-186	77	14	by	by	ADP
ctmj-186	77	15	improving	improve	VERB
ctmj-186	77	16	the	the	DET
ctmj-186	77	17	microcirculation	microcirculation	NOUN
ctmj-186	77	18	in	in	ADP
ctmj-186	77	19	internal	internal	ADJ
ctmj-186	77	20	organs	organ	NOUN
ctmj-186	77	21	and	and	CCONJ
ctmj-186	77	22	increasing	increase	VERB
ctmj-186	77	23	blood	blood	NOUN
ctmj-186	77	24	perfusion	perfusion	NOUN
ctmj-186	77	25	of	of	ADP
ctmj-186	77	26	organs	organ	NOUN
ctmj-186	77	27	[	[	X
ctmj-186	77	28	figure	figure	NOUN
ctmj-186	77	29	2a	2a	NUM
ctmj-186	77	30	-	-	SYM
ctmj-186	77	31	c	c	NOUN
ctmj-186	77	32	]	]	PUNCT
ctmj-186	77	33	.	.	PUNCT
ctmj-186	78	1	effect	effect	NOUN
ctmj-186	78	2	of	of	ADP
ctmj-186	78	3	compound	compound	NOUN
ctmj-186	78	4	danshen	danshen	NOUN
ctmj-186	78	5	dripping	dripping	ADJ
ctmj-186	78	6	pill	pill	NOUN
ctmj-186	78	7	on	on	ADP
ctmj-186	78	8	lipopolysaccharide‑induced	lipopolysaccharide‑induce	VERB
ctmj-186	78	9	rat	rat	NOUN
ctmj-186	78	10	model	model	NOUN
ctmj-186	78	11	effect	effect	NOUN
ctmj-186	78	12	of	of	ADP
ctmj-186	78	13	compound	compound	NOUN
ctmj-186	78	14	danshen	danshen	NOUN
ctmj-186	78	15	dripping	dripping	ADJ
ctmj-186	78	16	pill	pill	NOUN
ctmj-186	78	17	on	on	ADP
ctmj-186	78	18	coagulation	coagulation	NOUN
ctmj-186	78	19	function	function	NOUN
ctmj-186	78	20	in	in	ADP
ctmj-186	78	21	lipopolysaccharide‑induced	lipopolysaccharide‑induce	VERB
ctmj-186	78	22	model	model	NOUN
ctmj-186	78	23	rats	rat	NOUN
ctmj-186	78	24	the	the	DET
ctmj-186	78	25	prothrombin	prothrombin	ADJ
ctmj-186	78	26	time	time	NOUN
ctmj-186	78	27	(	(	PUNCT
ctmj-186	78	28	pt	pt	NOUN
ctmj-186	78	29	)	)	PUNCT
ctmj-186	78	30	in	in	ADP
ctmj-186	78	31	the	the	DET
ctmj-186	78	32	model	model	NOUN
ctmj-186	78	33	group	group	NOUN
ctmj-186	78	34	was	be	AUX
ctmj-186	78	35	significantly	significantly	ADV
ctmj-186	78	36	prolonged	prolong	VERB
ctmj-186	78	37	(	(	PUNCT
ctmj-186	78	38	model	model	NOUN
ctmj-186	78	39	vs.	vs.	ADP
ctmj-186	78	40	control	control	NOUN
ctmj-186	78	41	;	;	PUNCT
ctmj-186	78	42	p	p	X
ctmj-186	78	43	<	<	X
ctmj-186	78	44	0.01	0.01	NUM
ctmj-186	78	45	)	)	PUNCT
ctmj-186	78	46	and	and	CCONJ
ctmj-186	78	47	the	the	DET
ctmj-186	78	48	fib	fib	ADJ
ctmj-186	78	49	level	level	NOUN
ctmj-186	78	50	was	be	AUX
ctmj-186	78	51	significantly	significantly	ADV
ctmj-186	78	52	decreased	decrease	VERB
ctmj-186	78	53	(	(	PUNCT
ctmj-186	78	54	p	p	X
ctmj-186	78	55	<	<	X
ctmj-186	78	56	0.01	0.01	NUM
ctmj-186	78	57	)	)	PUNCT
ctmj-186	78	58	,	,	PUNCT
ctmj-186	78	59	suggesting	suggest	VERB
ctmj-186	78	60	lps‑induced	lps‑induce	VERB
ctmj-186	78	61	coagulation	coagulation	NOUN
ctmj-186	78	62	abnormalities	abnormality	NOUN
ctmj-186	78	63	in	in	ADP
ctmj-186	78	64	model	model	NOUN
ctmj-186	78	65	rats	rat	NOUN
ctmj-186	78	66	.	.	PUNCT
ctmj-186	79	1	after	after	SCONJ
ctmj-186	79	2	the	the	DET
ctmj-186	79	3	model	model	NOUN
ctmj-186	79	4	was	be	AUX
ctmj-186	79	5	replicated	replicate	VERB
ctmj-186	79	6	,	,	PUNCT
ctmj-186	79	7	different	different	ADJ
ctmj-186	79	8	doses	dose	NOUN
ctmj-186	79	9	of	of	ADP
ctmj-186	79	10	cddp	cddp	PROPN
ctmj-186	79	11	improved	improve	VERB
ctmj-186	79	12	lps‑induced	lps‑induce	VERB
ctmj-186	79	13	coagulation	coagulation	NOUN
ctmj-186	79	14	dysfunction	dysfunction	NOUN
ctmj-186	79	15	.	.	PUNCT
ctmj-186	80	1	notably	notably	ADV
ctmj-186	80	2	,	,	PUNCT
ctmj-186	80	3	the	the	DET
ctmj-186	80	4	cddp‑h	cddp‑h	ADJ
ctmj-186	80	5	group	group	NOUN
ctmj-186	80	6	showed	show	VERB
ctmj-186	80	7	significant	significant	ADJ
ctmj-186	80	8	improvement	improvement	NOUN
ctmj-186	80	9	than	than	ADP
ctmj-186	80	10	that	that	PRON
ctmj-186	80	11	of	of	ADP
ctmj-186	80	12	the	the	DET
ctmj-186	80	13	model	model	NOUN
ctmj-186	80	14	group	group	NOUN
ctmj-186	80	15	(	(	PUNCT
ctmj-186	80	16	p	p	X
ctmj-186	80	17	<	<	X
ctmj-186	80	18	0.01	0.01	NUM
ctmj-186	80	19	)	)	PUNCT
ctmj-186	80	20	,	,	PUNCT
ctmj-186	80	21	demonstrating	demonstrate	VERB
ctmj-186	80	22	an	an	DET
ctmj-186	80	23	effect	effect	NOUN
ctmj-186	80	24	comparable	comparable	ADJ
ctmj-186	80	25	to	to	ADP
ctmj-186	80	26	that	that	PRON
ctmj-186	80	27	of	of	ADP
ctmj-186	80	28	the	the	DET
ctmj-186	80	29	nadroparin	nadroparin	PROPN
ctmj-186	80	30	calcium	calcium	NOUN
ctmj-186	80	31	group	group	NOUN
ctmj-186	81	1	[	[	X
ctmj-186	81	2	figure	figure	NOUN
ctmj-186	81	3	1b	1b	NUM
ctmj-186	81	4	]	]	PUNCT
ctmj-186	81	5	.	.	PUNCT
ctmj-186	82	1	effect	effect	NOUN
ctmj-186	82	2	of	of	ADP
ctmj-186	82	3	compound	compound	NOUN
ctmj-186	82	4	danshen	danshen	NOUN
ctmj-186	82	5	dripping	dripping	ADJ
ctmj-186	82	6	pill	pill	NOUN
ctmj-186	82	7	on	on	ADP
ctmj-186	82	8	inflammatory	inflammatory	ADJ
ctmj-186	82	9	factors	factor	NOUN
ctmj-186	82	10	in	in	ADP
ctmj-186	82	11	lipopolysaccharide‑induced	lipopolysaccharide‑induce	VERB
ctmj-186	82	12	model	model	NOUN
ctmj-186	82	13	animals	animal	NOUN
ctmj-186	82	14	compared	compare	VERB
ctmj-186	82	15	with	with	ADP
ctmj-186	82	16	the	the	DET
ctmj-186	82	17	control	control	NOUN
ctmj-186	82	18	group	group	NOUN
ctmj-186	82	19	,	,	PUNCT
ctmj-186	82	20	the	the	DET
ctmj-186	82	21	model	model	NOUN
ctmj-186	82	22	group	group	NOUN
ctmj-186	82	23	demonstrated	demonstrate	VERB
ctmj-186	82	24	a	a	DET
ctmj-186	82	25	significant	significant	ADJ
ctmj-186	82	26	increase	increase	NOUN
ctmj-186	82	27	in	in	ADP
ctmj-186	82	28	serum	serum	NOUN
ctmj-186	82	29	il-10	il-10	X
ctmj-186	82	30	and	and	CCONJ
ctmj-186	82	31	tnf‑	tnf‑	VERB
ctmj-186	82	32	levels	level	NOUN
ctmj-186	82	33	(	(	PUNCT
ctmj-186	82	34	p	p	X
ctmj-186	82	35	<	<	X
ctmj-186	82	36	0.05	0.05	NUM
ctmj-186	82	37	)	)	PUNCT
ctmj-186	82	38	.	.	PUNCT
ctmj-186	83	1	different	different	ADJ
ctmj-186	83	2	doses	dose	NOUN
ctmj-186	83	3	of	of	ADP
ctmj-186	83	4	cddp	cddp	PROPN
ctmj-186	83	5	improved	improve	VERB
ctmj-186	83	6	the	the	DET
ctmj-186	83	7	lps‑induced	lps‑induce	VERB
ctmj-186	83	8	abnormal	abnormal	ADJ
ctmj-186	83	9	increase	increase	NOUN
ctmj-186	83	10	in	in	ADP
ctmj-186	83	11	inflammatory	inflammatory	ADJ
ctmj-186	83	12	factors	factor	NOUN
ctmj-186	83	13	(	(	PUNCT
ctmj-186	83	14	p	p	X
ctmj-186	83	15	<	<	X
ctmj-186	83	16	0.05	0.05	NUM
ctmj-186	83	17	)	)	PUNCT
ctmj-186	83	18	,	,	PUNCT
ctmj-186	83	19	which	which	PRON
ctmj-186	83	20	was	be	AUX
ctmj-186	83	21	equivalent	equivalent	ADJ
ctmj-186	83	22	to	to	ADP
ctmj-186	83	23	the	the	DET
ctmj-186	83	24	effect	effect	NOUN
ctmj-186	83	25	of	of	ADP
ctmj-186	83	26	nadroparin	nadroparin	ADJ
ctmj-186	83	27	calcium	calcium	NOUN
ctmj-186	83	28	,	,	PUNCT
ctmj-186	83	29	suggesting	suggest	VERB
ctmj-186	83	30	that	that	SCONJ
ctmj-186	83	31	cddp	cddp	PROPN
ctmj-186	83	32	exerts	exert	VERB
ctmj-186	83	33	an	an	DET
ctmj-186	83	34	inhibitory	inhibitory	ADJ
ctmj-186	83	35	effect	effect	NOUN
ctmj-186	83	36	on	on	ADP
ctmj-186	83	37	inflammatory	inflammatory	ADJ
ctmj-186	83	38	factors	factor	NOUN
ctmj-186	83	39	in	in	ADP
ctmj-186	83	40	lps‑induced	lps‑induced	ADJ
ctmj-186	83	41	model	model	NOUN
ctmj-186	83	42	animals	animal	NOUN
ctmj-186	83	43	[	[	PUNCT
ctmj-186	83	44	figure	figure	NOUN
ctmj-186	83	45	1c	1c	NOUN
ctmj-186	83	46	]	]	PUNCT
ctmj-186	83	47	.	.	PUNCT
ctmj-186	84	1	effect	effect	NOUN
ctmj-186	84	2	of	of	ADP
ctmj-186	84	3	compound	compound	NOUN
ctmj-186	84	4	danshen	danshen	NOUN
ctmj-186	84	5	dripping	dripping	ADJ
ctmj-186	84	6	pill	pill	NOUN
ctmj-186	84	7	on	on	ADP
ctmj-186	84	8	liver	liver	NOUN
ctmj-186	84	9	and	and	CCONJ
ctmj-186	84	10	kidney	kidney	NOUN
ctmj-186	84	11	function	function	NOUN
ctmj-186	84	12	of	of	ADP
ctmj-186	84	13	lipopolysaccharide‑induced	lipopolysaccharide‑induce	VERB
ctmj-186	84	14	animal	animal	NOUN
ctmj-186	84	15	model	model	NOUN
ctmj-186	84	16	compared	compare	VERB
ctmj-186	84	17	with	with	ADP
ctmj-186	84	18	the	the	DET
ctmj-186	84	19	control	control	NOUN
ctmj-186	84	20	group	group	NOUN
ctmj-186	84	21	,	,	PUNCT
ctmj-186	84	22	the	the	DET
ctmj-186	84	23	model	model	NOUN
ctmj-186	84	24	group	group	NOUN
ctmj-186	84	25	demonstrated	demonstrate	VERB
ctmj-186	84	26	an	an	DET
ctmj-186	84	27	abnormal	abnormal	ADJ
ctmj-186	84	28	increase	increase	NOUN
ctmj-186	84	29	in	in	ADP
ctmj-186	84	30	gpt	gpt	NOUN
ctmj-186	84	31	and	and	CCONJ
ctmj-186	84	32	got	get	VERB
ctmj-186	84	33	activities	activity	NOUN
ctmj-186	84	34	and	and	CCONJ
ctmj-186	84	35	blood	blood	NOUN
ctmj-186	84	36	ctmj	ctmj	NOUN
ctmj-186	84	37	|	|	ADV
ctmj-186	84	38	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-186	84	39	chinese	chinese	ADJ
ctmj-186	84	40	traditional	traditional	ADJ
ctmj-186	84	41	medicine	medicine	NOUN
ctmj-186	84	42	journal	journal	NOUN
ctmj-186	84	43	|	|	ADV
ctmj-186	84	44	2025	2025	NUM
ctmj-186	84	45	|	|	ADV
ctmj-186	84	46	vol	vol	NOUN
ctmj-186	84	47	8	8	NUM
ctmj-186	84	48	|issue	|issue	NOUN
ctmj-186	84	49	1	1	NUM
ctmj-186	84	50	25	25	NUM
ctmj-186	84	51	figure	figure	NOUN
ctmj-186	84	52	1	1	NUM
ctmj-186	84	53	:	:	PUNCT
ctmj-186	84	54	lipopolysaccharide‑induced	lipopolysaccharide‑induce	VERB
ctmj-186	84	55	disseminated	disseminate	VERB
ctmj-186	84	56	intravascular	intravascular	ADJ
ctmj-186	84	57	coagulation	coagulation	NOUN
ctmj-186	84	58	model	model	NOUN
ctmj-186	84	59	assay	assay	VERB
ctmj-186	84	60	.	.	PUNCT
ctmj-186	85	1	(	(	PUNCT
ctmj-186	85	2	a	a	X
ctmj-186	85	3	)	)	PUNCT
ctmj-186	85	4	the	the	DET
ctmj-186	85	5	72	72	NUM
ctmj-186	85	6	h	h	NOUN
ctmj-186	85	7	survival	survival	NOUN
ctmj-186	85	8	rate	rate	NOUN
ctmj-186	85	9	of	of	ADP
ctmj-186	85	10	model	model	NOUN
ctmj-186	85	11	mice	mouse	NOUN
ctmj-186	85	12	(	(	PUNCT
ctmj-186	85	13	n	n	NOUN
ctmj-186	85	14	=	=	SYM
ctmj-186	85	15	8)	8)	NUM
ctmj-186	85	16	.	.	PUNCT
ctmj-186	86	1	(	(	PUNCT
ctmj-186	86	2	b	b	NOUN
ctmj-186	86	3	;	;	PUNCT
ctmj-186	86	4	a	a	PRON
ctmj-186	86	5	and	and	CCONJ
ctmj-186	86	6	b	b	NOUN
ctmj-186	86	7	)	)	PUNCT
ctmj-186	86	8	effect	effect	NOUN
ctmj-186	86	9	of	of	ADP
ctmj-186	86	10	compound	compound	NOUN
ctmj-186	86	11	danshen	danshen	NOUN
ctmj-186	86	12	dripping	dripping	ADJ
ctmj-186	86	13	pill	pill	NOUN
ctmj-186	86	14	on	on	ADP
ctmj-186	86	15	pt	pt	NOUN
ctmj-186	86	16	value	value	NOUN
ctmj-186	86	17	and	and	CCONJ
ctmj-186	86	18	fib	fib	ADJ
ctmj-186	86	19	levels	level	NOUN
ctmj-186	86	20	in	in	ADP
ctmj-186	86	21	model	model	NOUN
ctmj-186	86	22	rats	rat	NOUN
ctmj-186	86	23	(	(	PUNCT
ctmj-186	86	24	n	n	NOUN
ctmj-186	86	25	=	=	SYM
ctmj-186	86	26	6	6	NUM
ctmj-186	86	27	)	)	PUNCT
ctmj-186	86	28	.	.	PUNCT
ctmj-186	87	1	(	(	PUNCT
ctmj-186	87	2	c	c	X
ctmj-186	87	3	;	;	PUNCT
ctmj-186	87	4	a	a	PRON
ctmj-186	87	5	and	and	CCONJ
ctmj-186	87	6	b	b	NOUN
ctmj-186	87	7	)	)	PUNCT
ctmj-186	87	8	effect	effect	NOUN
ctmj-186	87	9	of	of	ADP
ctmj-186	87	10	compound	compound	NOUN
ctmj-186	87	11	danshen	danshen	NOUN
ctmj-186	87	12	dripping	dripping	ADJ
ctmj-186	87	13	pill	pill	NOUN
ctmj-186	87	14	on	on	ADP
ctmj-186	87	15	inflammatory	inflammatory	ADJ
ctmj-186	87	16	factors	factor	NOUN
ctmj-186	87	17	in	in	ADP
ctmj-186	87	18	model	model	NOUN
ctmj-186	87	19	rats	rat	NOUN
ctmj-186	87	20	(	(	PUNCT
ctmj-186	87	21	n	n	NOUN
ctmj-186	87	22	=	=	SYM
ctmj-186	87	23	6	6	NUM
ctmj-186	87	24	)	)	PUNCT
ctmj-186	87	25	.	.	PUNCT
ctmj-186	88	1	(	(	PUNCT
ctmj-186	88	2	d	d	NOUN
ctmj-186	88	3	;	;	PUNCT
ctmj-186	88	4	a‑d	a‑d	NOUN
ctmj-186	88	5	)	)	PUNCT
ctmj-186	88	6	effect	effect	NOUN
ctmj-186	88	7	of	of	ADP
ctmj-186	88	8	compound	compound	NOUN
ctmj-186	88	9	danshen	danshen	NOUN
ctmj-186	88	10	dripping	dripping	ADJ
ctmj-186	88	11	pill	pill	NOUN
ctmj-186	88	12	on	on	ADP
ctmj-186	88	13	hepatic	hepatic	ADJ
ctmj-186	88	14	and	and	CCONJ
ctmj-186	88	15	kidney	kidney	NOUN
ctmj-186	88	16	injury	injury	NOUN
ctmj-186	88	17	in	in	ADP
ctmj-186	88	18	model	model	NOUN
ctmj-186	88	19	rats	rat	NOUN
ctmj-186	88	20	(	(	PUNCT
ctmj-186	88	21	n	n	NOUN
ctmj-186	88	22	=	=	SYM
ctmj-186	88	23	6	6	NUM
ctmj-186	88	24	)	)	PUNCT
ctmj-186	88	25	in	in	ADP
ctmj-186	88	26	comparison	comparison	NOUN
ctmj-186	88	27	with	with	ADP
ctmj-186	88	28	control	control	NOUN
ctmj-186	88	29	rates	rate	NOUN
ctmj-186	88	30	.	.	PUNCT
ctmj-186	89	1	#	#	SYM
ctmj-186	89	2	p	p	X
ctmj-186	89	3	<	<	X
ctmj-186	89	4	0.05	0.05	NUM
ctmj-186	89	5	,	,	PUNCT
ctmj-186	89	6	#	#	SYM
ctmj-186	89	7	#	#	SYM
ctmj-186	89	8	p	p	X
ctmj-186	89	9	<	<	X
ctmj-186	89	10	0.01	0.01	NUM
ctmj-186	89	11	;	;	PUNCT
ctmj-186	89	12	comparison	comparison	NOUN
ctmj-186	89	13	with	with	ADP
ctmj-186	89	14	the	the	DET
ctmj-186	89	15	model	model	NOUN
ctmj-186	89	16	group	group	NOUN
ctmj-186	89	17	,	,	PUNCT
ctmj-186	89	18	*	*	PUNCT
ctmj-186	89	19	p	p	X
ctmj-186	89	20	<	<	X
ctmj-186	89	21	0.05	0.05	NUM
ctmj-186	89	22	,	,	PUNCT
ctmj-186	89	23	*	*	PUNCT
ctmj-186	89	24	*	*	PUNCT
ctmj-186	89	25	p	p	X
ctmj-186	89	26	<	<	X
ctmj-186	89	27	0.01	0.01	NUM
ctmj-186	89	28	.	.	PUNCT
ctmj-186	89	29	cddp	cddp	PROPN
ctmj-186	89	30	:	:	PUNCT
ctmj-186	89	31	compound	compound	NOUN
ctmj-186	89	32	danshen	danshen	ADJ
ctmj-186	89	33	dripping	dripping	ADJ
ctmj-186	89	34	pills	pill	NOUN
ctmj-186	89	35	urea	urea	NOUN
ctmj-186	89	36	nitrogen	nitrogen	NOUN
ctmj-186	89	37	(	(	PUNCT
ctmj-186	89	38	bun	bun	PROPN
ctmj-186	89	39	)	)	PUNCT
ctmj-186	89	40	and	and	CCONJ
ctmj-186	89	41	creatinine	creatinine	NOUN
ctmj-186	89	42	(	(	PUNCT
ctmj-186	89	43	cr	cr	NOUN
ctmj-186	89	44	)	)	PUNCT
ctmj-186	89	45	levels	level	NOUN
ctmj-186	89	46	in	in	ADP
ctmj-186	89	47	the	the	DET
ctmj-186	89	48	model	model	NOUN
ctmj-186	89	49	group	group	NOUN
ctmj-186	89	50	(	(	PUNCT
ctmj-186	89	51	p	p	X
ctmj-186	89	52	<	<	X
ctmj-186	89	53	0.01	0.01	NUM
ctmj-186	89	54	)	)	PUNCT
ctmj-186	89	55	,	,	PUNCT
ctmj-186	89	56	suggesting	suggest	VERB
ctmj-186	89	57	that	that	SCONJ
ctmj-186	89	58	the	the	DET
ctmj-186	89	59	model	model	NOUN
ctmj-186	89	60	rats	rat	NOUN
ctmj-186	89	61	suffered	suffer	VERB
ctmj-186	89	62	a	a	DET
ctmj-186	89	63	certain	certain	ADJ
ctmj-186	89	64	degree	degree	NOUN
ctmj-186	89	65	of	of	ADP
ctmj-186	89	66	liver	liver	NOUN
ctmj-186	89	67	and	and	CCONJ
ctmj-186	89	68	kidney	kidney	NOUN
ctmj-186	89	69	damage	damage	NOUN
ctmj-186	89	70	.	.	PUNCT
ctmj-186	90	1	different	different	ADJ
ctmj-186	90	2	doses	dose	NOUN
ctmj-186	90	3	of	of	ADP
ctmj-186	90	4	cddp	cddp	PROPN
ctmj-186	90	5	significantly	significantly	ADV
ctmj-186	90	6	reduced	reduce	VERB
ctmj-186	90	7	the	the	DET
ctmj-186	90	8	activities	activity	NOUN
ctmj-186	90	9	of	of	ADP
ctmj-186	90	10	gpt	gpt	NOUN
ctmj-186	90	11	and	and	CCONJ
ctmj-186	90	12	got	get	VERB
ctmj-186	90	13	(	(	PUNCT
ctmj-186	90	14	p	p	X
ctmj-186	90	15	<	<	X
ctmj-186	90	16	0.01	0.01	NUM
ctmj-186	90	17	)	)	PUNCT
ctmj-186	90	18	and	and	CCONJ
ctmj-186	90	19	the	the	DET
ctmj-186	90	20	levels	level	NOUN
ctmj-186	90	21	of	of	ADP
ctmj-186	90	22	bun	bun	PROPN
ctmj-186	90	23	and	and	CCONJ
ctmj-186	90	24	cr	cr	PROPN
ctmj-186	90	25	(	(	PUNCT
ctmj-186	90	26	p	p	X
ctmj-186	90	27	<	<	X
ctmj-186	90	28	0.01	0.01	NUM
ctmj-186	90	29	)	)	PUNCT
ctmj-186	90	30	in	in	ADP
ctmj-186	90	31	rat	rat	NOUN
ctmj-186	90	32	plasma	plasma	NOUN
ctmj-186	90	33	,	,	PUNCT
ctmj-186	90	34	similar	similar	ADJ
ctmj-186	90	35	to	to	ADP
ctmj-186	90	36	the	the	DET
ctmj-186	90	37	effect	effect	NOUN
ctmj-186	90	38	exerted	exert	VERB
ctmj-186	90	39	by	by	ADP
ctmj-186	90	40	nadroparin	nadroparin	ADJ
ctmj-186	90	41	calcium	calcium	NOUN
ctmj-186	90	42	.	.	PUNCT
ctmj-186	91	1	these	these	DET
ctmj-186	91	2	results	result	NOUN
ctmj-186	91	3	suggested	suggest	VERB
ctmj-186	91	4	that	that	SCONJ
ctmj-186	91	5	cddp	cddp	PROPN
ctmj-186	91	6	exerts	exert	VERB
ctmj-186	91	7	a	a	DET
ctmj-186	91	8	protective	protective	ADJ
ctmj-186	91	9	effect	effect	NOUN
ctmj-186	91	10	against	against	ADP
ctmj-186	91	11	lps‑induced	lps‑induce	VERB
ctmj-186	91	12	liver	liver	NOUN
ctmj-186	91	13	and	and	CCONJ
ctmj-186	91	14	kidney	kidney	NOUN
ctmj-186	91	15	injury	injury	NOUN
ctmj-186	91	16	in	in	ADP
ctmj-186	91	17	model	model	NOUN
ctmj-186	91	18	animals	animal	NOUN
ctmj-186	91	19	[	[	PUNCT
ctmj-186	91	20	figure	figure	NOUN
ctmj-186	91	21	1d	1d	NUM
ctmj-186	91	22	]	]	PUNCT
ctmj-186	91	23	.	.	PUNCT
ctmj-186	92	1	histopathological	histopathological	ADJ
ctmj-186	92	2	observation	observation	NOUN
ctmj-186	92	3	of	of	ADP
ctmj-186	92	4	the	the	DET
ctmj-186	92	5	effects	effect	NOUN
ctmj-186	92	6	of	of	ADP
ctmj-186	92	7	cddp	cddp	NOUN
ctmj-186	92	8	on	on	ADP
ctmj-186	92	9	lipopolysaccharide	lipopolysaccharide	ADV
ctmj-186	92	10	-	-	PUNCT
ctmj-186	92	11	induced	induce	VERB
ctmj-186	92	12	animal	animal	NOUN
ctmj-186	92	13	model	model	NOUN
ctmj-186	92	14	.	.	PUNCT
ctmj-186	93	1	hematoxylin	hematoxylin	PROPN
ctmj-186	93	2	and	and	CCONJ
ctmj-186	93	3	eosin	eosin	NOUN
ctmj-186	93	4	staining	stain	VERB
ctmj-186	93	5	revealed	reveal	VERB
ctmj-186	93	6	initial	initial	ADJ
ctmj-186	93	7	pathological	pathological	ADJ
ctmj-186	93	8	damage	damage	NOUN
ctmj-186	93	9	6	6	NUM
ctmj-186	93	10	h	h	NOUN
ctmj-186	93	11	following	follow	VERB
ctmj-186	93	12	the	the	DET
ctmj-186	93	13	intraperitoneal	intraperitoneal	ADJ
ctmj-186	93	14	injection	injection	NOUN
ctmj-186	93	15	of	of	ADP
ctmj-186	93	16	lps	lps	PROPN
ctmj-186	93	17	in	in	ADP
ctmj-186	93	18	animals	animal	NOUN
ctmj-186	93	19	in	in	ADP
ctmj-186	93	20	the	the	DET
ctmj-186	93	21	model	model	NOUN
ctmj-186	93	22	group	group	NOUN
ctmj-186	93	23	.	.	PUNCT
ctmj-186	94	1	different	different	ADJ
ctmj-186	94	2	levels	level	NOUN
ctmj-186	94	3	of	of	ADP
ctmj-186	94	4	cddp	cddp	PROPN
ctmj-186	94	5	reduced	reduce	VERB
ctmj-186	94	6	the	the	DET
ctmj-186	94	7	initial	initial	ADJ
ctmj-186	94	8	pathological	pathological	ADJ
ctmj-186	94	9	damage	damage	NOUN
ctmj-186	94	10	caused	cause	VERB
ctmj-186	94	11	by	by	ADP
ctmj-186	94	12	lps‑induced	lps‑induce	VERB
ctmj-186	94	13	dic	dic	NOUN
ctmj-186	94	14	in	in	ADP
ctmj-186	94	15	the	the	DET
ctmj-186	94	16	lungs	lung	NOUN
ctmj-186	94	17	,	,	PUNCT
ctmj-186	94	18	liver	liver	NOUN
ctmj-186	94	19	,	,	PUNCT
ctmj-186	94	20	and	and	CCONJ
ctmj-186	94	21	kidneys	kidney	NOUN
ctmj-186	95	1	[	[	PUNCT
ctmj-186	95	2	figure	figure	NOUN
ctmj-186	95	3	3	3	NUM
ctmj-186	95	4	]	]	PUNCT
ctmj-186	95	5	.	.	PUNCT
ctmj-186	96	1	in	in	ADP
ctmj-186	96	2	the	the	DET
ctmj-186	96	3	control	control	NOUN
ctmj-186	96	4	group	group	NOUN
ctmj-186	96	5	,	,	PUNCT
ctmj-186	96	6	the	the	DET
ctmj-186	96	7	alveolar	alveolar	ADJ
ctmj-186	96	8	septum	septum	NOUN
ctmj-186	96	9	wall	wall	NOUN
ctmj-186	96	10	was	be	AUX
ctmj-186	96	11	thin	thin	ADJ
ctmj-186	96	12	,	,	PUNCT
ctmj-186	96	13	and	and	CCONJ
ctmj-186	96	14	the	the	DET
ctmj-186	96	15	cells	cell	NOUN
ctmj-186	96	16	were	be	AUX
ctmj-186	96	17	normal	normal	ADJ
ctmj-186	96	18	,	,	PUNCT
ctmj-186	96	19	whereas	whereas	SCONJ
ctmj-186	96	20	,	,	PUNCT
ctmj-186	96	21	in	in	ADP
ctmj-186	96	22	the	the	DET
ctmj-186	96	23	model	model	NOUN
ctmj-186	96	24	group	group	NOUN
ctmj-186	96	25	,	,	PUNCT
ctmj-186	96	26	the	the	DET
ctmj-186	96	27	alveolar	alveolar	ADJ
ctmj-186	96	28	septum	septum	NOUN
ctmj-186	96	29	wall	wall	NOUN
ctmj-186	96	30	was	be	AUX
ctmj-186	96	31	thick	thick	ADJ
ctmj-186	96	32	,	,	PUNCT
ctmj-186	96	33	with	with	ADP
ctmj-186	96	34	alveolar	alveolar	ADJ
ctmj-186	96	35	septal	septal	ADJ
ctmj-186	96	36	capillary	capillary	ADJ
ctmj-186	96	37	dilation	dilation	NOUN
ctmj-186	96	38	congestion	congestion	NOUN
ctmj-186	96	39	(	(	PUNCT
ctmj-186	96	40	▲	▲	PUNCT
ctmj-186	96	41	)	)	PUNCT
ctmj-186	96	42	,	,	PUNCT
ctmj-186	96	43	which	which	PRON
ctmj-186	96	44	increased	increase	VERB
ctmj-186	96	45	around	around	ADP
ctmj-186	96	46	the	the	DET
ctmj-186	96	47	blood	blood	NOUN
ctmj-186	96	48	vessels	vessel	NOUN
ctmj-186	96	49	,	,	PUNCT
ctmj-186	96	50	along	along	ADP
ctmj-186	96	51	with	with	ADP
ctmj-186	96	52	edema	edema	NOUN
ctmj-186	96	53	(	(	PUNCT
ctmj-186	96	54	★	★	NOUN
ctmj-186	96	55	)	)	PUNCT
ctmj-186	96	56	.	.	PUNCT
ctmj-186	97	1	in	in	ADP
ctmj-186	97	2	the	the	DET
ctmj-186	97	3	control	control	NOUN
ctmj-186	97	4	group	group	NOUN
ctmj-186	97	5	,	,	PUNCT
ctmj-186	97	6	the	the	DET
ctmj-186	97	7	liver	liver	NOUN
ctmj-186	97	8	cells	cell	NOUN
ctmj-186	97	9	were	be	AUX
ctmj-186	97	10	arranged	arrange	VERB
ctmj-186	97	11	in	in	ADP
ctmj-186	97	12	plates	plate	NOUN
ctmj-186	97	13	,	,	PUNCT
ctmj-186	97	14	the	the	DET
ctmj-186	97	15	central	central	ADJ
ctmj-186	97	16	vein	vein	NOUN
ctmj-186	97	17	was	be	AUX
ctmj-186	97	18	filled	fill	VERB
ctmj-186	97	19	with	with	ADP
ctmj-186	97	20	red	red	ADJ
ctmj-186	97	21	blood	blood	NOUN
ctmj-186	97	22	cells	cell	NOUN
ctmj-186	97	23	,	,	PUNCT
ctmj-186	97	24	and	and	CCONJ
ctmj-186	97	25	the	the	DET
ctmj-186	97	26	portal	portal	ADJ
ctmj-186	97	27	area	area	NOUN
ctmj-186	97	28	vessels	vessel	NOUN
ctmj-186	97	29	and	and	CCONJ
ctmj-186	97	30	bile	bile	NOUN
ctmj-186	97	31	ducts	duct	NOUN
ctmj-186	97	32	were	be	AUX
ctmj-186	97	33	arranged	arrange	VERB
ctmj-186	97	34	normally	normally	ADV
ctmj-186	97	35	;	;	PUNCT
ctmj-186	97	36	whereas	whereas	SCONJ
ctmj-186	97	37	the	the	DET
ctmj-186	97	38	model	model	NOUN
ctmj-186	97	39	group	group	NOUN
ctmj-186	97	40	exhibited	exhibit	VERB
ctmj-186	97	41	hepatocyte	hepatocyte	NOUN
ctmj-186	97	42	vacuolar	vacuolar	ADJ
ctmj-186	97	43	degeneration	degeneration	NOUN
ctmj-186	97	44	(	(	PUNCT
ctmj-186	97	45	×	×	NOUN
ctmj-186	97	46	)	)	PUNCT
ctmj-186	97	47	,	,	PUNCT
ctmj-186	97	48	partial	partial	ADJ
ctmj-186	97	49	nuclear	nuclear	ADJ
ctmj-186	97	50	lysis	lysis	NOUN
ctmj-186	97	51	,	,	PUNCT
ctmj-186	97	52	and	and	CCONJ
ctmj-186	97	53	hepatic	hepatic	ADJ
ctmj-186	97	54	sinusoid	sinusoid	ADJ
ctmj-186	97	55	dilatation	dilatation	NOUN
ctmj-186	97	56	and	and	CCONJ
ctmj-186	97	57	congestion	congestion	NOUN
ctmj-186	97	58	(	(	PUNCT
ctmj-186	97	59	on	on	ADP
ctmj-186	97	60	,	,	PUNCT
ctmj-186	97	61	without	without	ADP
ctmj-186	97	62	inflammatory	inflammatory	ADJ
ctmj-186	97	63	cell	cell	NOUN
ctmj-186	97	64	infiltration	infiltration	NOUN
ctmj-186	97	65	.	.	PUNCT
ctmj-186	98	1	in	in	ADP
ctmj-186	98	2	the	the	DET
ctmj-186	98	3	model	model	NOUN
ctmj-186	98	4	group	group	NOUN
ctmj-186	98	5	,	,	PUNCT
ctmj-186	98	6	no	no	DET
ctmj-186	98	7	abnormalities	abnormality	NOUN
ctmj-186	98	8	were	be	AUX
ctmj-186	98	9	observed	observe	VERB
ctmj-186	98	10	in	in	ADP
ctmj-186	98	11	the	the	DET
ctmj-186	98	12	glomeruli	glomeruli	NOUN
ctmj-186	98	13	,	,	PUNCT
ctmj-186	98	14	but	but	CCONJ
ctmj-186	98	15	there	there	PRON
ctmj-186	98	16	was	be	VERB
ctmj-186	98	17	an	an	DET
ctmj-186	98	18	increase	increase	NOUN
ctmj-186	98	19	in	in	ADP
ctmj-186	98	20	red	red	ADJ
ctmj-186	98	21	blood	blood	NOUN
ctmj-186	98	22	cells	cell	NOUN
ctmj-186	98	23	and	and	CCONJ
ctmj-186	98	24	congestion	congestion	NOUN
ctmj-186	98	25	in	in	ADP
ctmj-186	98	26	the	the	DET
ctmj-186	98	27	renal	renal	ADJ
ctmj-186	98	28	interstitial	interstitial	ADJ
ctmj-186	98	29	capillary	capillary	ADJ
ctmj-186	98	30	(	(	PUNCT
ctmj-186	98	31	ap	ap	PROPN
ctmj-186	98	32	.	.	PUNCT
ctmj-186	99	1	compared	compare	VERB
ctmj-186	99	2	with	with	ADP
ctmj-186	99	3	the	the	DET
ctmj-186	99	4	model	model	NOUN
ctmj-186	99	5	and	and	CCONJ
ctmj-186	99	6	control	control	NOUN
ctmj-186	99	7	group	group	NOUN
ctmj-186	99	8	,	,	PUNCT
ctmj-186	99	9	the	the	DET
ctmj-186	99	10	cddp	cddp	PROPN
ctmj-186	99	11	group	group	PROPN
ctmj-186	99	12	exhibited	exhibit	VERB
ctmj-186	99	13	reduced	reduce	VERB
ctmj-186	99	14	pulmonary	pulmonary	ADJ
ctmj-186	99	15	edema	edema	NOUN
ctmj-186	99	16	and	and	CCONJ
ctmj-186	99	17	pulmonary	pulmonary	ADJ
ctmj-186	99	18	perivascular	perivascular	ADJ
ctmj-186	99	19	space	space	NOUN
ctmj-186	99	20	,	,	PUNCT
ctmj-186	99	21	decreased	decrease	VERB
ctmj-186	99	22	hepatocyte	hepatocyte	ADJ
ctmj-186	99	23	vacuolar	vacuolar	ADJ
ctmj-186	99	24	degeneration	degeneration	NOUN
ctmj-186	99	25	,	,	PUNCT
ctmj-186	99	26	and	and	CCONJ
ctmj-186	99	27	improved	improve	VERB
ctmj-186	99	28	renal	renal	ADJ
ctmj-186	99	29	interstitial	interstitial	ADJ
ctmj-186	99	30	capillary	capillary	ADJ
ctmj-186	99	31	congestion	congestion	NOUN
ctmj-186	99	32	.	.	PUNCT
ctmj-186	100	1	transcriptome	transcriptome	ADJ
ctmj-186	100	2	sequencing	sequence	VERB
ctmj-186	100	3	analysis	analysis	NOUN
ctmj-186	100	4	and	and	CCONJ
ctmj-186	100	5	verification	verification	NOUN
ctmj-186	100	6	transcriptome	transcriptome	ADJ
ctmj-186	100	7	sequencing	sequence	VERB
ctmj-186	100	8	analysis	analysis	NOUN
ctmj-186	100	9	we	we	PRON
ctmj-186	100	10	used	use	VERB
ctmj-186	100	11	the	the	DET
ctmj-186	100	12	screening	screening	NOUN
ctmj-186	100	13	conditions	condition	NOUN
ctmj-186	100	14	of	of	ADP
ctmj-186	100	15	|	|	ADV
ctmj-186	100	16	log2fc	log2fc	PROPN
ctmj-186	101	1	|	|	ADV
ctmj-186	101	2	≥1	≥1	NUM
ctmj-186	101	3	and	and	CCONJ
ctmj-186	101	4	q	q	ADJ
ctmj-186	101	5	≤	≤	NUM
ctmj-186	101	6	0.05	0.05	NUM
ctmj-186	101	7	and	and	CCONJ
ctmj-186	101	8	found	find	VERB
ctmj-186	101	9	543	543	NUM
ctmj-186	101	10	common	common	ADJ
ctmj-186	101	11	and	and	CCONJ
ctmj-186	101	12	significantly	significantly	ADV
ctmj-186	101	13	differentially	differentially	ADV
ctmj-186	101	14	expressed	express	VERB
ctmj-186	101	15	genes	gene	NOUN
ctmj-186	101	16	in	in	ADP
ctmj-186	101	17	the	the	DET
ctmj-186	101	18	control	control	NOUN
ctmj-186	101	19	group	group	NOUN
ctmj-186	101	20	,	,	PUNCT
ctmj-186	101	21	model	model	NOUN
ctmj-186	101	22	group	group	NOUN
ctmj-186	101	23	,	,	PUNCT
ctmj-186	101	24	and	and	CCONJ
ctmj-186	101	25	cddp	cddp	PROPN
ctmj-186	101	26	group	group	NOUN
ctmj-186	102	1	[	[	X
ctmj-186	102	2	figure	figure	NOUN
ctmj-186	102	3	4a	4a	NOUN
ctmj-186	102	4	]	]	PUNCT
ctmj-186	102	5	.	.	PUNCT
ctmj-186	103	1	a	a	DET
ctmj-186	103	2	b	b	NOUN
ctmj-186	103	3	a	a	DET
ctmj-186	103	4	a	a	DET
ctmj-186	103	5	b	b	PROPN
ctmj-186	103	6	b	b	PROPN
ctmj-186	103	7	c	c	NOUN
ctmj-186	103	8	d	d	X
ctmj-186	103	9	ctmj	ctmj	NOUN
ctmj-186	103	10	|	|	ADV
ctmj-186	103	11	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-186	103	12	chinese	chinese	ADJ
ctmj-186	103	13	traditional	traditional	ADJ
ctmj-186	103	14	medicine	medicine	NOUN
ctmj-186	103	15	journal	journal	NOUN
ctmj-186	103	16	|	|	ADV
ctmj-186	103	17	2025	2025	NUM
ctmj-186	103	18	|	|	ADV
ctmj-186	103	19	vol	vol	NOUN
ctmj-186	103	20	8	8	NUM
ctmj-186	103	21	|issue	|issue	NOUN
ctmj-186	103	22	1	1	NUM
ctmj-186	103	23	26	26	NUM
ctmj-186	103	24	a	a	DET
ctmj-186	103	25	b	b	NOUN
ctmj-186	103	26	c	c	NOUN
ctmj-186	103	27	d	d	NOUN
ctmj-186	103	28	figure	figure	NOUN
ctmj-186	103	29	2	2	NUM
ctmj-186	103	30	:	:	PUNCT
ctmj-186	103	31	dextran‑induced	dextran‑induce	VERB
ctmj-186	103	32	microcirculatory	microcirculatory	ADJ
ctmj-186	103	33	disturbance	disturbance	NOUN
ctmj-186	103	34	model	model	NOUN
ctmj-186	103	35	assay	assay	PROPN
ctmj-186	103	36	(	(	PUNCT
ctmj-186	103	37	a	a	X
ctmj-186	103	38	)	)	PUNCT
ctmj-186	103	39	liver	liver	NOUN
ctmj-186	103	40	blood	blood	NOUN
ctmj-186	103	41	flow	flow	NOUN
ctmj-186	103	42	in	in	ADP
ctmj-186	103	43	different	different	ADJ
ctmj-186	103	44	groups	group	NOUN
ctmj-186	103	45	.	.	PUNCT
ctmj-186	104	1	(	(	PUNCT
ctmj-186	104	2	b	b	X
ctmj-186	104	3	)	)	PUNCT
ctmj-186	104	4	liver	liver	NOUN
ctmj-186	104	5	blood	blood	NOUN
ctmj-186	104	6	flow	flow	NOUN
ctmj-186	104	7	in	in	ADP
ctmj-186	104	8	different	different	ADJ
ctmj-186	104	9	groups	group	NOUN
ctmj-186	104	10	.	.	PUNCT
ctmj-186	105	1	(	(	PUNCT
ctmj-186	105	2	c	c	X
ctmj-186	105	3	)	)	PUNCT
ctmj-186	105	4	liver	liver	NOUN
ctmj-186	105	5	and	and	CCONJ
ctmj-186	105	6	gastric	gastric	ADJ
ctmj-186	105	7	fundus	fundus	NOUN
ctmj-186	105	8	blood	blood	NOUN
ctmj-186	105	9	flow	flow	NOUN
ctmj-186	105	10	between	between	ADP
ctmj-186	105	11	0	0	NUM
ctmj-186	105	12	and	and	CCONJ
ctmj-186	105	13	30	30	NUM
ctmj-186	105	14	min	min	NOUN
ctmj-186	105	15	after	after	ADP
ctmj-186	105	16	modeling	modeling	NOUN
ctmj-186	105	17	in	in	ADP
ctmj-186	105	18	each	each	DET
ctmj-186	105	19	group	group	NOUN
ctmj-186	105	20	,	,	PUNCT
ctmj-186	105	21	#	#	SYM
ctmj-186	105	22	p	p	X
ctmj-186	105	23	<	<	X
ctmj-186	105	24	0.05	0.05	NUM
ctmj-186	105	25	,	,	PUNCT
ctmj-186	105	26	#	#	SYM
ctmj-186	105	27	#	#	SYM
ctmj-186	105	28	p	p	X
ctmj-186	105	29	<	<	X
ctmj-186	105	30	0.01	0.01	NUM
ctmj-186	105	31	;	;	PUNCT
ctmj-186	105	32	comparison	comparison	NOUN
ctmj-186	105	33	with	with	ADP
ctmj-186	105	34	the	the	DET
ctmj-186	105	35	model	model	NOUN
ctmj-186	105	36	group	group	NOUN
ctmj-186	105	37	,	,	PUNCT
ctmj-186	105	38	*	*	PUNCT
ctmj-186	105	39	p	p	X
ctmj-186	105	40	<	<	X
ctmj-186	105	41	0.05	0.05	NUM
ctmj-186	105	42	,	,	PUNCT
ctmj-186	105	43	*	*	PUNCT
ctmj-186	105	44	*	*	PUNCT
ctmj-186	105	45	p	p	X
ctmj-186	105	46	<	<	X
ctmj-186	105	47	0.01	0.01	NUM
ctmj-186	105	48	(	(	PUNCT
ctmj-186	105	49	n	n	NOUN
ctmj-186	105	50	=	=	SYM
ctmj-186	105	51	6	6	NUM
ctmj-186	105	52	)	)	PUNCT
ctmj-186	105	53	.	.	PUNCT
ctmj-186	106	1	cddp	cddp	PROPN
ctmj-186	106	2	:	:	PUNCT
ctmj-186	106	3	compound	compound	NOUN
ctmj-186	106	4	danshen	danshen	ADJ
ctmj-186	106	5	dripping	dripping	ADJ
ctmj-186	106	6	pills	pill	NOUN
ctmj-186	106	7	figure	figure	VERB
ctmj-186	106	8	3	3	NUM
ctmj-186	106	9	:	:	PUNCT
ctmj-186	106	10	hematoxylin	hematoxylin	NOUN
ctmj-186	106	11	and	and	CCONJ
ctmj-186	106	12	eosin	eosin	NOUN
ctmj-186	106	13	staining	stain	VERB
ctmj-186	106	14	in	in	ADP
ctmj-186	106	15	different	different	ADJ
ctmj-186	106	16	groups(×400	groups(×400	PROPN
ctmj-186	106	17	)	)	PUNCT
ctmj-186	106	18	.	.	PUNCT
ctmj-186	107	1	the	the	DET
ctmj-186	107	2	he	he	PRON
ctmj-186	107	3	staining	stain	VERB
ctmj-186	107	4	of	of	ADP
ctmj-186	107	5	the	the	DET
ctmj-186	107	6	organ	organ	NOUN
ctmj-186	107	7	tissues	tissue	NOUN
ctmj-186	107	8	were	be	AUX
ctmj-186	107	9	observed	observe	VERB
ctmj-186	107	10	under	under	ADP
ctmj-186	107	11	a	a	DET
ctmj-186	107	12	400x	400x	NUM
ctmj-186	107	13	microscope	microscope	NOUN
ctmj-186	107	14	.	.	PUNCT
ctmj-186	108	1	hematoxylin	hematoxylin	PROPN
ctmj-186	108	2	and	and	CCONJ
ctmj-186	108	3	eosin	eosin	NOUN
ctmj-186	108	4	staining	stain	VERB
ctmj-186	108	5	in	in	ADP
ctmj-186	108	6	different	different	ADJ
ctmj-186	108	7	groups	group	NOUN
ctmj-186	108	8	.	.	PUNCT
ctmj-186	109	1	in	in	ADP
ctmj-186	109	2	the	the	DET
ctmj-186	109	3	lung	lung	NOUN
ctmj-186	109	4	,	,	PUNCT
ctmj-186	109	5	the	the	DET
ctmj-186	109	6	model	model	NOUN
ctmj-186	109	7	group	group	NOUN
ctmj-186	109	8	exhibits	exhibit	VERB
ctmj-186	109	9	alveolar	alveolar	ADJ
ctmj-186	109	10	septum	septum	NOUN
ctmj-186	109	11	thickening	thickening	NOUN
ctmj-186	109	12	,	,	PUNCT
ctmj-186	110	1	alveolar	alveolar	ADJ
ctmj-186	110	2	septum	septum	NOUN
ctmj-186	110	3	capillarydilation	capillarydilation	NOUN
ctmj-186	110	4	congestion	congestion	NOUN
ctmj-186	110	5	(	(	PUNCT
ctmj-186	110	6	▲	▲	PUNCT
ctmj-186	110	7	)	)	PUNCT
ctmj-186	110	8	and	and	CCONJ
ctmj-186	110	9	increased	increase	VERB
ctmj-186	110	10	edema	edema	NOUN
ctmj-186	110	11	around	around	ADP
ctmj-186	110	12	the	the	DET
ctmj-186	110	13	blood	blood	NOUN
ctmj-186	110	14	vessels	vessel	NOUN
ctmj-186	110	15	(	(	PUNCT
ctmj-186	110	16	★	★	NOUN
ctmj-186	110	17	)	)	PUNCT
ctmj-186	110	18	.	.	PUNCT
ctmj-186	111	1	in	in	ADP
ctmj-186	111	2	the	the	DET
ctmj-186	111	3	liver	liver	NOUN
ctmj-186	111	4	,	,	PUNCT
ctmj-186	111	5	the	the	DET
ctmj-186	111	6	model	model	NOUN
ctmj-186	111	7	group	group	NOUN
ctmj-186	111	8	exhibits	exhibit	VERB
ctmj-186	111	9	hepatocyte	hepatocyte	NOUN
ctmj-186	111	10	vacuolar	vacuolar	ADJ
ctmj-186	111	11	degeneration(×	degeneration(×	PROPN
ctmj-186	111	12	)	)	PUNCT
ctmj-186	111	13	,	,	PUNCT
ctmj-186	111	14	partial	partial	ADJ
ctmj-186	111	15	nuclear	nuclear	ADJ
ctmj-186	111	16	lysis	lysis	NOUN
ctmj-186	111	17	,	,	PUNCT
ctmj-186	111	18	and	and	CCONJ
ctmj-186	111	19	hepatic	hepatic	ADJ
ctmj-186	111	20	sinusoid	sinusoid	ADJ
ctmj-186	111	21	dilatation	dilatation	NOUN
ctmj-186	111	22	and	and	CCONJ
ctmj-186	111	23	congestion	congestion	NOUN
ctmj-186	111	24	(	(	PUNCT
ctmj-186	111	25	▲	▲	NOUN
ctmj-186	111	26	)	)	PUNCT
ctmj-186	111	27	.	.	PUNCT
ctmj-186	112	1	in	in	ADP
ctmj-186	112	2	the	the	DET
ctmj-186	112	3	kidney	kidney	NOUN
ctmj-186	112	4	,	,	PUNCT
ctmj-186	112	5	the	the	DET
ctmj-186	112	6	model	model	NOUN
ctmj-186	112	7	group	group	NOUN
ctmj-186	112	8	exhibits	exhibit	VERB
ctmj-186	112	9	increased	increase	VERB
ctmj-186	112	10	in	in	ADP
ctmj-186	112	11	red	red	ADJ
ctmj-186	112	12	blood	blood	NOUN
ctmj-186	112	13	cells	cell	NOUN
ctmj-186	112	14	andcongestion	andcongestion	NOUN
ctmj-186	112	15	in	in	ADP
ctmj-186	112	16	the	the	DET
ctmj-186	112	17	renal	renal	ADJ
ctmj-186	112	18	interstitial	interstitial	ADJ
ctmj-186	112	19	capillary	capillary	ADJ
ctmj-186	112	20	(	(	PUNCT
ctmj-186	112	21	▲	▲	NOUN
ctmj-186	112	22	)	)	PUNCT
ctmj-186	112	23	,	,	PUNCT
ctmj-186	112	24	pulmonary	pulmonary	ADJ
ctmj-186	112	25	edema	edema	NOUN
ctmj-186	112	26	was	be	AUX
ctmj-186	112	27	slightly	slightly	ADV
ctmj-186	112	28	reduced	reduce	VERB
ctmj-186	112	29	and	and	CCONJ
ctmj-186	112	30	perivascular	perivascular	ADJ
ctmj-186	112	31	space	space	NOUN
ctmj-186	112	32	was	be	AUX
ctmj-186	112	33	reduced	reduce	VERB
ctmj-186	112	34	(	(	PUNCT
ctmj-186	112	35			NOUN
ctmj-186	112	36	)	)	PUNCT
ctmj-186	112	37	.	.	PUNCT
ctmj-186	113	1	a	a	DET
ctmj-186	113	2	:	:	PUNCT
ctmj-186	113	3	control	control	NOUN
ctmj-186	113	4	group;b	group;b	PROPN
ctmj-186	113	5	:	:	PUNCT
ctmj-186	113	6	model	model	NOUN
ctmj-186	113	7	group	group	NOUN
ctmj-186	113	8	;	;	PUNCT
ctmj-186	113	9	c	c	X
ctmj-186	113	10	:	:	PUNCT
ctmj-186	113	11	cddp‑h	cddp‑h	ADJ
ctmj-186	113	12	group	group	NOUN
ctmj-186	113	13	;	;	PUNCT
ctmj-186	113	14	d	d	X
ctmj-186	113	15	:	:	PUNCT
ctmj-186	113	16	fraxiparine	fraxiparine	ADJ
ctmj-186	113	17	group	group	NOUN
ctmj-186	113	18	.	.	PUNCT
ctmj-186	114	1	cddp	cddp	PROPN
ctmj-186	114	2	:	:	PUNCT
ctmj-186	114	3	compound	compound	NOUN
ctmj-186	114	4	danshen	danshen	ADJ
ctmj-186	114	5	dripping	dripping	ADJ
ctmj-186	114	6	pills	pill	NOUN
ctmj-186	114	7	differential	differential	ADJ
ctmj-186	114	8	gene	gene	NOUN
ctmj-186	114	9	enrichment	enrichment	NOUN
ctmj-186	114	10	analysis	analysis	NOUN
ctmj-186	114	11	the	the	DET
ctmj-186	114	12	gene	gene	NOUN
ctmj-186	114	13	ontology	ontology	NOUN
ctmj-186	114	14	(	(	PUNCT
ctmj-186	114	15	go	go	VERB
ctmj-186	114	16	)	)	PUNCT
ctmj-186	114	17	enrichment	enrichment	NOUN
ctmj-186	114	18	analysis	analysis	NOUN
ctmj-186	114	19	and	and	CCONJ
ctmj-186	114	20	kegg	kegg	NOUN
ctmj-186	114	21	pathway	pathway	NOUN
ctmj-186	114	22	enrichment	enrichment	NOUN
ctmj-186	114	23	analyses	analysis	NOUN
ctmj-186	114	24	were	be	AUX
ctmj-186	114	25	performed	perform	VERB
ctmj-186	114	26	on	on	ADP
ctmj-186	114	27	the	the	DET
ctmj-186	114	28	543	543	NUM
ctmj-186	114	29	genes	gene	NOUN
ctmj-186	114	30	.	.	PUNCT
ctmj-186	115	1	the	the	DET
ctmj-186	115	2	results	result	NOUN
ctmj-186	115	3	demonstrated	demonstrate	VERB
ctmj-186	115	4	that	that	SCONJ
ctmj-186	115	5	cddp	cddp	NOUN
ctmj-186	115	6	primarily	primarily	ADV
ctmj-186	115	7	participated	participate	VERB
ctmj-186	115	8	in	in	ADP
ctmj-186	115	9	the	the	DET
ctmj-186	115	10	regulation	regulation	NOUN
ctmj-186	115	11	of	of	ADP
ctmj-186	115	12	immune	immune	ADJ
ctmj-186	115	13	inflammatory	inflammatory	ADJ
ctmj-186	115	14	response	response	NOUN
ctmj-186	115	15	,	,	PUNCT
ctmj-186	115	16	complement	complement	NOUN
ctmj-186	115	17	system	system	NOUN
ctmj-186	115	18	,	,	PUNCT
ctmj-186	115	19	oxidative	oxidative	ADJ
ctmj-186	115	20	stress	stress	NOUN
ctmj-186	115	21	response	response	NOUN
ctmj-186	115	22	,	,	PUNCT
ctmj-186	115	23	covid-19	covid-19	PROPN
ctmj-186	115	24	-	-	PUNCT
ctmj-186	115	25	related	relate	VERB
ctmj-186	115	26	coagulation	coagulation	NOUN
ctmj-186	115	27	disorders	disorder	NOUN
ctmj-186	115	28	,	,	PUNCT
ctmj-186	115	29	platelet	platelet	NOUN
ctmj-186	115	30	activation	activation	NOUN
ctmj-186	115	31	,	,	PUNCT
ctmj-186	115	32	aggregation	aggregation	NOUN
ctmj-186	115	33	,	,	PUNCT
ctmj-186	115	34	and	and	CCONJ
ctmj-186	115	35	apoptosis	apoptosis	NOUN
ctmj-186	115	36	.	.	PUNCT
ctmj-186	116	1	it	it	PRON
ctmj-186	116	2	has	have	AUX
ctmj-186	116	3	been	be	AUX
ctmj-186	116	4	suggested	suggest	VERB
ctmj-186	116	5	that	that	SCONJ
ctmj-186	116	6	cddp	cddp	NOUN
ctmj-186	116	7	confers	confer	VERB
ctmj-186	116	8	therapeutic	therapeutic	ADJ
ctmj-186	116	9	potential	potential	NOUN
ctmj-186	116	10	against	against	ADP
ctmj-186	116	11	dic	dic	NOUN
ctmj-186	116	12	by	by	ADP
ctmj-186	116	13	regulating	regulate	VERB
ctmj-186	116	14	the	the	DET
ctmj-186	116	15	immune	immune	ADJ
ctmj-186	116	16	complement	complement	NOUN
ctmj-186	116	17	system	system	NOUN
ctmj-186	116	18	,	,	PUNCT
ctmj-186	116	19	exerting	exert	VERB
ctmj-186	116	20	anti‑inflammatory	anti‑inflammatory	NOUN
ctmj-186	116	21	properties	property	NOUN
ctmj-186	116	22	,	,	PUNCT
ctmj-186	116	23	promoting	promote	VERB
ctmj-186	116	24	coagulation	coagulation	NOUN
ctmj-186	116	25	and	and	CCONJ
ctmj-186	116	26	platelet	platelet	NOUN
ctmj-186	116	27	activation	activation	NOUN
ctmj-186	116	28	,	,	PUNCT
ctmj-186	116	29	countering	counter	VERB
ctmj-186	116	30	antioxidative	antioxidative	ADJ
ctmj-186	116	31	stress	stress	NOUN
ctmj-186	116	32	,	,	PUNCT
ctmj-186	116	33	and	and	CCONJ
ctmj-186	116	34	inhibiting	inhibit	VERB
ctmj-186	116	35	apoptosis	apoptosis	NOUN
ctmj-186	116	36	.	.	PUNCT
ctmj-186	117	1	gene	gene	NOUN
ctmj-186	117	2	ontology	ontology	NOUN
ctmj-186	117	3	enrichment	enrichment	NOUN
ctmj-186	117	4	analysis	analysis	NOUN
ctmj-186	117	5	we	we	PRON
ctmj-186	117	6	used	use	VERB
ctmj-186	117	7	the	the	DET
ctmj-186	117	8	dr	dr	PROPN
ctmj-186	117	9	.	.	PROPN
ctmj-186	117	10	tom	tom	PROPN
ctmj-186	117	11	online	online	PROPN
ctmj-186	117	12	system	system	NOUN
ctmj-186	117	13	to	to	PART
ctmj-186	117	14	analyze	analyze	VERB
ctmj-186	117	15	the	the	DET
ctmj-186	117	16	biological	biological	ADJ
ctmj-186	117	17	processes	process	NOUN
ctmj-186	117	18	,	,	PUNCT
ctmj-186	117	19	cellular	cellular	ADJ
ctmj-186	117	20	components	component	NOUN
ctmj-186	117	21	,	,	PUNCT
ctmj-186	117	22	and	and	CCONJ
ctmj-186	117	23	molecular	molecular	ADJ
ctmj-186	117	24	functions	function	NOUN
ctmj-186	117	25	of	of	ADP
ctmj-186	117	26	the	the	DET
ctmj-186	117	27	a	a	DET
ctmj-186	117	28	b	b	PROPN
ctmj-186	117	29	c	c	PROPN
ctmj-186	117	30	ctmj	ctmj	NOUN
ctmj-186	117	31	|	|	ADV
ctmj-186	117	32	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-186	117	33	chinese	chinese	ADJ
ctmj-186	117	34	traditional	traditional	ADJ
ctmj-186	117	35	medicine	medicine	NOUN
ctmj-186	117	36	journal	journal	NOUN
ctmj-186	117	37	|	|	ADV
ctmj-186	117	38	2025	2025	NUM
ctmj-186	117	39	|	|	ADV
ctmj-186	117	40	vol	vol	NOUN
ctmj-186	117	41	8	8	NUM
ctmj-186	117	42	|issue	|issue	NOUN
ctmj-186	117	43	1	1	NUM
ctmj-186	117	44	27	27	NUM
ctmj-186	117	45	figure	figure	NOUN
ctmj-186	117	46	4	4	NUM
ctmj-186	117	47	:	:	PUNCT
ctmj-186	117	48	whole	whole	ADJ
ctmj-186	117	49	blood	blood	NOUN
ctmj-186	117	50	transcriptome	transcriptome	ADJ
ctmj-186	117	51	sequencing	sequence	VERB
ctmj-186	117	52	differential	differential	ADJ
ctmj-186	117	53	gene	gene	NOUN
ctmj-186	117	54	analysis	analysis	NOUN
ctmj-186	117	55	and	and	CCONJ
ctmj-186	117	56	verification	verification	NOUN
ctmj-186	117	57	.	.	PUNCT
ctmj-186	118	1	(	(	PUNCT
ctmj-186	118	2	a	a	X
ctmj-186	118	3	)	)	PUNCT
ctmj-186	118	4	differential	differential	ADJ
ctmj-186	118	5	gene	gene	NOUN
ctmj-186	118	6	veen	veen	NOUN
ctmj-186	118	7	map	map	NOUN
ctmj-186	118	8	(	(	PUNCT
ctmj-186	118	9	control	control	NOUN
ctmj-186	118	10	vs.	vs.	ADP
ctmj-186	118	11	model	model	NOUN
ctmj-186	118	12	vs.	vs.	ADP
ctmj-186	118	13	cddp‑h	cddp‑h	VERB
ctmj-186	118	14	groups	group	NOUN
ctmj-186	118	15	)	)	PUNCT
ctmj-186	118	16	;	;	PUNCT
ctmj-186	118	17	(	(	PUNCT
ctmj-186	118	18	b	b	X
ctmj-186	118	19	)	)	PUNCT
ctmj-186	118	20	pathway	pathway	NOUN
ctmj-186	118	21	maps	map	VERB
ctmj-186	118	22	enrichment	enrichment	NOUN
ctmj-186	118	23	analysis	analysis	NOUN
ctmj-186	118	24	of	of	ADP
ctmj-186	118	25	differential	differential	ADJ
ctmj-186	118	26	genes	gene	NOUN
ctmj-186	118	27	(	(	PUNCT
ctmj-186	118	28	q‑value	q‑value	NOUN
ctmj-186	118	29	ranked	rank	VERB
ctmj-186	118	30	top	top	ADJ
ctmj-186	118	31	50	50	NUM
ctmj-186	118	32	)	)	PUNCT
ctmj-186	118	33	;	;	PUNCT
ctmj-186	118	34	(	(	PUNCT
ctmj-186	118	35	c	c	X
ctmj-186	118	36	)	)	PUNCT
ctmj-186	118	37	results	result	NOUN
ctmj-186	118	38	of	of	ADP
ctmj-186	118	39	quantitative	quantitative	ADJ
ctmj-186	118	40	polymerase	polymerase	NOUN
ctmj-186	118	41	chain	chain	NOUN
ctmj-186	118	42	reaction	reaction	NOUN
ctmj-186	118	43	assay	assay	PROPN
ctmj-186	118	44	(	(	PUNCT
ctmj-186	118	45	n	n	NOUN
ctmj-186	118	46	=	=	SYM
ctmj-186	118	47	5	5	NUM
ctmj-186	118	48	)	)	PUNCT
ctmj-186	118	49	,	,	PUNCT
ctmj-186	118	50	in	in	ADP
ctmj-186	118	51	comparison	comparison	NOUN
ctmj-186	118	52	with	with	ADP
ctmj-186	118	53	the	the	DET
ctmj-186	118	54	control	control	NOUN
ctmj-186	118	55	group	group	NOUN
ctmj-186	118	56	.	.	PUNCT
ctmj-186	119	1	#	#	SYM
ctmj-186	119	2	p	p	X
ctmj-186	119	3	<	<	X
ctmj-186	119	4	0.05	0.05	NUM
ctmj-186	119	5	,	,	PUNCT
ctmj-186	119	6	#	#	SYM
ctmj-186	119	7	#	#	SYM
ctmj-186	119	8	p	p	X
ctmj-186	119	9	<	<	X
ctmj-186	119	10	0.01	0.01	NUM
ctmj-186	119	11	.	.	PUNCT
ctmj-186	119	12	cddp	cddp	PROPN
ctmj-186	119	13	:	:	PUNCT
ctmj-186	119	14	compound	compound	NOUN
ctmj-186	119	15	danshen	danshen	ADJ
ctmj-186	119	16	dripping	dripping	ADJ
ctmj-186	119	17	pills	pill	NOUN
ctmj-186	119	18	differentially	differentially	ADV
ctmj-186	119	19	expressed	express	VERB
ctmj-186	119	20	genes	gene	NOUN
ctmj-186	119	21	.	.	PUNCT
ctmj-186	120	1	the	the	DET
ctmj-186	120	2	results	result	NOUN
ctmj-186	120	3	demonstrated	demonstrate	VERB
ctmj-186	120	4	that	that	SCONJ
ctmj-186	120	5	the	the	DET
ctmj-186	120	6	go	go	NOUN
ctmj-186	120	7	terms	term	NOUN
ctmj-186	120	8	enriched	enrich	VERB
ctmj-186	120	9	by	by	ADP
ctmj-186	120	10	differentially	differentially	ADV
ctmj-186	120	11	expressed	express	VERB
ctmj-186	120	12	genes	gene	NOUN
ctmj-186	120	13	involved	involve	VERB
ctmj-186	120	14	2727	2727	NUM
ctmj-186	120	15	biological	biological	ADJ
ctmj-186	120	16	processes	process	NOUN
ctmj-186	120	17	,	,	PUNCT
ctmj-186	120	18	462	462	NUM
ctmj-186	120	19	cellular	cellular	ADJ
ctmj-186	120	20	components	component	NOUN
ctmj-186	120	21	,	,	PUNCT
ctmj-186	120	22	and	and	CCONJ
ctmj-186	120	23	804	804	NUM
ctmj-186	120	24	molecular	molecular	ADJ
ctmj-186	120	25	functions	function	NOUN
ctmj-186	120	26	.	.	PUNCT
ctmj-186	121	1	the	the	DET
ctmj-186	121	2	biological	biological	ADJ
ctmj-186	121	3	processes	process	NOUN
ctmj-186	121	4	primarily	primarily	ADV
ctmj-186	121	5	included	include	VERB
ctmj-186	121	6	inflammatory	inflammatory	ADJ
ctmj-186	121	7	response	response	NOUN
ctmj-186	121	8	,	,	PUNCT
ctmj-186	121	9	immune	immune	ADJ
ctmj-186	121	10	system	system	NOUN
ctmj-186	121	11	process	process	NOUN
ctmj-186	121	12	,	,	PUNCT
ctmj-186	121	13	response	response	NOUN
ctmj-186	121	14	to	to	ADP
ctmj-186	121	15	lipopolysaccharides	lipopolysaccharide	NOUN
ctmj-186	121	16	,	,	PUNCT
ctmj-186	121	17	innate	innate	ADJ
ctmj-186	121	18	immune	immune	ADJ
ctmj-186	121	19	response	response	NOUN
ctmj-186	121	20	,	,	PUNCT
ctmj-186	121	21	neutrophil	neutrophil	ADJ
ctmj-186	121	22	response	response	NOUN
ctmj-186	121	23	,	,	PUNCT
ctmj-186	121	24	and	and	CCONJ
ctmj-186	121	25	antioxidative	antioxidative	ADJ
ctmj-186	121	26	stress	stress	NOUN
ctmj-186	121	27	.	.	PUNCT
ctmj-186	122	1	cellular	cellular	ADJ
ctmj-186	122	2	components	component	NOUN
ctmj-186	122	3	primarily	primarily	ADV
ctmj-186	122	4	involved	involve	VERB
ctmj-186	122	5	the	the	DET
ctmj-186	122	6	cytoplasm	cytoplasm	NOUN
ctmj-186	122	7	,	,	PUNCT
ctmj-186	122	8	cell	cell	NOUN
ctmj-186	122	9	fluids	fluid	NOUN
ctmj-186	122	10	,	,	PUNCT
ctmj-186	122	11	ribosomes	ribosome	NOUN
ctmj-186	122	12	,	,	PUNCT
ctmj-186	122	13	soluble	soluble	ADJ
ctmj-186	122	14	fibrin	fibrin	NOUN
ctmj-186	122	15	,	,	PUNCT
ctmj-186	122	16	and	and	CCONJ
ctmj-186	122	17	mitochondria	mitochondria	PROPN
ctmj-186	122	18	.	.	PUNCT
ctmj-186	123	1	the	the	DET
ctmj-186	123	2	molecular	molecular	ADJ
ctmj-186	123	3	functions	function	NOUN
ctmj-186	123	4	included	include	VERB
ctmj-186	123	5	protein	protein	NOUN
ctmj-186	123	6	labeling	labeling	NOUN
ctmj-186	123	7	,	,	PUNCT
ctmj-186	123	8	ubiquitin	ubiquitin	ADJ
ctmj-186	123	9	protein	protein	NOUN
ctmj-186	123	10	ligation	ligation	NOUN
ctmj-186	123	11	,	,	PUNCT
ctmj-186	123	12	cytokine	cytokine	ADJ
ctmj-186	123	13	receptor	receptor	NOUN
ctmj-186	123	14	activation	activation	NOUN
ctmj-186	123	15	,	,	PUNCT
ctmj-186	123	16	il-1	il-1	ADP
ctmj-186	123	17	receptor	receptor	NOUN
ctmj-186	123	18	activation	activation	NOUN
ctmj-186	123	19	,	,	PUNCT
ctmj-186	123	20	complement	complement	NOUN
ctmj-186	123	21	component	component	NOUN
ctmj-186	123	22	c3b	c3b	NOUN
ctmj-186	123	23	binding	binding	ADJ
ctmj-186	123	24	,	,	PUNCT
ctmj-186	123	25	and	and	CCONJ
ctmj-186	123	26	toll	toll	NOUN
ctmj-186	123	27	-	-	PUNCT
ctmj-186	123	28	like	like	ADJ
ctmj-186	123	29	receptor	receptor	NOUN
ctmj-186	123	30	binding	bind	VERB
ctmj-186	123	31	.	.	PUNCT
ctmj-186	124	1	these	these	DET
ctmj-186	124	2	results	result	NOUN
ctmj-186	124	3	indicated	indicate	VERB
ctmj-186	124	4	a	a	DET
ctmj-186	124	5	strong	strong	ADJ
ctmj-186	124	6	connection	connection	NOUN
ctmj-186	124	7	between	between	ADP
ctmj-186	124	8	differentially	differentially	ADV
ctmj-186	124	9	expressed	express	VERB
ctmj-186	124	10	genes	gene	NOUN
ctmj-186	124	11	and	and	CCONJ
ctmj-186	124	12	the	the	DET
ctmj-186	124	13	coagulation	coagulation	NOUN
ctmj-186	124	14	–	–	PUNCT
ctmj-186	124	15	immune	immune	ADJ
ctmj-186	124	16	system	system	NOUN
ctmj-186	124	17	,	,	PUNCT
ctmj-186	124	18	suggesting	suggest	VERB
ctmj-186	124	19	that	that	SCONJ
ctmj-186	124	20	cddp	cddp	PROPN
ctmj-186	124	21	exerts	exert	VERB
ctmj-186	124	22	its	its	PRON
ctmj-186	124	23	therapeutic	therapeutic	ADJ
ctmj-186	124	24	effect	effect	NOUN
ctmj-186	124	25	on	on	ADP
ctmj-186	124	26	dic	dic	NOUN
ctmj-186	124	27	through	through	ADP
ctmj-186	124	28	the	the	DET
ctmj-186	124	29	above	above	ADJ
ctmj-186	124	30	pathways	pathway	NOUN
ctmj-186	124	31	.	.	PUNCT
ctmj-186	125	1	kegg	kegg	NOUN
ctmj-186	125	2	enrichment	enrichment	NOUN
ctmj-186	125	3	analysis	analysis	NOUN
ctmj-186	125	4	the	the	DET
ctmj-186	125	5	kegg	kegg	NOUN
ctmj-186	125	6	pathway	pathway	NOUN
ctmj-186	125	7	enrichment	enrichment	NOUN
ctmj-186	125	8	analysis	analysis	NOUN
ctmj-186	125	9	was	be	AUX
ctmj-186	125	10	performed	perform	VERB
ctmj-186	125	11	on	on	ADP
ctmj-186	125	12	the	the	DET
ctmj-186	125	13	differentially	differentially	ADV
ctmj-186	125	14	expressed	express	VERB
ctmj-186	125	15	genes	gene	NOUN
ctmj-186	125	16	using	use	VERB
ctmj-186	125	17	the	the	DET
ctmj-186	125	18	metacore	metacore	ADJ
ctmj-186	125	19	database	database	NOUN
ctmj-186	125	20	(	(	PUNCT
ctmj-186	125	21	https://portal	https://portal	ADJ
ctmj-186	125	22	.	.	PUNCT
ctmj-186	126	1	genego	genego	PROPN
ctmj-186	126	2	.	.	PUNCT
ctmj-186	127	1	com/	com/	NOUN
ctmj-186	127	2	)	)	PUNCT
ctmj-186	127	3	.	.	PUNCT
ctmj-186	128	1	the	the	DET
ctmj-186	128	2	top	top	ADJ
ctmj-186	128	3	50	50	NUM
ctmj-186	128	4	pathways	pathway	NOUN
ctmj-186	128	5	with	with	ADP
ctmj-186	128	6	the	the	DET
ctmj-186	128	7	smallest	small	ADJ
ctmj-186	128	8	q	q	NOUN
ctmj-186	128	9	-	-	PUNCT
ctmj-186	128	10	values	value	NOUN
ctmj-186	128	11	,	,	PUNCT
ctmj-186	128	12	that	that	ADV
ctmj-186	128	13	is	is	ADV
ctmj-186	128	14	,	,	PUNCT
ctmj-186	128	15	the	the	DET
ctmj-186	128	16	most	most	ADV
ctmj-186	128	17	significant	significant	ADJ
ctmj-186	128	18	enrichment	enrichment	NOUN
ctmj-186	128	19	,	,	PUNCT
ctmj-186	128	20	were	be	AUX
ctmj-186	128	21	selected	select	VERB
ctmj-186	128	22	for	for	ADP
ctmj-186	128	23	display	display	NOUN
ctmj-186	128	24	.	.	PUNCT
ctmj-186	129	1	in	in	ADP
ctmj-186	129	2	addition	addition	NOUN
ctmj-186	129	3	,	,	PUNCT
ctmj-186	129	4	the	the	DET
ctmj-186	129	5	top	top	ADJ
ctmj-186	129	6	50	50	NUM
ctmj-186	129	7	pathways	pathway	NOUN
ctmj-186	129	8	were	be	AUX
ctmj-186	129	9	found	find	VERB
ctmj-186	129	10	to	to	PART
ctmj-186	129	11	be	be	AUX
ctmj-186	129	12	the	the	DET
ctmj-186	129	13	immune	immune	ADJ
ctmj-186	129	14	response	response	NOUN
ctmj-186	129	15	complement	complement	NOUN
ctmj-186	129	16	pathway	pathway	NOUN
ctmj-186	129	17	,	,	PUNCT
ctmj-186	129	18	il-6	il-6	PRON
ctmj-186	129	19	-	-	PUNCT
ctmj-186	129	20	induced	induce	VERB
ctmj-186	129	21	acute	acute	ADJ
ctmj-186	129	22	phase	phase	NOUN
ctmj-186	129	23	response	response	NOUN
ctmj-186	129	24	of	of	ADP
ctmj-186	129	25	hepatocytes	hepatocyte	NOUN
ctmj-186	129	26	,	,	PUNCT
ctmj-186	129	27	neutrophil	neutrophil	ADJ
ctmj-186	129	28	chemotaxis	chemotaxis	ADJ
ctmj-186	129	29	,	,	PUNCT
ctmj-186	129	30	oxidative	oxidative	ADJ
ctmj-186	129	31	stress	stress	NOUN
ctmj-186	129	32	response	response	NOUN
ctmj-186	129	33	,	,	PUNCT
ctmj-186	129	34	thrombotic	thrombotic	ADJ
ctmj-186	129	35	microangiopathy	microangiopathy	ADJ
ctmj-186	129	36	,	,	PUNCT
ctmj-186	129	37	high	high	ADJ
ctmj-186	129	38	mobility	mobility	NOUN
ctmj-186	129	39	group	group	NOUN
ctmj-186	129	40	box	box	PROPN
ctmj-186	129	41	1	1	NUM
ctmj-186	129	42	signaling	signal	VERB
ctmj-186	129	43	pathway	pathway	NOUN
ctmj-186	129	44	,	,	PUNCT
ctmj-186	129	45	tnf‑	tnf‑	VERB
ctmj-186	129	46	signaling	signal	VERB
ctmj-186	129	47	pathway	pathway	NOUN
ctmj-186	129	48	,	,	PUNCT
ctmj-186	129	49	il-1	il-1	ADP
ctmj-186	129	50			NOUN
ctmj-186	129	51	signaling	signal	VERB
ctmj-186	129	52	pathway	pathway	NOUN
ctmj-186	129	53	,	,	PUNCT
ctmj-186	129	54	and	and	CCONJ
ctmj-186	129	55	covid-19	covid-19	PROPN
ctmj-186	129	56	-	-	PUNCT
ctmj-186	129	57	related	relate	VERB
ctmj-186	129	58	coagulation	coagulation	NOUN
ctmj-186	129	59	disorders	disorder	NOUN
ctmj-186	129	60	.	.	PUNCT
ctmj-186	130	1	most	most	ADJ
ctmj-186	130	2	of	of	ADP
ctmj-186	130	3	these	these	DET
ctmj-186	130	4	pathways	pathway	NOUN
ctmj-186	130	5	were	be	AUX
ctmj-186	130	6	related	relate	VERB
ctmj-186	130	7	to	to	ADP
ctmj-186	130	8	the	the	DET
ctmj-186	130	9	immune	immune	ADJ
ctmj-186	130	10	response	response	NOUN
ctmj-186	130	11	and	and	CCONJ
ctmj-186	130	12	coagulation	coagulation	NOUN
ctmj-186	130	13	system	system	NOUN
ctmj-186	130	14	,	,	PUNCT
ctmj-186	130	15	suggesting	suggest	VERB
ctmj-186	130	16	potential	potential	ADJ
ctmj-186	130	17	pathways	pathway	NOUN
ctmj-186	130	18	for	for	ADP
ctmj-186	130	19	the	the	DET
ctmj-186	130	20	treatment	treatment	NOUN
ctmj-186	130	21	of	of	ADP
ctmj-186	130	22	dic	dic	PROPN
ctmj-186	130	23	using	use	VERB
ctmj-186	130	24	cddp	cddp	PROPN
ctmj-186	131	1	[	[	X
ctmj-186	131	2	figure	figure	NOUN
ctmj-186	131	3	4b	4b	X
ctmj-186	131	4	]	]	PUNCT
ctmj-186	131	5	.	.	PUNCT
ctmj-186	132	1	analysis	analysis	NOUN
ctmj-186	132	2	of	of	ADP
ctmj-186	132	3	key	key	ADJ
ctmj-186	132	4	targets	target	NOUN
ctmj-186	132	5	and	and	CCONJ
ctmj-186	132	6	pathways	pathway	NOUN
ctmj-186	132	7	of	of	ADP
ctmj-186	132	8	cddp	cddp	PROPN
ctmj-186	132	9	in	in	ADP
ctmj-186	132	10	the	the	DET
ctmj-186	132	11	treatment	treatment	NOUN
ctmj-186	132	12	of	of	ADP
ctmj-186	132	13	dic	dic	PROPN
ctmj-186	132	14	the	the	DET
ctmj-186	132	15	results	result	NOUN
ctmj-186	132	16	of	of	ADP
ctmj-186	132	17	the	the	DET
ctmj-186	132	18	transcriptome	transcriptome	ADJ
ctmj-186	132	19	analysis	analysis	NOUN
ctmj-186	132	20	,	,	PUNCT
ctmj-186	132	21	p	p	NOUN
ctmj-186	132	22	values	value	NOUN
ctmj-186	132	23	of	of	ADP
ctmj-186	132	24	differential	differential	ADJ
ctmj-186	132	25	gene	gene	NOUN
ctmj-186	132	26	enrichment	enrichment	NOUN
ctmj-186	132	27	,	,	PUNCT
ctmj-186	132	28	and	and	CCONJ
ctmj-186	132	29	functions	function	NOUN
ctmj-186	132	30	of	of	ADP
ctmj-186	132	31	the	the	DET
ctmj-186	132	32	enriched	enriched	ADJ
ctmj-186	132	33	pathways	pathway	NOUN
ctmj-186	132	34	were	be	AUX
ctmj-186	132	35	used	use	VERB
ctmj-186	132	36	to	to	PART
ctmj-186	132	37	further	far	ADV
ctmj-186	132	38	classify	classify	VERB
ctmj-186	132	39	the	the	DET
ctmj-186	132	40	differentially	differentially	ADV
ctmj-186	132	41	expressed	express	VERB
ctmj-186	132	42	genes	gene	NOUN
ctmj-186	132	43	.	.	PUNCT
ctmj-186	133	1	the	the	DET
ctmj-186	133	2	related	related	ADJ
ctmj-186	133	3	targets	target	NOUN
ctmj-186	133	4	and	and	CCONJ
ctmj-186	133	5	corresponding	correspond	VERB
ctmj-186	133	6	pathways	pathway	NOUN
ctmj-186	133	7	of	of	ADP
ctmj-186	133	8	cddp	cddp	PROPN
ctmj-186	133	9	in	in	ADP
ctmj-186	133	10	the	the	DET
ctmj-186	133	11	dic	dic	PROPN
ctmj-186	133	12	model	model	NOUN
ctmj-186	133	13	rats	rat	NOUN
ctmj-186	133	14	were	be	AUX
ctmj-186	133	15	analyzed	analyze	VERB
ctmj-186	133	16	.	.	PUNCT
ctmj-186	134	1	comprehensive	comprehensive	ADJ
ctmj-186	134	2	analysis	analysis	NOUN
ctmj-186	134	3	revealed	reveal	VERB
ctmj-186	134	4	that	that	SCONJ
ctmj-186	134	5	cddp	cddp	PROPN
ctmj-186	134	6	exerts	exert	VERB
ctmj-186	134	7	a	a	DET
ctmj-186	134	8	therapeutic	therapeutic	ADJ
ctmj-186	134	9	effect	effect	NOUN
ctmj-186	134	10	on	on	ADP
ctmj-186	134	11	dic	dic	NOUN
ctmj-186	134	12	by	by	ADP
ctmj-186	134	13	affecting	affect	VERB
ctmj-186	134	14	the	the	DET
ctmj-186	134	15	oxidative	oxidative	ADJ
ctmj-186	134	16	stress	stress	NOUN
ctmj-186	134	17	response	response	NOUN
ctmj-186	134	18	and	and	CCONJ
ctmj-186	134	19	acting	act	VERB
ctmj-186	134	20	on	on	ADP
ctmj-186	134	21	apoptosis	apoptosis	NOUN
ctmj-186	134	22	-	-	PUNCT
ctmj-186	134	23	related	relate	VERB
ctmj-186	134	24	pathways	pathway	NOUN
ctmj-186	134	25	.	.	PUNCT
ctmj-186	135	1	in	in	ADP
ctmj-186	135	2	addition	addition	NOUN
ctmj-186	135	3	,	,	PUNCT
ctmj-186	135	4	the	the	DET
ctmj-186	135	5	analysis	analysis	NOUN
ctmj-186	135	6	revealed	reveal	VERB
ctmj-186	135	7	that	that	SCONJ
ctmj-186	135	8	cddp	cddp	PROPN
ctmj-186	135	9	exerted	exert	VERB
ctmj-186	135	10	therapeutic	therapeutic	ADJ
ctmj-186	135	11	potential	potential	NOUN
ctmj-186	135	12	against	against	ADP
ctmj-186	135	13	covid‑19	covid‑19	NOUN
ctmj-186	135	14	by	by	ADP
ctmj-186	135	15	affecting	affect	VERB
ctmj-186	135	16	thrombosis	thrombosis	NOUN
ctmj-186	135	17	[	[	X
ctmj-186	135	18	figure	figure	NOUN
ctmj-186	135	19	5	5	NUM
ctmj-186	135	20	]	]	PUNCT
ctmj-186	135	21	.	.	PUNCT
ctmj-186	136	1	validation	validation	NOUN
ctmj-186	136	2	of	of	ADP
ctmj-186	136	3	transcriptomics	transcriptomic	NOUN
ctmj-186	136	4	analysis	analysis	NOUN
ctmj-186	136	5	results	result	VERB
ctmj-186	136	6	the	the	DET
ctmj-186	136	7	results	result	NOUN
ctmj-186	136	8	of	of	ADP
ctmj-186	136	9	transcriptome	transcriptome	ADJ
ctmj-186	136	10	analysis	analysis	NOUN
ctmj-186	136	11	revealed	reveal	VERB
ctmj-186	136	12	that	that	SCONJ
ctmj-186	136	13	the	the	DET
ctmj-186	136	14	key	key	ADJ
ctmj-186	136	15	targets	target	NOUN
ctmj-186	136	16	of	of	ADP
ctmj-186	136	17	cddp	cddp	NOUN
ctmj-186	136	18	in	in	ADP
ctmj-186	136	19	the	the	DET
ctmj-186	136	20	treatment	treatment	NOUN
ctmj-186	136	21	of	of	ADP
ctmj-186	136	22	dic	dic	PROPN
ctmj-186	136	23	were	be	AUX
ctmj-186	136	24	primarily	primarily	ADV
ctmj-186	136	25	enriched	enrich	VERB
ctmj-186	136	26	in	in	ADP
ctmj-186	136	27	immune	immune	ADJ
ctmj-186	136	28	coagulation	coagulation	NOUN
ctmj-186	136	29	,	,	PUNCT
ctmj-186	136	30	oxidative	oxidative	ADJ
ctmj-186	136	31	stress	stress	NOUN
ctmj-186	136	32	,	,	PUNCT
ctmj-186	136	33	platelet	platelet	NOUN
ctmj-186	136	34	activation	activation	NOUN
ctmj-186	136	35	,	,	PUNCT
ctmj-186	136	36	inflammasome	inflammasome	VERB
ctmj-186	136	37	,	,	PUNCT
ctmj-186	136	38	and	and	CCONJ
ctmj-186	136	39	apoptosis‑related	apoptosis‑relate	VERB
ctmj-186	136	40	pathways	pathway	NOUN
ctmj-186	136	41	.	.	PUNCT
ctmj-186	137	1	based	base	VERB
ctmj-186	137	2	on	on	ADP
ctmj-186	137	3	literature	literature	PROPN
ctmj-186	137	4	research	research	NOUN
ctmj-186	137	5	,	,	PUNCT
ctmj-186	137	6	four	four	NUM
ctmj-186	137	7	key	key	ADJ
ctmj-186	137	8	genes	gene	NOUN
ctmj-186	137	9	,	,	PUNCT
ctmj-186	137	10	namely	namely	ADV
ctmj-186	137	11	,	,	PUNCT
ctmj-186	137	12	sqstml	sqstml	NOUN
ctmj-186	137	13	,	,	PUNCT
ctmj-186	137	14	ctsd	ctsd	VERB
ctmj-186	137	15	,	,	PUNCT
ctmj-186	137	16	mylk2	mylk2	ADJ
ctmj-186	137	17	,	,	PUNCT
ctmj-186	137	18	and	and	CCONJ
ctmj-186	137	19	nfkbib	nfkbib	NOUN
ctmj-186	137	20	,	,	PUNCT
ctmj-186	137	21	were	be	AUX
ctmj-186	137	22	selected	select	VERB
ctmj-186	137	23	for	for	ADP
ctmj-186	137	24	qpcr	qpcr	ADJ
ctmj-186	137	25	verification	verification	NOUN
ctmj-186	137	26	,	,	PUNCT
ctmj-186	137	27	and	and	CCONJ
ctmj-186	137	28	the	the	DET
ctmj-186	137	29	effect	effect	NOUN
ctmj-186	137	30	of	of	ADP
ctmj-186	137	31	cddp	cddp	PROPN
ctmj-186	137	32	on	on	ADP
ctmj-186	137	33	lps‑induced	lps‑induce	VERB
ctmj-186	137	34	model	model	NOUN
ctmj-186	137	35	animals	animal	NOUN
ctmj-186	137	36	was	be	AUX
ctmj-186	137	37	preliminarily	preliminarily	ADV
ctmj-186	137	38	observed	observe	VERB
ctmj-186	137	39	.	.	PUNCT
ctmj-186	138	1	the	the	DET
ctmj-186	138	2	results	result	NOUN
ctmj-186	138	3	demonstrated	demonstrate	VERB
ctmj-186	138	4	that	that	SCONJ
ctmj-186	138	5	,	,	PUNCT
ctmj-186	138	6	compared	compare	VERB
ctmj-186	138	7	with	with	ADP
ctmj-186	138	8	the	the	DET
ctmj-186	138	9	control	control	NOUN
ctmj-186	138	10	group	group	NOUN
ctmj-186	138	11	,	,	PUNCT
ctmj-186	138	12	the	the	DET
ctmj-186	138	13	model	model	NOUN
ctmj-186	138	14	group	group	NOUN
ctmj-186	138	15	significantly	significantly	ADV
ctmj-186	138	16	increased	increase	VERB
ctmj-186	138	17	expression	expression	NOUN
ctmj-186	138	18	of	of	ADP
ctmj-186	138	19	four	four	NUM
ctmj-186	138	20	target	target	NOUN
ctmj-186	138	21	genes	gene	NOUN
ctmj-186	138	22	,	,	PUNCT
ctmj-186	138	23	mylk2	mylk2	ADJ
ctmj-186	138	24	,	,	PUNCT
ctmj-186	138	25	nfkbib	nfkbib	NOUN
ctmj-186	138	26	(	(	PUNCT
ctmj-186	138	27	p	p	X
ctmj-186	138	28	<	<	X
ctmj-186	138	29	0.05	0.05	NUM
ctmj-186	138	30	)	)	PUNCT
ctmj-186	138	31	,	,	PUNCT
ctmj-186	138	32	ctsd	ctsd	VERB
ctmj-186	138	33	,	,	PUNCT
ctmj-186	138	34	and	and	CCONJ
ctmj-186	138	35	sqstml	sqstml	VERB
ctmj-186	138	36	(	(	PUNCT
ctmj-186	138	37	p	p	X
ctmj-186	138	38	<	<	X
ctmj-186	138	39	0.01	0.01	NUM
ctmj-186	138	40	)	)	PUNCT
ctmj-186	138	41	,	,	PUNCT
ctmj-186	138	42	in	in	ADP
ctmj-186	138	43	the	the	DET
ctmj-186	138	44	whole	whole	ADJ
ctmj-186	138	45	blood	blood	NOUN
ctmj-186	138	46	of	of	ADP
ctmj-186	138	47	a	a	DET
ctmj-186	138	48	c	c	PROPN
ctmj-186	138	49	b	b	PROPN
ctmj-186	138	50	ctmj	ctmj	NOUN
ctmj-186	138	51	|	|	ADV
ctmj-186	138	52	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-186	138	53	chinese	chinese	ADJ
ctmj-186	138	54	traditional	traditional	ADJ
ctmj-186	138	55	medicine	medicine	NOUN
ctmj-186	138	56	journal	journal	NOUN
ctmj-186	138	57	|	|	ADV
ctmj-186	138	58	2025	2025	NUM
ctmj-186	138	59	|	|	ADV
ctmj-186	138	60	vol	vol	NOUN
ctmj-186	138	61	8	8	NUM
ctmj-186	138	62	|issue	|issue	NOUN
ctmj-186	138	63	1	1	NUM
ctmj-186	138	64	28	28	NUM
ctmj-186	138	65	figure	figure	NOUN
ctmj-186	138	66	5	5	NUM
ctmj-186	138	67	:	:	PUNCT
ctmj-186	138	68	coagulation	coagulation	NOUN
ctmj-186	138	69	disorder‑related	disorder‑relate	VERB
ctmj-186	138	70	pathways	pathway	NOUN
ctmj-186	138	71	the	the	DET
ctmj-186	138	72	model	model	NOUN
ctmj-186	138	73	rats	rat	VERB
ctmj-186	138	74	6	6	NUM
ctmj-186	138	75	h	h	NOUN
ctmj-186	138	76	after	after	ADP
ctmj-186	138	77	model	model	NOUN
ctmj-186	138	78	replication	replication	NOUN
ctmj-186	138	79	.	.	PUNCT
ctmj-186	139	1	cddp	cddp	PROPN
ctmj-186	139	2	inhibited	inhibit	VERB
ctmj-186	139	3	the	the	DET
ctmj-186	139	4	overexpression	overexpression	NOUN
ctmj-186	139	5	of	of	ADP
ctmj-186	139	6	mylk2	mylk2	ADJ
ctmj-186	139	7	,	,	PUNCT
ctmj-186	139	8	nfkbib	nfkbib	ADJ
ctmj-186	139	9	,	,	PUNCT
ctmj-186	139	10	ctsd	ctsd	ADJ
ctmj-186	139	11	,	,	PUNCT
ctmj-186	139	12	and	and	CCONJ
ctmj-186	139	13	sqstml	sqstml	VERB
ctmj-186	139	14	to	to	ADP
ctmj-186	139	15	varying	vary	VERB
ctmj-186	139	16	degrees	degree	NOUN
ctmj-186	139	17	.	.	PUNCT
ctmj-186	140	1	the	the	DET
ctmj-186	140	2	results	result	NOUN
ctmj-186	140	3	of	of	ADP
ctmj-186	140	4	qrt‑pcr	qrt‑pcr	ADV
ctmj-186	140	5	were	be	AUX
ctmj-186	140	6	consistent	consistent	ADJ
ctmj-186	140	7	with	with	ADP
ctmj-186	140	8	those	those	PRON
ctmj-186	140	9	of	of	ADP
ctmj-186	140	10	transcriptome	transcriptome	ADJ
ctmj-186	140	11	sequencing	sequence	VERB
ctmj-186	141	1	[	[	X
ctmj-186	141	2	figure	figure	NOUN
ctmj-186	141	3	4c	4c	NOUN
ctmj-186	141	4	]	]	PUNCT
ctmj-186	141	5	.	.	PUNCT
ctmj-186	142	1	discussion	discussion	NOUN
ctmj-186	142	2	in	in	ADP
ctmj-186	142	3	dic	dic	PROPN
ctmj-186	142	4	,	,	PUNCT
ctmj-186	142	5	an	an	DET
ctmj-186	142	6	acquired	acquire	VERB
ctmj-186	142	7	coagulation	coagulation	NOUN
ctmj-186	142	8	condition	condition	NOUN
ctmj-186	142	9	,	,	PUNCT
ctmj-186	142	10	microthrombuses	microthrombuse	NOUN
ctmj-186	142	11	develop	develop	VERB
ctmj-186	142	12	all	all	ADV
ctmj-186	142	13	over	over	ADP
ctmj-186	142	14	the	the	DET
ctmj-186	142	15	place	place	NOUN
ctmj-186	142	16	and	and	CCONJ
ctmj-186	142	17	systemic	systemic	ADJ
ctmj-186	142	18	coagulation	coagulation	NOUN
ctmj-186	142	19	is	be	AUX
ctmj-186	142	20	activated	activate	VERB
ctmj-186	142	21	.	.	PUNCT
ctmj-186	143	1	a	a	DET
ctmj-186	143	2	number	number	NOUN
ctmj-186	143	3	of	of	ADP
ctmj-186	143	4	biological	biological	ADJ
ctmj-186	143	5	systems	system	NOUN
ctmj-186	143	6	,	,	PUNCT
ctmj-186	143	7	including	include	VERB
ctmj-186	143	8	those	those	PRON
ctmj-186	143	9	involved	involve	VERB
ctmj-186	143	10	in	in	ADP
ctmj-186	143	11	coagulation	coagulation	NOUN
ctmj-186	143	12	,	,	PUNCT
ctmj-186	143	13	innate	innate	ADJ
ctmj-186	143	14	immunity	immunity	NOUN
ctmj-186	143	15	,	,	PUNCT
ctmj-186	143	16	inflammation	inflammation	NOUN
ctmj-186	143	17	,	,	PUNCT
ctmj-186	143	18	complement	complement	NOUN
ctmj-186	143	19	,	,	PUNCT
ctmj-186	143	20	and	and	CCONJ
ctmj-186	143	21	fibrinolysis	fibrinolysis	NOUN
ctmj-186	143	22	,	,	PUNCT
ctmj-186	143	23	are	be	AUX
ctmj-186	143	24	disrupted	disrupt	VERB
ctmj-186	143	25	by	by	ADP
ctmj-186	143	26	the	the	DET
ctmj-186	143	27	disorder	disorder	NOUN
ctmj-186	143	28	's	's	PART
ctmj-186	143	29	severe	severe	ADJ
ctmj-186	143	30	microcirculatory	microcirculatory	ADJ
ctmj-186	143	31	abnormalities	abnormality	NOUN
ctmj-186	143	32	.	.	PUNCT
ctmj-186	144	1	(	(	PUNCT
ctmj-186	144	2	2	2	NUM
ctmj-186	144	3	,	,	PUNCT
ctmj-186	144	4	3	3	NUM
ctmj-186	144	5	)	)	PUNCT
ctmj-186	144	6	.	.	PUNCT
ctmj-186	145	1	according	accord	VERB
ctmj-186	145	2	to	to	ADP
ctmj-186	145	3	clinical	clinical	ADJ
ctmj-186	145	4	research	research	NOUN
ctmj-186	145	5	,	,	PUNCT
ctmj-186	145	6	dic	dic	ADJ
ctmj-186	145	7	symptoms	symptom	NOUN
ctmj-186	145	8	are	be	AUX
ctmj-186	145	9	seen	see	VERB
ctmj-186	145	10	by	by	ADP
ctmj-186	145	11	10%-30	10%-30	NUM
ctmj-186	145	12	%	%	NOUN
ctmj-186	145	13	of	of	ADP
ctmj-186	145	14	intensive	intensive	ADJ
ctmj-186	145	15	care	care	NOUN
ctmj-186	145	16	unit	unit	NOUN
ctmj-186	145	17	(	(	PUNCT
ctmj-186	145	18	icu	icu	PROPN
ctmj-186	145	19	)	)	PUNCT
ctmj-186	145	20	patients	patient	NOUN
ctmj-186	145	21	,	,	PUNCT
ctmj-186	145	22	leading	lead	VERB
ctmj-186	145	23	to	to	ADP
ctmj-186	145	24	an	an	DET
ctmj-186	145	25	increased	increase	VERB
ctmj-186	145	26	death	death	NOUN
ctmj-186	145	27	rate	rate	NOUN
ctmj-186	145	28	.	.	PUNCT
ctmj-186	146	1	the	the	DET
ctmj-186	146	2	main	main	ADJ
ctmj-186	146	3	cause	cause	NOUN
ctmj-186	146	4	of	of	ADP
ctmj-186	146	5	dic	dic	NOUN
ctmj-186	146	6	is	be	AUX
ctmj-186	146	7	infection	infection	NOUN
ctmj-186	146	8	.	.	PUNCT
ctmj-186	147	1	when	when	SCONJ
ctmj-186	147	2	it	it	PRON
ctmj-186	147	3	comes	come	VERB
ctmj-186	147	4	to	to	ADP
ctmj-186	147	5	treating	treat	VERB
ctmj-186	147	6	infectious	infectious	ADJ
ctmj-186	147	7	disorders	disorder	NOUN
ctmj-186	147	8	,	,	PUNCT
ctmj-186	147	9	traditional	traditional	ADJ
ctmj-186	147	10	chinese	chinese	ADJ
ctmj-186	147	11	medicine	medicine	NOUN
ctmj-186	147	12	offers	offer	VERB
ctmj-186	147	13	some	some	DET
ctmj-186	147	14	distinct	distinct	ADJ
ctmj-186	147	15	benefits	benefit	NOUN
ctmj-186	147	16	.	.	PUNCT
ctmj-186	148	1	[	[	X
ctmj-186	148	2	14	14	NUM
ctmj-186	148	3	]	]	PUNCT
ctmj-186	148	4	here	here	ADV
ctmj-186	148	5	,	,	PUNCT
ctmj-186	148	6	we	we	PRON
ctmj-186	148	7	looked	look	VERB
ctmj-186	148	8	at	at	ADP
ctmj-186	148	9	how	how	SCONJ
ctmj-186	148	10	cddp	cddp	PROPN
ctmj-186	148	11	affected	affect	VERB
ctmj-186	148	12	the	the	DET
ctmj-186	148	13	rate	rate	NOUN
ctmj-186	148	14	of	of	ADP
ctmj-186	148	15	survival	survival	NOUN
ctmj-186	148	16	in	in	ADP
ctmj-186	148	17	an	an	DET
ctmj-186	148	18	animal	animal	NOUN
ctmj-186	148	19	model	model	NOUN
ctmj-186	148	20	that	that	PRON
ctmj-186	148	21	was	be	AUX
ctmj-186	148	22	induced	induce	VERB
ctmj-186	148	23	with	with	ADP
ctmj-186	148	24	lps	lps	PROPN
ctmj-186	148	25	.	.	PUNCT
ctmj-186	149	1	the	the	DET
ctmj-186	149	2	findings	finding	NOUN
ctmj-186	149	3	showed	show	VERB
ctmj-186	149	4	demonstrated	demonstrate	VERB
ctmj-186	149	5	the	the	DET
ctmj-186	149	6	survival	survival	NOUN
ctmj-186	149	7	rate	rate	NOUN
ctmj-186	149	8	of	of	ADP
ctmj-186	149	9	lps	lps	PROPN
ctmj-186	149	10	-	-	PUNCT
ctmj-186	149	11	induced	induce	VERB
ctmj-186	149	12	model	model	NOUN
ctmj-186	149	13	mice	mouse	NOUN
ctmj-186	149	14	was	be	AUX
ctmj-186	149	15	significantly	significantly	ADV
ctmj-186	149	16	enhanced	enhance	VERB
ctmj-186	149	17	by	by	ADP
ctmj-186	149	18	a	a	DET
ctmj-186	149	19	single	single	ADJ
ctmj-186	149	20	oral	oral	ADJ
ctmj-186	149	21	dosage	dosage	NOUN
ctmj-186	149	22	of	of	ADP
ctmj-186	149	23	cddp	cddp	NOUN
ctmj-186	149	24	at	at	ADP
ctmj-186	149	25	varied	varied	ADJ
ctmj-186	149	26	doses	dose	NOUN
ctmj-186	149	27	.	.	PUNCT
ctmj-186	150	1	the	the	DET
ctmj-186	150	2	main	main	ADJ
ctmj-186	150	3	clinical	clinical	ADJ
ctmj-186	150	4	symptom	symptom	NOUN
ctmj-186	150	5	of	of	ADP
ctmj-186	150	6	dic	dic	PROPN
ctmj-186	150	7	has	have	AUX
ctmj-186	150	8	been	be	AUX
ctmj-186	150	9	described	describe	VERB
ctmj-186	150	10	as	as	ADP
ctmj-186	150	11	organ	organ	NOUN
ctmj-186	150	12	failure	failure	NOUN
ctmj-186	150	13	due	due	ADP
ctmj-186	150	14	to	to	ADP
ctmj-186	150	15	the	the	DET
ctmj-186	150	16	production	production	NOUN
ctmj-186	150	17	of	of	ADP
ctmj-186	150	18	microthrombi	microthrombi	NOUN
ctmj-186	150	19	in	in	ADP
ctmj-186	150	20	various	various	ADJ
ctmj-186	150	21	organ	organ	NOUN
ctmj-186	150	22	microvessels	microvessel	NOUN
ctmj-186	150	23	.	.	PUNCT
ctmj-186	151	1	[	[	X
ctmj-186	151	2	15	15	NUM
ctmj-186	151	3	]	]	PUNCT
ctmj-186	151	4	by	by	ADP
ctmj-186	151	5	injecting	inject	VERB
ctmj-186	151	6	10	10	NUM
ctmj-186	151	7	%	%	NOUN
ctmj-186	151	8	dextran	dextran	NOUN
ctmj-186	151	9	t500	t500	PROPN
ctmj-186	151	10	into	into	ADP
ctmj-186	151	11	the	the	DET
ctmj-186	151	12	tail	tail	NOUN
ctmj-186	151	13	vein	vein	NOUN
ctmj-186	151	14	of	of	ADP
ctmj-186	151	15	rats	rat	NOUN
ctmj-186	151	16	,	,	PUNCT
ctmj-186	151	17	we	we	PRON
ctmj-186	151	18	were	be	AUX
ctmj-186	151	19	able	able	ADJ
ctmj-186	151	20	to	to	PART
ctmj-186	151	21	replicate	replicate	VERB
ctmj-186	151	22	an	an	DET
ctmj-186	151	23	animal	animal	NOUN
ctmj-186	151	24	model	model	NOUN
ctmj-186	151	25	of	of	ADP
ctmj-186	151	26	dic	dic	ADJ
ctmj-186	151	27	microcirculatory	microcirculatory	ADJ
ctmj-186	151	28	disorder	disorder	NOUN
ctmj-186	151	29	.	.	PUNCT
ctmj-186	152	1	after	after	ADP
ctmj-186	152	2	5	5	NUM
ctmj-186	152	3	-	-	SYM
ctmj-186	152	4	30	30	NUM
ctmj-186	152	5	minutes	minute	NOUN
ctmj-186	152	6	of	of	ADP
ctmj-186	152	7	model	model	NOUN
ctmj-186	152	8	replication	replication	NOUN
ctmj-186	152	9	,	,	PUNCT
ctmj-186	152	10	we	we	PRON
ctmj-186	152	11	observed	observe	VERB
ctmj-186	152	12	that	that	SCONJ
ctmj-186	152	13	a	a	DET
ctmj-186	152	14	single	single	ADJ
ctmj-186	152	15	oral	oral	ADJ
ctmj-186	152	16	dose	dose	NOUN
ctmj-186	152	17	of	of	ADP
ctmj-186	152	18	cddp	cddp	PROPN
ctmj-186	152	19	increased	increase	VERB
ctmj-186	152	20	organ	organ	NOUN
ctmj-186	152	21	blood	blood	NOUN
ctmj-186	152	22	flow	flow	NOUN
ctmj-186	152	23	and	and	CCONJ
ctmj-186	152	24	continuously	continuously	ADV
ctmj-186	152	25	improved	improve	VERB
ctmj-186	152	26	blood	blood	NOUN
ctmj-186	152	27	perfusion	perfusion	NOUN
ctmj-186	152	28	in	in	ADP
ctmj-186	152	29	the	the	DET
ctmj-186	152	30	gastric	gastric	ADJ
ctmj-186	152	31	fundus	fundus	NOUN
ctmj-186	152	32	and	and	CCONJ
ctmj-186	152	33	liver	liver	NOUN
ctmj-186	152	34	,	,	PUNCT
ctmj-186	152	35	suggesting	suggest	VERB
ctmj-186	152	36	that	that	SCONJ
ctmj-186	152	37	cddp	cddp	PROPN
ctmj-186	152	38	may	may	AUX
ctmj-186	152	39	have	have	VERB
ctmj-186	152	40	therapeutic	therapeutic	ADJ
ctmj-186	152	41	effects	effect	NOUN
ctmj-186	152	42	on	on	ADP
ctmj-186	152	43	dic	dic	ADJ
ctmj-186	152	44	by	by	ADP
ctmj-186	152	45	improving	improve	VERB
ctmj-186	152	46	microcirculation	microcirculation	NOUN
ctmj-186	152	47	in	in	ADP
ctmj-186	152	48	these	these	DET
ctmj-186	152	49	model	model	NOUN
ctmj-186	152	50	animals	animal	NOUN
ctmj-186	152	51	.	.	PUNCT
ctmj-186	153	1	the	the	DET
ctmj-186	153	2	etiology	etiology	NOUN
ctmj-186	153	3	and	and	CCONJ
ctmj-186	153	4	clinical	clinical	ADJ
ctmj-186	153	5	manifestations	manifestation	NOUN
ctmj-186	153	6	of	of	ADP
ctmj-186	153	7	dic	dic	PROPN
ctmj-186	153	8	in	in	ADP
ctmj-186	153	9	lpsinduced	lpsinduced	ADJ
ctmj-186	153	10	rats	rat	NOUN
ctmj-186	153	11	are	be	AUX
ctmj-186	153	12	similar	similar	ADJ
ctmj-186	153	13	to	to	ADP
ctmj-186	153	14	those	those	PRON
ctmj-186	153	15	in	in	ADP
ctmj-186	153	16	humans	human	NOUN
ctmj-186	153	17	suffering	suffer	VERB
ctmj-186	153	18	from	from	ADP
ctmj-186	153	19	clinical	clinical	ADJ
ctmj-186	153	20	infections	infection	NOUN
ctmj-186	153	21	.	.	PUNCT
ctmj-186	154	1	a	a	DET
ctmj-186	154	2	hallmark	hallmark	NOUN
ctmj-186	154	3	of	of	ADP
ctmj-186	154	4	this	this	DET
ctmj-186	154	5	paradigm	paradigm	NOUN
ctmj-186	154	6	is	be	AUX
ctmj-186	154	7	the	the	DET
ctmj-186	154	8	development	development	NOUN
ctmj-186	154	9	of	of	ADP
ctmj-186	154	10	microthrombi	microthrombi	NOUN
ctmj-186	154	11	and	and	CCONJ
ctmj-186	154	12	extensive	extensive	ADJ
ctmj-186	154	13	coagulation	coagulation	NOUN
ctmj-186	154	14	.	.	PUNCT
ctmj-186	155	1	[	[	X
ctmj-186	155	2	16	16	NUM
ctmj-186	155	3	]	]	PUNCT
ctmj-186	155	4	to	to	PART
ctmj-186	155	5	examine	examine	VERB
ctmj-186	155	6	cddp	cddp	PROPN
ctmj-186	155	7	's	's	PART
ctmj-186	155	8	therapeutic	therapeutic	ADJ
ctmj-186	155	9	potential	potential	NOUN
ctmj-186	155	10	,	,	PUNCT
ctmj-186	155	11	we	we	PRON
ctmj-186	155	12	used	use	VERB
ctmj-186	155	13	an	an	DET
ctmj-186	155	14	lps	lps	PROPN
ctmj-186	155	15	-	-	PUNCT
ctmj-186	155	16	induced	induce	VERB
ctmj-186	155	17	dic	dic	ADJ
ctmj-186	155	18	rat	rat	NOUN
ctmj-186	155	19	model	model	NOUN
ctmj-186	155	20	in	in	ADP
ctmj-186	155	21	this	this	DET
ctmj-186	155	22	investigation	investigation	NOUN
ctmj-186	155	23	.	.	PUNCT
ctmj-186	156	1	prolonged	prolonged	ADJ
ctmj-186	156	2	pt	pt	NOUN
ctmj-186	156	3	during	during	ADP
ctmj-186	156	4	consumptive	consumptive	ADJ
ctmj-186	156	5	hypocoagulation	hypocoagulation	NOUN
ctmj-186	156	6	and	and	CCONJ
ctmj-186	156	7	secondary	secondary	ADJ
ctmj-186	156	8	is	be	AUX
ctmj-186	156	9	seen	see	VERB
ctmj-186	156	10	in	in	ADP
ctmj-186	156	11	the	the	DET
ctmj-186	156	12	majority	majority	NOUN
ctmj-186	156	13	of	of	ADP
ctmj-186	156	14	dic	dic	ADJ
ctmj-186	156	15	patients	patient	NOUN
ctmj-186	156	16	,	,	PUNCT
ctmj-186	156	17	according	accord	VERB
ctmj-186	156	18	to	to	ADP
ctmj-186	156	19	clinical	clinical	ADJ
ctmj-186	156	20	ctmj	ctmj	NOUN
ctmj-186	156	21	|	|	ADV
ctmj-186	156	22	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-186	156	23	chinese	chinese	ADJ
ctmj-186	156	24	traditional	traditional	ADJ
ctmj-186	156	25	medicine	medicine	NOUN
ctmj-186	156	26	journal	journal	NOUN
ctmj-186	156	27	|	|	ADV
ctmj-186	156	28	2025	2025	NUM
ctmj-186	156	29	|	|	ADV
ctmj-186	156	30	vol	vol	NOUN
ctmj-186	156	31	8	8	NUM
ctmj-186	156	32	|issue	|issue	NOUN
ctmj-186	156	33	1	1	NUM
ctmj-186	156	34	29	29	NUM
ctmj-186	156	35	findings	finding	NOUN
ctmj-186	156	36	.	.	PUNCT
ctmj-186	157	1	time	time	NOUN
ctmj-186	157	2	periods	period	NOUN
ctmj-186	157	3	including	include	VERB
ctmj-186	157	4	fibrinolysis	fibrinolysis	NOUN
ctmj-186	157	5	(	(	PUNCT
ctmj-186	157	6	hypercoagulation	hypercoagulation	NOUN
ctmj-186	157	7	)	)	PUNCT
ctmj-186	157	8	.	.	PUNCT
ctmj-186	158	1	another	another	DET
ctmj-186	158	2	inflammatory	inflammatory	ADJ
ctmj-186	158	3	biomarker	biomarker	NOUN
ctmj-186	158	4	that	that	PRON
ctmj-186	158	5	shows	show	VERB
ctmj-186	158	6	the	the	DET
ctmj-186	158	7	greatest	great	ADJ
ctmj-186	158	8	plasma	plasma	NOUN
ctmj-186	158	9	coagulation	coagulation	NOUN
ctmj-186	158	10	factor	factor	NOUN
ctmj-186	158	11	level	level	NOUN
ctmj-186	158	12	is	be	AUX
ctmj-186	158	13	fib	fib	ADJ
ctmj-186	158	14	,	,	PUNCT
ctmj-186	158	15	a	a	DET
ctmj-186	158	16	glycoprotein	glycoprotein	NOUN
ctmj-186	158	17	produced	produce	VERB
ctmj-186	158	18	by	by	ADP
ctmj-186	158	19	liver	liver	NOUN
ctmj-186	158	20	cells	cell	NOUN
ctmj-186	158	21	.	.	PUNCT
ctmj-186	159	1	17	17	NUM
ctmj-186	159	2	and	and	CCONJ
ctmj-186	159	3	18	18	NUM
ctmj-186	159	4	our	our	PRON
ctmj-186	159	5	results	result	NOUN
ctmj-186	159	6	show	show	VERB
ctmj-186	159	7	that	that	SCONJ
ctmj-186	159	8	cddp	cddp	NOUN
ctmj-186	159	9	enhances	enhance	VERB
ctmj-186	159	10	normal	normal	ADJ
ctmj-186	159	11	coagulation	coagulation	NOUN
ctmj-186	159	12	function	function	NOUN
ctmj-186	159	13	in	in	ADP
ctmj-186	159	14	lpsinduced	lpsinduced	ADJ
ctmj-186	159	15	model	model	NOUN
ctmj-186	159	16	animals	animal	NOUN
ctmj-186	159	17	,	,	PUNCT
ctmj-186	159	18	as	as	SCONJ
ctmj-186	159	19	it	it	PRON
ctmj-186	159	20	prolongs	prolong	VERB
ctmj-186	159	21	pt	pt	NOUN
ctmj-186	159	22	and	and	CCONJ
ctmj-186	159	23	reduces	reduce	VERB
ctmj-186	159	24	lpsinduced	lpsinduce	VERB
ctmj-186	159	25	plasma	plasma	NOUN
ctmj-186	159	26	fib	fib	NOUN
ctmj-186	159	27	level	level	NOUN
ctmj-186	159	28	in	in	ADP
ctmj-186	159	29	rats	rat	NOUN
ctmj-186	159	30	.	.	PUNCT
ctmj-186	160	1	additionally	additionally	ADV
ctmj-186	160	2	,	,	PUNCT
ctmj-186	160	3	cytokines	cytokine	NOUN
ctmj-186	160	4	including	include	VERB
ctmj-186	160	5	tnf	tnf	PROPN
ctmj-186	160	6	and	and	CCONJ
ctmj-186	160	7	il-1	il-1	ADJ
ctmj-186	160	8	facilitated	facilitate	VERB
ctmj-186	160	9	coagulation	coagulation	NOUN
ctmj-186	160	10	activation	activation	NOUN
ctmj-186	160	11	,	,	PUNCT
ctmj-186	160	12	fibrinolysis	fibrinolysis	NOUN
ctmj-186	160	13	injury	injury	NOUN
ctmj-186	160	14	,	,	PUNCT
ctmj-186	160	15	and	and	CCONJ
ctmj-186	160	16	organ	organ	NOUN
ctmj-186	160	17	damage	damage	NOUN
ctmj-186	160	18	in	in	ADP
ctmj-186	160	19	the	the	DET
ctmj-186	160	20	lps	lps	PROPN
ctmj-186	160	21	-	-	PUNCT
ctmj-186	160	22	induced	induce	VERB
ctmj-186	160	23	dic	dic	ADJ
ctmj-186	160	24	animal	animal	NOUN
ctmj-186	160	25	model	model	NOUN
ctmj-186	160	26	.	.	PUNCT
ctmj-186	161	1	[	[	X
ctmj-186	161	2	15	15	NUM
ctmj-186	161	3	]	]	X
ctmj-186	161	4	a	a	DET
ctmj-186	161	5	single	single	ADJ
ctmj-186	161	6	oral	oral	ADJ
ctmj-186	161	7	dose	dose	NOUN
ctmj-186	161	8	of	of	ADP
ctmj-186	161	9	cddp	cddp	PROPN
ctmj-186	161	10	considerably	considerably	ADV
ctmj-186	161	11	reduced	reduce	VERB
ctmj-186	161	12	the	the	DET
ctmj-186	161	13	levels	level	NOUN
ctmj-186	161	14	of	of	ADP
ctmj-186	161	15	inflammatory	inflammatory	ADJ
ctmj-186	161	16	cytokines	cytokine	NOUN
ctmj-186	161	17	like	like	ADP
ctmj-186	161	18	il-10	il-10	PRON
ctmj-186	161	19	and	and	CCONJ
ctmj-186	161	20	tnf	tnf	PROPN
ctmj-186	161	21	-	-	PUNCT
ctmj-186	161	22	α	α	PROPN
ctmj-186	161	23	in	in	ADP
ctmj-186	161	24	dic	dic	ADJ
ctmj-186	161	25	model	model	NOUN
ctmj-186	161	26	rats	rat	NOUN
ctmj-186	161	27	,	,	PUNCT
ctmj-186	161	28	as	as	ADV
ctmj-186	161	29	well	well	ADV
ctmj-186	161	30	as	as	ADP
ctmj-186	161	31	the	the	DET
ctmj-186	161	32	activity	activity	NOUN
ctmj-186	161	33	of	of	ADP
ctmj-186	161	34	markers	marker	NOUN
ctmj-186	161	35	for	for	ADP
ctmj-186	161	36	liver	liver	NOUN
ctmj-186	161	37	and	and	CCONJ
ctmj-186	161	38	kidney	kidney	NOUN
ctmj-186	161	39	damage	damage	NOUN
ctmj-186	161	40	like	like	ADP
ctmj-186	161	41	gpt	gpt	NOUN
ctmj-186	161	42	and	and	CCONJ
ctmj-186	161	43	got	get	VERB
ctmj-186	161	44	,	,	PUNCT
ctmj-186	161	45	as	as	ADV
ctmj-186	161	46	well	well	ADV
ctmj-186	161	47	as	as	ADP
ctmj-186	161	48	the	the	DET
ctmj-186	161	49	levels	level	NOUN
ctmj-186	161	50	of	of	ADP
ctmj-186	161	51	bun	bun	PROPN
ctmj-186	161	52	and	and	CCONJ
ctmj-186	161	53	cr	cr	NOUN
ctmj-186	161	54	in	in	ADP
ctmj-186	161	55	their	their	PRON
ctmj-186	161	56	plasma	plasma	NOUN
ctmj-186	161	57	,	,	PUNCT
ctmj-186	161	58	according	accord	VERB
ctmj-186	161	59	to	to	ADP
ctmj-186	161	60	the	the	DET
ctmj-186	161	61	results	result	NOUN
ctmj-186	161	62	.	.	PUNCT
ctmj-186	162	1	the	the	DET
ctmj-186	162	2	results	result	NOUN
ctmj-186	162	3	indicated	indicate	VERB
ctmj-186	162	4	that	that	SCONJ
ctmj-186	162	5	cddp	cddp	NOUN
ctmj-186	162	6	prevents	prevent	VERB
ctmj-186	162	7	damage	damage	NOUN
ctmj-186	162	8	to	to	ADP
ctmj-186	162	9	the	the	DET
ctmj-186	162	10	main	main	ADJ
ctmj-186	162	11	organs	organ	NOUN
ctmj-186	162	12	by	by	ADP
ctmj-186	162	13	reducing	reduce	VERB
ctmj-186	162	14	inflammatory	inflammatory	ADJ
ctmj-186	162	15	factor	factor	NOUN
ctmj-186	162	16	expression	expression	NOUN
ctmj-186	162	17	.	.	PUNCT
ctmj-186	163	1	furthermore	furthermore	ADV
ctmj-186	163	2	,	,	PUNCT
ctmj-186	163	3	the	the	DET
ctmj-186	163	4	early	early	ADJ
ctmj-186	163	5	pathological	pathological	ADJ
ctmj-186	163	6	damage	damage	NOUN
ctmj-186	163	7	to	to	ADP
ctmj-186	163	8	the	the	DET
ctmj-186	163	9	lungs	lung	NOUN
ctmj-186	163	10	,	,	PUNCT
ctmj-186	163	11	liver	liver	NOUN
ctmj-186	163	12	,	,	PUNCT
ctmj-186	163	13	and	and	CCONJ
ctmj-186	163	14	kidneys	kidney	NOUN
ctmj-186	163	15	produced	produce	VERB
ctmj-186	163	16	by	by	ADP
ctmj-186	163	17	lps	lps	PROPN
ctmj-186	163	18	-	-	PUNCT
ctmj-186	163	19	induced	induce	VERB
ctmj-186	163	20	dic	dic	NOUN
ctmj-186	163	21	was	be	AUX
ctmj-186	163	22	ameliorated	ameliorate	VERB
ctmj-186	163	23	by	by	ADP
ctmj-186	163	24	cddp	cddp	NOUN
ctmj-186	163	25	,	,	PUNCT
ctmj-186	163	26	as	as	SCONJ
ctmj-186	163	27	shown	show	VERB
ctmj-186	163	28	by	by	ADP
ctmj-186	163	29	he	he	PRON
ctmj-186	163	30	pathological	pathological	ADJ
ctmj-186	163	31	staining	staining	NOUN
ctmj-186	163	32	.	.	PUNCT
ctmj-186	164	1	these	these	DET
ctmj-186	164	2	findings	finding	NOUN
ctmj-186	164	3	provide	provide	VERB
ctmj-186	164	4	promising	promise	VERB
ctmj-186	164	5	evidence	evidence	NOUN
ctmj-186	164	6	that	that	SCONJ
ctmj-186	164	7	cddp	cddp	PROPN
ctmj-186	164	8	may	may	AUX
ctmj-186	164	9	be	be	AUX
ctmj-186	164	10	useful	useful	ADJ
ctmj-186	164	11	in	in	ADP
ctmj-186	164	12	the	the	DET
ctmj-186	164	13	treatment	treatment	NOUN
ctmj-186	164	14	of	of	ADP
ctmj-186	164	15	dic	dic	NOUN
ctmj-186	164	16	in	in	ADP
ctmj-186	164	17	animals	animal	NOUN
ctmj-186	164	18	by	by	ADP
ctmj-186	164	19	enhancing	enhance	VERB
ctmj-186	164	20	microcirculatory	microcirculatory	ADJ
ctmj-186	164	21	function	function	NOUN
ctmj-186	164	22	and	and	CCONJ
ctmj-186	164	23	protecting	protect	VERB
ctmj-186	164	24	important	important	ADJ
ctmj-186	164	25	organs	organ	NOUN
ctmj-186	164	26	by	by	ADP
ctmj-186	164	27	reducing	reduce	VERB
ctmj-186	164	28	inflammatory	inflammatory	ADJ
ctmj-186	164	29	factor	factor	NOUN
ctmj-186	164	30	expression	expression	NOUN
ctmj-186	164	31	.	.	PUNCT
ctmj-186	165	1	after	after	ADP
ctmj-186	165	2	that	that	PRON
ctmj-186	165	3	,	,	PUNCT
ctmj-186	165	4	we	we	PRON
ctmj-186	165	5	looked	look	VERB
ctmj-186	165	6	at	at	ADP
ctmj-186	165	7	potential	potential	ADJ
ctmj-186	165	8	cddp	cddp	NOUN
ctmj-186	165	9	targets	target	NOUN
ctmj-186	165	10	in	in	ADP
ctmj-186	165	11	dic	dic	ADJ
ctmj-186	165	12	therapy	therapy	NOUN
ctmj-186	165	13	by	by	ADP
ctmj-186	165	14	sequencing	sequence	VERB
ctmj-186	165	15	the	the	DET
ctmj-186	165	16	whole	whole	ADJ
ctmj-186	165	17	-	-	PUNCT
ctmj-186	165	18	blood	blood	NOUN
ctmj-186	165	19	transcriptome	transcriptome	NOUN
ctmj-186	165	20	of	of	ADP
ctmj-186	165	21	animals	animal	NOUN
ctmj-186	165	22	across	across	ADP
ctmj-186	165	23	several	several	ADJ
ctmj-186	165	24	groups	group	NOUN
ctmj-186	165	25	.	.	PUNCT
ctmj-186	166	1	in	in	ADP
ctmj-186	166	2	lps	lps	PROPN
ctmj-186	166	3	-	-	PUNCT
ctmj-186	166	4	induced	induce	VERB
ctmj-186	166	5	dic	dic	ADJ
ctmj-186	166	6	model	model	NOUN
ctmj-186	166	7	rats	rat	NOUN
ctmj-186	166	8	,	,	PUNCT
ctmj-186	166	9	cddp	cddp	PROPN
ctmj-186	166	10	showed	show	VERB
ctmj-186	166	11	therapeutic	therapeutic	ADJ
ctmj-186	166	12	potential	potential	NOUN
ctmj-186	166	13	via	via	ADP
ctmj-186	166	14	immunological	immunological	ADJ
ctmj-186	166	15	modulation	modulation	NOUN
ctmj-186	166	16	,	,	PUNCT
ctmj-186	166	17	anticoagulation	anticoagulation	NOUN
ctmj-186	166	18	,	,	PUNCT
ctmj-186	166	19	antiinflammation	antiinflammation	NOUN
ctmj-186	166	20	,	,	PUNCT
ctmj-186	166	21	inhibition	inhibition	NOUN
ctmj-186	166	22	of	of	ADP
ctmj-186	166	23	platelet	platelet	NOUN
ctmj-186	166	24	activation	activation	NOUN
ctmj-186	166	25	,	,	PUNCT
ctmj-186	166	26	and	and	CCONJ
ctmj-186	166	27	cell	cell	NOUN
ctmj-186	166	28	death	death	NOUN
ctmj-186	166	29	,	,	PUNCT
ctmj-186	166	30	according	accord	VERB
ctmj-186	166	31	to	to	ADP
ctmj-186	166	32	the	the	DET
ctmj-186	166	33	go	go	NOUN
ctmj-186	166	34	and	and	CCONJ
ctmj-186	166	35	kegg	kegg	NOUN
ctmj-186	166	36	enrichment	enrichment	NOUN
ctmj-186	166	37	analyses	analysis	NOUN
ctmj-186	166	38	of	of	ADP
ctmj-186	166	39	the	the	DET
ctmj-186	166	40	differentially	differentially	ADV
ctmj-186	166	41	expressed	express	VERB
ctmj-186	166	42	genes	gene	NOUN
ctmj-186	166	43	.	.	PUNCT
ctmj-186	167	1	we	we	PRON
ctmj-186	167	2	confirmed	confirm	VERB
ctmj-186	167	3	the	the	DET
ctmj-186	167	4	target	target	NOUN
ctmj-186	167	5	genes	gene	NOUN
ctmj-186	167	6	using	use	VERB
ctmj-186	167	7	qpcr	qpcr	ADV
ctmj-186	167	8	:	:	PUNCT
ctmj-186	167	9	sqstml	sqstml	NOUN
ctmj-186	167	10	,	,	PUNCT
ctmj-186	167	11	ctsd	ctsd	VERB
ctmj-186	167	12	,	,	PUNCT
ctmj-186	167	13	mylk2	mylk2	ADJ
ctmj-186	167	14	,	,	PUNCT
ctmj-186	167	15	and	and	CCONJ
ctmj-186	167	16	nfkbib	nfkbib	NOUN
ctmj-186	167	17	.	.	PUNCT
ctmj-186	168	1	our	our	PRON
ctmj-186	168	2	selection	selection	NOUN
ctmj-186	168	3	was	be	AUX
ctmj-186	168	4	based	base	VERB
ctmj-186	168	5	on	on	ADP
ctmj-186	168	6	experimental	experimental	ADJ
ctmj-186	168	7	findings	finding	NOUN
ctmj-186	168	8	and	and	CCONJ
ctmj-186	168	9	a	a	DET
ctmj-186	168	10	literature	literature	NOUN
ctmj-186	168	11	study	study	NOUN
ctmj-186	168	12	.	.	PUNCT
ctmj-186	169	1	this	this	DET
ctmj-186	169	2	prediction	prediction	NOUN
ctmj-186	169	3	approach	approach	NOUN
ctmj-186	169	4	was	be	AUX
ctmj-186	169	5	confirmed	confirm	VERB
ctmj-186	169	6	to	to	PART
ctmj-186	169	7	be	be	AUX
ctmj-186	169	8	feasible	feasible	ADJ
ctmj-186	169	9	since	since	SCONJ
ctmj-186	169	10	the	the	DET
ctmj-186	169	11	target	target	NOUN
ctmj-186	169	12	genes	gene	NOUN
ctmj-186	169	13	were	be	AUX
ctmj-186	169	14	considerably	considerably	ADV
ctmj-186	169	15	elevated	elevate	VERB
ctmj-186	169	16	in	in	ADP
ctmj-186	169	17	the	the	DET
ctmj-186	169	18	cddp	cddp	PROPN
ctmj-186	169	19	group	group	NOUN
ctmj-186	169	20	compared	compare	VERB
ctmj-186	169	21	to	to	ADP
ctmj-186	169	22	the	the	DET
ctmj-186	169	23	model	model	NOUN
ctmj-186	169	24	group	group	NOUN
ctmj-186	169	25	,	,	PUNCT
ctmj-186	169	26	which	which	PRON
ctmj-186	169	27	was	be	AUX
ctmj-186	169	28	in	in	ADP
ctmj-186	169	29	agreement	agreement	NOUN
ctmj-186	169	30	with	with	ADP
ctmj-186	169	31	the	the	DET
ctmj-186	169	32	projected	project	VERB
ctmj-186	169	33	outcomes	outcome	NOUN
ctmj-186	169	34	.	.	PUNCT
ctmj-186	170	1	cddp	cddp	PROPN
ctmj-186	170	2	skewed	skew	VERB
ctmj-186	170	3	the	the	DET
ctmj-186	170	4	expression	expression	NOUN
ctmj-186	170	5	of	of	ADP
ctmj-186	170	6	the	the	DET
ctmj-186	170	7	innate	innate	ADJ
ctmj-186	170	8	immune	immune	ADJ
ctmj-186	170	9	regulating	regulate	VERB
ctmj-186	170	10	factor	factor	NOUN
ctmj-186	170	11	sqstml	sqstml	NOUN
ctmj-186	170	12	.	.	PUNCT
ctmj-186	171	1	in	in	ADP
ctmj-186	171	2	addition	addition	NOUN
ctmj-186	171	3	,	,	PUNCT
ctmj-186	171	4	it	it	PRON
ctmj-186	171	5	is	be	AUX
ctmj-186	171	6	thought	think	VERB
ctmj-186	171	7	of	of	ADP
ctmj-186	171	8	as	as	ADP
ctmj-186	171	9	a	a	DET
ctmj-186	171	10	predictor	predictor	NOUN
ctmj-186	171	11	of	of	ADP
ctmj-186	171	12	outcome	outcome	NOUN
ctmj-186	171	13	in	in	ADP
ctmj-186	171	14	cases	case	NOUN
ctmj-186	171	15	of	of	ADP
ctmj-186	171	16	serious	serious	ADJ
ctmj-186	171	17	infections	infection	NOUN
ctmj-186	171	18	in	in	ADP
ctmj-186	171	19	humans	human	NOUN
ctmj-186	171	20	and	and	CCONJ
ctmj-186	171	21	in	in	ADP
ctmj-186	171	22	animal	animal	NOUN
ctmj-186	171	23	models	model	NOUN
ctmj-186	171	24	generated	generate	VERB
ctmj-186	171	25	by	by	ADP
ctmj-186	171	26	lps	lps	PROPN
ctmj-186	171	27	.	.	PUNCT
ctmj-186	172	1	the	the	DET
ctmj-186	172	2	year	year	NOUN
ctmj-186	172	3	19	19	NUM
ctmj-186	172	4	activated	activate	VERB
ctmj-186	172	5	nuclear	nuclear	ADJ
ctmj-186	172	6	factor	factor	NOUN
ctmj-186	172	7	-	-	PUNCT
ctmj-186	172	8	kappab	kappab	NOUN
ctmj-186	172	9	(	(	PUNCT
ctmj-186	172	10	nf	nf	NOUN
ctmj-186	172	11	-	-	PUNCT
ctmj-186	172	12	κb	κb	NOUN
ctmj-186	172	13	)	)	PUNCT
ctmj-186	172	14	is	be	AUX
ctmj-186	172	15	linked	link	VERB
ctmj-186	172	16	to	to	ADP
ctmj-186	172	17	several	several	ADJ
ctmj-186	172	18	organ	organ	NOUN
ctmj-186	172	19	dysfunctions	dysfunction	NOUN
ctmj-186	172	20	,	,	PUNCT
ctmj-186	172	21	and	and	CCONJ
ctmj-186	172	22	it	it	PRON
ctmj-186	172	23	is	be	AUX
ctmj-186	172	24	known	know	VERB
ctmj-186	172	25	to	to	PART
ctmj-186	172	26	have	have	VERB
ctmj-186	172	27	a	a	DET
ctmj-186	172	28	significant	significant	ADJ
ctmj-186	172	29	role	role	NOUN
ctmj-186	172	30	in	in	ADP
ctmj-186	172	31	endothelial	endothelial	ADJ
ctmj-186	172	32	cell	cell	NOUN
ctmj-186	172	33	damage	damage	NOUN
ctmj-186	172	34	and	and	CCONJ
ctmj-186	172	35	apoptosis	apoptosis	NOUN
ctmj-186	172	36	brought	bring	VERB
ctmj-186	172	37	on	on	ADP
ctmj-186	172	38	by	by	ADP
ctmj-186	172	39	severe	severe	ADJ
ctmj-186	172	40	infections	infection	NOUN
ctmj-186	172	41	.	.	PUNCT
ctmj-186	173	1	patients	patient	NOUN
ctmj-186	173	2	with	with	ADP
ctmj-186	173	3	sepsis	sepsis	NOUN
ctmj-186	173	4	may	may	AUX
ctmj-186	173	5	have	have	VERB
ctmj-186	173	6	a	a	DET
ctmj-186	173	7	better	well	ADJ
ctmj-186	173	8	chance	chance	NOUN
ctmj-186	173	9	of	of	ADP
ctmj-186	173	10	surviving	survive	VERB
ctmj-186	173	11	if	if	SCONJ
ctmj-186	173	12	the	the	DET
ctmj-186	173	13	nf-b	nf-b	PROPN
ctmj-186	173	14	activity	activity	NOUN
ctmj-186	173	15	is	be	AUX
ctmj-186	173	16	inhibited	inhibit	VERB
ctmj-186	173	17	.	.	PUNCT
ctmj-186	174	1	among	among	ADP
ctmj-186	174	2	the	the	DET
ctmj-186	174	3	many	many	ADJ
ctmj-186	174	4	roles	role	NOUN
ctmj-186	174	5	it	it	PRON
ctmj-186	174	6	plays	play	VERB
ctmj-186	174	7	in	in	ADP
ctmj-186	174	8	the	the	DET
ctmj-186	174	9	heart	heart	NOUN
ctmj-186	174	10	and	and	CCONJ
ctmj-186	174	11	in	in	ADP
ctmj-186	174	12	the	the	DET
ctmj-186	174	13	activation	activation	NOUN
ctmj-186	174	14	and	and	CCONJ
ctmj-186	174	15	aggregation	aggregation	NOUN
ctmj-186	174	16	of	of	ADP
ctmj-186	174	17	platelets	platelet	NOUN
ctmj-186	174	18	,	,	PUNCT
ctmj-186	174	19	mylk2	mylk2	NOUN
ctmj-186	174	20	,	,	PUNCT
ctmj-186	174	21	an	an	DET
ctmj-186	174	22	affiliate	affiliate	NOUN
ctmj-186	174	23	of	of	ADP
ctmj-186	174	24	the	the	DET
ctmj-186	174	25	myosin	myosin	PROPN
ctmj-186	174	26	light	light	PROPN
ctmj-186	174	27	chain	chain	PROPN
ctmj-186	174	28	kinase	kinase	PROPN
ctmj-186	174	29	family	family	PROPN
ctmj-186	174	30	,	,	PUNCT
ctmj-186	174	31	is	be	AUX
ctmj-186	174	32	mentioned	mention	VERB
ctmj-186	174	33	in	in	ADP
ctmj-186	174	34	reference	reference	NOUN
ctmj-186	174	35	[	[	X
ctmj-186	174	36	20	20	NUM
ctmj-186	174	37	]	]	PUNCT
ctmj-186	174	38	.	.	PUNCT
ctmj-186	175	1	references	reference	NOUN
ctmj-186	175	2	[	[	X
ctmj-186	175	3	21,22	21,22	X
ctmj-186	175	4	]	]	X
ctmj-186	175	5	after	after	ADP
ctmj-186	175	6	ischemia	ischemia	NOUN
ctmj-186	175	7	and	and	CCONJ
ctmj-186	175	8	hypoxia	hypoxia	NOUN
ctmj-186	175	9	,	,	PUNCT
ctmj-186	175	10	autophagy	autophagy	NOUN
ctmj-186	175	11	activates	activate	VERB
ctmj-186	175	12	ctsd	ctsd	NOUN
ctmj-186	175	13	,	,	PUNCT
ctmj-186	175	14	leading	lead	VERB
ctmj-186	175	15	to	to	ADP
ctmj-186	175	16	lysosomal	lysosomal	ADJ
ctmj-186	175	17	dysfunction	dysfunction	NOUN
ctmj-186	175	18	.	.	PUNCT
ctmj-186	176	1	cell	cell	NOUN
ctmj-186	176	2	apoptosis	apoptosis	NOUN
ctmj-186	176	3	involves	involve	VERB
ctmj-186	176	4	both	both	CCONJ
ctmj-186	176	5	internal	internal	ADJ
ctmj-186	176	6	and	and	CCONJ
ctmj-186	176	7	extrinsic	extrinsic	ADJ
ctmj-186	176	8	processes	process	NOUN
ctmj-186	176	9	,	,	PUNCT
ctmj-186	176	10	to	to	PART
ctmj-186	176	11	which	which	PRON
ctmj-186	176	12	it	it	PRON
ctmj-186	176	13	contributes	contribute	VERB
ctmj-186	176	14	at	at	ADP
ctmj-186	176	15	various	various	ADJ
ctmj-186	176	16	stages	stage	NOUN
ctmj-186	176	17	.	.	PUNCT
ctmj-186	177	1	[	[	X
ctmj-186	177	2	23	23	NUM
ctmj-186	177	3	]	]	PUNCT
ctmj-186	177	4	the	the	DET
ctmj-186	177	5	ctsd	ctsd	NOUN
ctmj-186	177	6	may	may	AUX
ctmj-186	177	7	also	also	ADV
ctmj-186	177	8	initiate	initiate	VERB
ctmj-186	177	9	cell	cell	NOUN
ctmj-186	177	10	death	death	NOUN
ctmj-186	177	11	by	by	ADP
ctmj-186	177	12	directly	directly	ADV
ctmj-186	177	13	activating	activate	VERB
ctmj-186	177	14	caspase	caspase	PROPN
ctmj-186	177	15	3	3	X
ctmj-186	177	16	.	.	PUNCT
ctmj-186	178	1	this	this	DET
ctmj-186	178	2	research	research	NOUN
ctmj-186	178	3	found	find	VERB
ctmj-186	178	4	that	that	SCONJ
ctmj-186	178	5	cddp	cddp	NOUN
ctmj-186	178	6	improved	improve	VERB
ctmj-186	178	7	the	the	DET
ctmj-186	178	8	aberrant	aberrant	ADJ
ctmj-186	178	9	expression	expression	NOUN
ctmj-186	178	10	of	of	ADP
ctmj-186	178	11	the	the	DET
ctmj-186	178	12	blood	blood	NOUN
ctmj-186	178	13	of	of	ADP
ctmj-186	178	14	rats	rat	NOUN
ctmj-186	178	15	that	that	PRON
ctmj-186	178	16	were	be	AUX
ctmj-186	178	17	induced	induce	VERB
ctmj-186	178	18	dic	dic	ADJ
ctmj-186	178	19	by	by	ADP
ctmj-186	178	20	lps	lps	PROPN
ctmj-186	178	21	included	include	VERB
ctmj-186	178	22	sqstml	sqstml	NOUN
ctmj-186	178	23	,	,	PUNCT
ctmj-186	178	24	ctsd	ctsd	VERB
ctmj-186	178	25	,	,	PUNCT
ctmj-186	178	26	mylk2	mylk2	ADJ
ctmj-186	178	27	,	,	PUNCT
ctmj-186	178	28	and	and	CCONJ
ctmj-186	178	29	nfkbib	nfkbib	ADJ
ctmj-186	178	30	.	.	PUNCT
ctmj-186	179	1	in	in	ADP
ctmj-186	179	2	this	this	DET
ctmj-186	179	3	work	work	NOUN
ctmj-186	179	4	,	,	PUNCT
ctmj-186	179	5	we	we	PRON
ctmj-186	179	6	found	find	VERB
ctmj-186	179	7	that	that	SCONJ
ctmj-186	179	8	cddp	cddp	NOUN
ctmj-186	179	9	increased	increase	VERB
ctmj-186	179	10	blood	blood	NOUN
ctmj-186	179	11	flow	flow	NOUN
ctmj-186	179	12	to	to	ADP
ctmj-186	179	13	the	the	DET
ctmj-186	179	14	primary	primary	ADJ
ctmj-186	179	15	organs	organ	NOUN
ctmj-186	179	16	of	of	ADP
ctmj-186	179	17	rats	rat	NOUN
ctmj-186	179	18	with	with	ADP
ctmj-186	179	19	dic	dic	PROPN
ctmj-186	179	20	,	,	PUNCT
ctmj-186	179	21	which	which	PRON
ctmj-186	179	22	protected	protect	VERB
ctmj-186	179	23	those	those	DET
ctmj-186	179	24	organs	organ	NOUN
ctmj-186	179	25	from	from	ADP
ctmj-186	179	26	damage	damage	NOUN
ctmj-186	179	27	.	.	PUNCT
ctmj-186	180	1	also	also	ADV
ctmj-186	180	2	,	,	PUNCT
ctmj-186	180	3	it	it	PRON
ctmj-186	180	4	blocks	block	VERB
ctmj-186	180	5	cell	cell	NOUN
ctmj-186	180	6	death	death	NOUN
ctmj-186	180	7	,	,	PUNCT
ctmj-186	180	8	controls	control	VERB
ctmj-186	180	9	inflammatory	inflammatory	ADJ
ctmj-186	180	10	factor	factor	NOUN
ctmj-186	180	11	expression	expression	NOUN
ctmj-186	180	12	,	,	PUNCT
ctmj-186	180	13	decreases	decrease	VERB
ctmj-186	180	14	coagulation	coagulation	NOUN
ctmj-186	180	15	malfunction	malfunction	NOUN
ctmj-186	180	16	in	in	ADP
ctmj-186	180	17	dic	dic	PROPN
ctmj-186	180	18	,	,	PUNCT
ctmj-186	180	19	and	and	CCONJ
ctmj-186	180	20	blocks	block	VERB
ctmj-186	180	21	platelet	platelet	NOUN
ctmj-186	180	22	activation	activation	NOUN
ctmj-186	180	23	pathways	pathway	NOUN
ctmj-186	180	24	.	.	PUNCT
ctmj-186	181	1	supporting	support	VERB
ctmj-186	181	2	the	the	DET
ctmj-186	181	3	expression	expression	NOUN
ctmj-186	181	4	of	of	ADP
ctmj-186	181	5	important	important	ADJ
ctmj-186	181	6	genes	gene	NOUN
ctmj-186	181	7	linked	link	VERB
ctmj-186	181	8	to	to	ADP
ctmj-186	181	9	disease	disease	NOUN
ctmj-186	181	10	development	development	NOUN
ctmj-186	181	11	,	,	PUNCT
ctmj-186	181	12	including	include	VERB
ctmj-186	181	13	sqstml	sqstml	NOUN
ctmj-186	181	14	and	and	CCONJ
ctmj-186	181	15	nfkbib	nfkbib	NOUN
ctmj-186	181	16	,	,	PUNCT
ctmj-186	181	17	may	may	AUX
ctmj-186	181	18	be	be	AUX
ctmj-186	181	19	the	the	DET
ctmj-186	181	20	underlying	underlying	ADJ
ctmj-186	181	21	mechanism	mechanism	NOUN
ctmj-186	181	22	.	.	PUNCT
ctmj-186	182	1	in	in	ADP
ctmj-186	182	2	conclusion	conclusion	NOUN
ctmj-186	182	3	,	,	PUNCT
ctmj-186	182	4	cddp	cddp	PROPN
ctmj-186	182	5	has	have	AUX
ctmj-186	182	6	promise	promise	NOUN
ctmj-186	182	7	for	for	ADP
ctmj-186	182	8	enhancing	enhance	VERB
ctmj-186	182	9	dic	dic	ADJ
ctmj-186	182	10	prognosis	prognosis	NOUN
ctmj-186	182	11	and	and	CCONJ
ctmj-186	182	12	creating	create	VERB
ctmj-186	182	13	a	a	DET
ctmj-186	182	14	more	more	ADV
ctmj-186	182	15	efficient	efficient	ADJ
ctmj-186	182	16	treatment	treatment	NOUN
ctmj-186	182	17	plan	plan	NOUN
ctmj-186	182	18	.	.	PUNCT
ctmj-186	183	1	conclusions	conclusion	NOUN
ctmj-186	183	2	this	this	DET
ctmj-186	183	3	study	study	NOUN
ctmj-186	183	4	showed	show	VERB
ctmj-186	183	5	that	that	SCONJ
ctmj-186	183	6	cddp	cddp	NOUN
ctmj-186	183	7	may	may	AUX
ctmj-186	183	8	have	have	VERB
ctmj-186	183	9	protective	protective	ADJ
ctmj-186	183	10	effects	effect	NOUN
ctmj-186	183	11	in	in	ADP
ctmj-186	183	12	dic	dic	ADJ
ctmj-186	183	13	model	model	NOUN
ctmj-186	183	14	animals	animal	NOUN
ctmj-186	183	15	by	by	ADP
ctmj-186	183	16	improving	improve	VERB
ctmj-186	183	17	organ	organ	NOUN
ctmj-186	183	18	blood	blood	NOUN
ctmj-186	183	19	flow	flow	NOUN
ctmj-186	183	20	and	and	CCONJ
ctmj-186	183	21	coagulation	coagulation	NOUN
ctmj-186	183	22	abnormalities	abnormality	NOUN
ctmj-186	183	23	and	and	CCONJ
ctmj-186	183	24	inhibiting	inhibit	VERB
ctmj-186	183	25	the	the	DET
ctmj-186	183	26	expression	expression	NOUN
ctmj-186	183	27	of	of	ADP
ctmj-186	183	28	inflammatory	inflammatory	ADJ
ctmj-186	183	29	factors	factor	NOUN
ctmj-186	183	30	.	.	PUNCT
ctmj-186	184	1	the	the	DET
ctmj-186	184	2	therapeutic	therapeutic	ADJ
ctmj-186	184	3	effects	effect	NOUN
ctmj-186	184	4	of	of	ADP
ctmj-186	184	5	cddp	cddp	PROPN
ctmj-186	184	6	on	on	ADP
ctmj-186	184	7	dic	dic	ADJ
ctmj-186	184	8	model	model	NOUN
ctmj-186	184	9	animals	animal	NOUN
ctmj-186	184	10	may	may	AUX
ctmj-186	184	11	be	be	AUX
ctmj-186	184	12	achieved	achieve	VERB
ctmj-186	184	13	by	by	ADP
ctmj-186	184	14	increasing	increase	VERB
ctmj-186	184	15	the	the	DET
ctmj-186	184	16	expression	expression	NOUN
ctmj-186	184	17	of	of	ADP
ctmj-186	184	18	key	key	ADJ
ctmj-186	184	19	genes	gene	NOUN
ctmj-186	184	20	related	relate	VERB
ctmj-186	184	21	to	to	ADP
ctmj-186	184	22	dic	dic	PROPN
ctmj-186	184	23	,	,	PUNCT
ctmj-186	184	24	including	include	VERB
ctmj-186	184	25	sqstml	sqstml	NOUN
ctmj-186	184	26	and	and	CCONJ
ctmj-186	184	27	nfkbib	nfkbib	NOUN
ctmj-186	184	28	,	,	PUNCT
ctmj-186	184	29	thereby	thereby	ADV
ctmj-186	184	30	improving	improve	VERB
ctmj-186	184	31	the	the	DET
ctmj-186	184	32	prognosis	prognosis	NOUN
ctmj-186	184	33	of	of	ADP
ctmj-186	184	34	model	model	NOUN
ctmj-186	184	35	animals	animal	NOUN
ctmj-186	184	36	.	.	PUNCT
ctmj-186	185	1	this	this	DET
ctmj-186	185	2	study	study	NOUN
ctmj-186	185	3	only	only	ADV
ctmj-186	185	4	preliminarily	preliminarily	ADV
ctmj-186	185	5	explored	explore	VERB
ctmj-186	185	6	the	the	DET
ctmj-186	185	7	efficacy	efficacy	NOUN
ctmj-186	185	8	and	and	CCONJ
ctmj-186	185	9	mechanism	mechanism	NOUN
ctmj-186	185	10	of	of	ADP
ctmj-186	185	11	cddp	cddp	NOUN
ctmj-186	185	12	in	in	ADP
ctmj-186	185	13	the	the	DET
ctmj-186	185	14	treatment	treatment	NOUN
ctmj-186	185	15	of	of	ADP
ctmj-186	185	16	dic	dic	NOUN
ctmj-186	185	17	,	,	PUNCT
ctmj-186	185	18	and	and	CCONJ
ctmj-186	185	19	the	the	DET
ctmj-186	185	20	key	key	ADJ
ctmj-186	185	21	targets	target	NOUN
ctmj-186	185	22	and	and	CCONJ
ctmj-186	185	23	pathways	pathway	NOUN
ctmj-186	185	24	of	of	ADP
ctmj-186	185	25	action	action	NOUN
ctmj-186	185	26	should	should	AUX
ctmj-186	185	27	be	be	AUX
ctmj-186	185	28	further	far	ADV
ctmj-186	185	29	clarified	clarify	VERB
ctmj-186	185	30	and	and	CCONJ
ctmj-186	185	31	verified	verify	VERB
ctmj-186	185	32	to	to	PART
ctmj-186	185	33	explain	explain	VERB
ctmj-186	185	34	the	the	DET
ctmj-186	185	35	mechanism	mechanism	NOUN
ctmj-186	185	36	of	of	ADP
ctmj-186	185	37	action	action	NOUN
ctmj-186	185	38	of	of	ADP
ctmj-186	185	39	cddp	cddp	NOUN
ctmj-186	185	40	in	in	ADP
ctmj-186	185	41	the	the	DET
ctmj-186	185	42	treatment	treatment	NOUN
ctmj-186	185	43	of	of	ADP
ctmj-186	185	44	dic	dic	PROPN
ctmj-186	185	45	further	far	ADV
ctmj-186	185	46	clearly	clearly	ADV
ctmj-186	185	47	.	.	PUNCT
ctmj-186	186	1	financial	financial	ADJ
ctmj-186	186	2	support	support	NOUN
ctmj-186	186	3	and	and	CCONJ
ctmj-186	186	4	sponsorship	sponsorship	NOUN
ctmj-186	186	5	nil	nil	NOUN
ctmj-186	186	6	.	.	PUNCT
ctmj-186	187	1	conflicts	conflict	NOUN
ctmj-186	187	2	of	of	ADP
ctmj-186	187	3	interest	interest	NOUN
ctmj-186	187	4	the	the	DET
ctmj-186	187	5	authors	author	NOUN
ctmj-186	187	6	assert	assert	VERB
ctmj-186	187	7	that	that	SCONJ
ctmj-186	187	8	the	the	DET
ctmj-186	187	9	study	study	NOUN
ctmj-186	187	10	was	be	AUX
ctmj-186	187	11	conducted	conduct	VERB
ctmj-186	187	12	without	without	ADP
ctmj-186	187	13	any	any	DET
ctmj-186	187	14	commercial	commercial	ADJ
ctmj-186	187	15	or	or	CCONJ
ctmj-186	187	16	financial	financial	ADJ
ctmj-186	187	17	affiliation	affiliation	NOUN
ctmj-186	187	18	that	that	PRON
ctmj-186	187	19	may	may	AUX
ctmj-186	187	20	pose	pose	VERB
ctmj-186	187	21	a	a	DET
ctmj-186	187	22	conflict	conflict	NOUN
ctmj-186	187	23	of	of	ADP
ctmj-186	187	24	interest	interest	NOUN
ctmj-186	187	25	.	.	PUNCT
ctmj-186	188	1	references	reference	NOUN
ctmj-186	188	2	1	1	NUM
ctmj-186	188	3	.	.	PUNCT
ctmj-186	189	1	wada	wada	PROPN
ctmj-186	189	2	h	h	PROPN
ctmj-186	189	3	,	,	PUNCT
ctmj-186	189	4	thachil	thachil	PROPN
ctmj-186	189	5	j	j	PROPN
ctmj-186	189	6	,	,	PUNCT
ctmj-186	189	7	di	di	PROPN
ctmj-186	189	8	nisio	nisio	PROPN
ctmj-186	189	9	m	m	PROPN
ctmj-186	189	10	,	,	PUNCT
ctmj-186	189	11	mathew	mathew	PROPN
ctmj-186	189	12	p	p	PROPN
ctmj-186	189	13	,	,	PUNCT
ctmj-186	189	14	et	et	PROPN
ctmj-186	189	15	al	al	PROPN
ctmj-186	189	16	.	.	PROPN
ctmj-186	189	17	guidance	guidance	NOUN
ctmj-186	189	18	for	for	ADP
ctmj-186	189	19	diagnosis	diagnosis	NOUN
ctmj-186	189	20	and	and	CCONJ
ctmj-186	189	21	treatment	treatment	NOUN
ctmj-186	189	22	of	of	ADP
ctmj-186	189	23	dic	dic	NOUN
ctmj-186	189	24	from	from	ADP
ctmj-186	189	25	harmonization	harmonization	NOUN
ctmj-186	189	26	of	of	ADP
ctmj-186	189	27	the	the	DET
ctmj-186	189	28	recommendations	recommendation	NOUN
ctmj-186	189	29	from	from	ADP
ctmj-186	189	30	three	three	NUM
ctmj-186	189	31	guidelines	guideline	NOUN
ctmj-186	189	32	.	.	PUNCT
ctmj-186	190	1	:	:	PUNCT
ctmj-186	191	1	jth	jth	PROPN
ctmj-186	191	2	2013;11:761	2013;11:761	PROPN
ctmj-186	191	3	-	-	NUM
ctmj-186	191	4	767	767	NUM
ctmj-186	191	5	.	.	PUNCT
ctmj-186	192	1	2	2	X
ctmj-186	192	2	.	.	X
ctmj-186	192	3	berthelsen	berthelsen	PROPN
ctmj-186	192	4	lo	lo	PROPN
ctmj-186	192	5	,	,	PUNCT
ctmj-186	192	6	kristensen	kristensen	PROPN
ctmj-186	192	7	at	at	ADP
ctmj-186	192	8	,	,	PUNCT
ctmj-186	192	9	tranholm	tranholm	NOUN
ctmj-186	192	10	m.	m.	NOUN
ctmj-186	192	11	animal	animal	NOUN
ctmj-186	192	12	models	model	NOUN
ctmj-186	192	13	of	of	ADP
ctmj-186	192	14	dic	dic	PROPN
ctmj-186	192	15	and	and	CCONJ
ctmj-186	192	16	their	their	PRON
ctmj-186	192	17	relevance	relevance	NOUN
ctmj-186	192	18	to	to	ADP
ctmj-186	192	19	human	human	PROPN
ctmj-186	192	20	dic	dic	PROPN
ctmj-186	192	21	:	:	PUNCT
ctmj-186	192	22	a	a	DET
ctmj-186	192	23	systematic	systematic	ADJ
ctmj-186	192	24	review	review	NOUN
ctmj-186	192	25	.	.	PUNCT
ctmj-186	193	1	thromb	thromb	PROPN
ctmj-186	193	2	res	re	NOUN
ctmj-186	193	3	2011;128:103	2011;128:103	PROPN
ctmj-186	193	4	-	-	SYM
ctmj-186	193	5	16	16	NUM
ctmj-186	193	6	.	.	PUNCT
ctmj-186	194	1	3	3	X
ctmj-186	194	2	.	.	X
ctmj-186	194	3	popescu	popescu	PROPN
ctmj-186	194	4	ni	ni	PROPN
ctmj-186	194	5	,	,	PUNCT
ctmj-186	194	6	lupu	lupu	PROPN
ctmj-186	194	7	c	c	PROPN
ctmj-186	194	8	,	,	PUNCT
ctmj-186	194	9	lupu	lupu	PROPN
ctmj-186	194	10	f.	f.	PROPN
ctmj-186	194	11	disseminated	disseminate	VERB
ctmj-186	194	12	intravascular	intravascular	ADJ
ctmj-186	194	13	coagulation	coagulation	NOUN
ctmj-186	194	14	and	and	CCONJ
ctmj-186	194	15	its	its	PRON
ctmj-186	194	16	immune	immune	ADJ
ctmj-186	194	17	mechanisms	mechanism	NOUN
ctmj-186	194	18	.	.	PUNCT
ctmj-186	195	1	blood	blood	NOUN
ctmj-186	195	2	2022;139:1973	2022;139:1973	NUM
ctmj-186	195	3	-	-	SYM
ctmj-186	195	4	86	86	NUM
ctmj-186	195	5	.	.	PUNCT
ctmj-186	196	1	4	4	NUM
ctmj-186	196	2	.	.	X
ctmj-186	196	3	abrams	abrams	PROPN
ctmj-186	196	4	st	st	PROPN
ctmj-186	196	5	,	,	PUNCT
ctmj-186	196	6	su	su	PROPN
ctmj-186	196	7	d	d	PROPN
ctmj-186	196	8	,	,	PUNCT
ctmj-186	196	9	sahraoui	sahraoui	PROPN
ctmj-186	196	10	y	y	PROPN
ctmj-186	196	11	,	,	PUNCT
ctmj-186	196	12	lin	lin	PROPN
ctmj-186	196	13	z	z	PROPN
ctmj-186	196	14	,	,	PUNCT
ctmj-186	196	15	cheng	cheng	PROPN
ctmj-186	196	16	z	z	PROPN
ctmj-186	196	17	,	,	PUNCT
ctmj-186	196	18	nesbitt	nesbitt	PROPN
ctmj-186	197	1	k	k	PROPN
ctmj-186	197	2	,	,	PUNCT
ctmj-186	197	3	et	et	PROPN
ctmj-186	197	4	al	al	PROPN
ctmj-186	197	5	.	.	PROPN
ctmj-186	197	6	assembly	assembly	PROPN
ctmj-186	197	7	of	of	ADP
ctmj-186	197	8	alternative	alternative	ADJ
ctmj-186	197	9	prothrombinase	prothrombinase	NOUN
ctmj-186	197	10	by	by	ADP
ctmj-186	197	11	extracellular	extracellular	ADJ
ctmj-186	197	12	histones	histone	NOUN
ctmj-186	197	13	initiates	initiate	VERB
ctmj-186	197	14	and	and	CCONJ
ctmj-186	197	15	disseminates	disseminate	VERB
ctmj-186	197	16	intravascular	intravascular	ADJ
ctmj-186	197	17	coagulation	coagulation	NOUN
ctmj-186	197	18	.	.	PUNCT
ctmj-186	198	1	blood	blood	NOUN
ctmj-186	198	2	2021;137:103	2021;137:103	NUM
ctmj-186	198	3	-	-	SYM
ctmj-186	198	4	14	14	NUM
ctmj-186	198	5	.	.	PUNCT
ctmj-186	198	6	5	5	NUM
ctmj-186	198	7	.	.	X
ctmj-186	198	8	adelborg	adelborg	PROPN
ctmj-186	198	9	k	k	PROPN
ctmj-186	198	10	,	,	PUNCT
ctmj-186	198	11	larsen	larsen	PROPN
ctmj-186	198	12	jb	jb	PROPN
ctmj-186	198	13	,	,	PUNCT
ctmj-186	198	14	hvas	hvas	PROPN
ctmj-186	198	15	am	be	AUX
ctmj-186	198	16	.	.	PUNCT
ctmj-186	198	17	disseminated	disseminate	VERB
ctmj-186	198	18	intravascular	intravascular	ADJ
ctmj-186	198	19	coagulation	coagulation	NOUN
ctmj-186	198	20	:	:	PUNCT
ctmj-186	198	21	epidemiology	epidemiology	NOUN
ctmj-186	198	22	,	,	PUNCT
ctmj-186	198	23	biomarkers	biomarker	NOUN
ctmj-186	198	24	,	,	PUNCT
ctmj-186	198	25	and	and	CCONJ
ctmj-186	198	26	management	management	NOUN
ctmj-186	198	27	.	.	PUNCT
ctmj-186	199	1	br	br	PROPN
ctmj-186	199	2	j	j	PROPN
ctmj-186	199	3	haematol	haematol	PROPN
ctmj-186	199	4	2021;192:803	2021;192:803	PROPN
ctmj-186	199	5	-	-	SYM
ctmj-186	199	6	18	18	NUM
ctmj-186	199	7	.	.	NOUN
ctmj-186	199	8	6	6	NUM
ctmj-186	199	9	.	.	PUNCT
ctmj-186	199	10	gando	gando	PROPN
ctmj-186	199	11	s	s	PROPN
ctmj-186	199	12	,	,	PUNCT
ctmj-186	199	13	levi	levi	PROPN
ctmj-186	199	14	m	m	PROPN
ctmj-186	199	15	,	,	PUNCT
ctmj-186	199	16	toh	toh	PROPN
ctmj-186	199	17	ch	ch	NOUN
ctmj-186	199	18	.	.	PROPN
ctmj-186	199	19	disseminated	disseminate	VERB
ctmj-186	199	20	intravascular	intravascular	ADJ
ctmj-186	199	21	coagulation	coagulation	NOUN
ctmj-186	199	22	.	.	PUNCT
ctmj-186	200	1	nat	nat	PROPN
ctmj-186	200	2	rev	rev	VERB
ctmj-186	200	3	dis	dis	PROPN
ctmj-186	200	4	primers	primer	NOUN
ctmj-186	200	5	2016;2:16037	2016;2:16037	NOUN
ctmj-186	200	6	.	.	PUNCT
ctmj-186	201	1	7	7	X
ctmj-186	201	2	.	.	X
ctmj-186	201	3	guan	guan	PROPN
ctmj-186	201	4	wj	wj	PROPN
ctmj-186	201	5	,	,	PUNCT
ctmj-186	201	6	ni	ni	PROPN
ctmj-186	201	7	zy	zy	PROPN
ctmj-186	201	8	,	,	PUNCT
ctmj-186	201	9	hu	hu	PROPN
ctmj-186	201	10	y	y	PROPN
ctmj-186	201	11	,	,	PUNCT
ctmj-186	201	12	liang	liang	PROPN
ctmj-186	201	13	wh	wh	PROPN
ctmj-186	201	14	,	,	PUNCT
ctmj-186	201	15	ou	ou	PROPN
ctmj-186	201	16	cq	cq	PROPN
ctmj-186	201	17	,	,	PUNCT
ctmj-186	201	18	he	he	PRON
ctmj-186	201	19	jx	jx	PROPN
ctmj-186	201	20	.	.	PUNCT
ctmj-186	202	1	clinical	clinical	ADJ
ctmj-186	202	2	characteristics	characteristic	NOUN
ctmj-186	202	3	of	of	ADP
ctmj-186	202	4	coronavirus	coronavirus	NOUN
ctmj-186	202	5	disease	disease	NOUN
ctmj-186	202	6	2019	2019	NUM
ctmj-186	202	7	in	in	ADP
ctmj-186	202	8	china	china	PROPN
ctmj-186	202	9	.	.	PUNCT
ctmj-186	203	1	n	n	PROPN
ctmj-186	203	2	eng	eng	PROPN
ctmj-186	203	3	j	j	PROPN
ctmj-186	203	4	med	med	PROPN
ctmj-186	203	5	2020;382:1708‑20	2020;382:1708‑20	PROPN
ctmj-186	203	6	.	.	PROPN
ctmj-186	203	7	8	8	NUM
ctmj-186	203	8	.	.	PUNCT
ctmj-186	204	1	yao	yao	PROPN
ctmj-186	204	2	cl	cl	PROPN
ctmj-186	204	3	,	,	PUNCT
ctmj-186	204	4	wei	wei	PROPN
ctmj-186	204	5	wl	wl	PROPN
ctmj-186	204	6	,	,	PUNCT
ctmj-186	204	7	zhang	zhang	PROPN
ctmj-186	204	8	jq	jq	PROPN
ctmj-186	204	9	,	,	PUNCT
ctmj-186	204	10	bi	bi	PROPN
ctmj-186	204	11	qr	qr	PROPN
ctmj-186	204	12	,	,	PUNCT
ctmj-186	204	13	li	li	PROPN
ctmj-186	204	14	jy	jy	PROPN
ctmj-186	204	15	,	,	PUNCT
ctmj-186	204	16	khan	khan	PROPN
ctmj-186	204	17	i	i	PROPN
ctmj-186	204	18	,	,	PUNCT
ctmj-186	204	19	et	et	PROPN
ctmj-186	204	20	al	al	PROPN
ctmj-186	204	21	.	.	PUNCT
ctmj-186	205	1	traditional	traditional	ADJ
ctmj-186	205	2	chinese	chinese	ADJ
ctmj-186	205	3	medicines	medicine	NOUN
ctmj-186	205	4	against	against	ADP
ctmj-186	205	5	covid-19	covid-19	PROPN
ctmj-186	205	6	:	:	PUNCT
ctmj-186	205	7	a	a	DET
ctmj-186	205	8	global	global	ADJ
ctmj-186	205	9	overview	overview	NOUN
ctmj-186	205	10	.	.	PUNCT
ctmj-186	206	1	world	world	PROPN
ctmj-186	206	2	j	j	PROPN
ctmj-186	206	3	tradit	tradit	PROPN
ctmj-186	206	4	chin	chin	PROPN
ctmj-186	206	5	med	med	PROPN
ctmj-186	206	6	2022;8:279	2022;8:279	PROPN
ctmj-186	206	7	-	-	SYM
ctmj-186	206	8	313	313	NUM
ctmj-186	206	9	.	.	NOUN
ctmj-186	206	10	9	9	NUM
ctmj-186	206	11	.	.	X
ctmj-186	206	12	vincent	vincent	PROPN
ctmj-186	206	13	jl	jl	PROPN
ctmj-186	206	14	,	,	PUNCT
ctmj-186	206	15	levi	levi	PROPN
ctmj-186	206	16	m	m	PROPN
ctmj-186	206	17	,	,	PUNCT
ctmj-186	206	18	hunt	hunt	NOUN
ctmj-186	206	19	bj	bj	NOUN
ctmj-186	206	20	.	.	PUNCT
ctmj-186	206	21	prevention	prevention	NOUN
ctmj-186	206	22	and	and	CCONJ
ctmj-186	206	23	management	management	NOUN
ctmj-186	206	24	of	of	ADP
ctmj-186	206	25	thrombosis	thrombosis	NOUN
ctmj-186	206	26	in	in	ADP
ctmj-186	206	27	hospitalised	hospitalise	VERB
ctmj-186	206	28	patients	patient	NOUN
ctmj-186	206	29	with	with	ADP
ctmj-186	206	30	covid-19	covid-19	PROPN
ctmj-186	206	31	pneumonia	pneumonia	NOUN
ctmj-186	206	32	.	.	PUNCT
ctmj-186	207	1	lancet	lancet	PROPN
ctmj-186	207	2	respir	respir	VERB
ctmj-186	207	3	med	med	ADJ
ctmj-186	207	4	2022;10:214	2022;10:214	PROPN
ctmj-186	207	5	-	-	SYM
ctmj-186	207	6	20	20	NUM
ctmj-186	207	7	.	.	PUNCT
ctmj-186	208	1	ctmj	ctmj	NOUN
ctmj-186	208	2	|	|	ADV
ctmj-186	208	3	traditionalmedicinejournals.com	traditionalmedicinejournals.com	X
ctmj-186	208	4	chinese	chinese	ADJ
ctmj-186	208	5	traditional	traditional	ADJ
ctmj-186	208	6	medicine	medicine	NOUN
ctmj-186	208	7	journal	journal	NOUN
ctmj-186	208	8	|	|	ADV
ctmj-186	208	9	2025	2025	NUM
ctmj-186	208	10	|	|	ADV
ctmj-186	208	11	vol	vol	NOUN
ctmj-186	208	12	8	8	NUM
ctmj-186	208	13	|issue	|issue	NOUN
ctmj-186	208	14	1	1	NUM
ctmj-186	208	15	30	30	NUM
ctmj-186	208	16	10	10	NUM
ctmj-186	208	17	.	.	PUNCT
ctmj-186	209	1	zarychanski	zarychanski	PROPN
ctmj-186	209	2	r	r	PROPN
ctmj-186	209	3	,	,	PUNCT
ctmj-186	209	4	abou‑setta	abou‑setta	PROPN
ctmj-186	209	5	am	am	NOUN
ctmj-186	209	6	,	,	PUNCT
ctmj-186	209	7	kanji	kanji	X
ctmj-186	209	8	s	s	PROPN
ctmj-186	209	9	,	,	PUNCT
ctmj-186	209	10	turgeon	turgeon	PROPN
ctmj-186	209	11	af	af	PROPN
ctmj-186	209	12	,	,	PUNCT
ctmj-186	209	13	kumar	kumar	PROPN
ctmj-186	209	14	a	a	PROPN
ctmj-186	209	15	,	,	PUNCT
ctmj-186	209	16	houston	houston	PROPN
ctmj-186	209	17	ds	ds	PROPN
ctmj-186	209	18	,	,	PUNCT
ctmj-186	209	19	et	et	PROPN
ctmj-186	209	20	al	al	PROPN
ctmj-186	209	21	.	.	PUNCT
ctmj-186	210	1	the	the	DET
ctmj-186	210	2	efficacy	efficacy	NOUN
ctmj-186	210	3	and	and	CCONJ
ctmj-186	210	4	safety	safety	NOUN
ctmj-186	210	5	of	of	ADP
ctmj-186	210	6	heparin	heparin	NOUN
ctmj-186	210	7	in	in	ADP
ctmj-186	210	8	patients	patient	NOUN
ctmj-186	210	9	with	with	ADP
ctmj-186	210	10	sepsis	sepsis	NOUN
ctmj-186	210	11	:	:	PUNCT
ctmj-186	210	12	a	a	DET
ctmj-186	210	13	systematic	systematic	ADJ
ctmj-186	210	14	review	review	NOUN
ctmj-186	210	15	and	and	CCONJ
ctmj-186	210	16	metaanalysis	metaanalysis	NOUN
ctmj-186	210	17	.	.	PUNCT
ctmj-186	211	1	crit	crit	PROPN
ctmj-186	211	2	care	care	PROPN
ctmj-186	211	3	med	me	VERB
ctmj-186	211	4	2015;43:511	2015;43:511	NUM
ctmj-186	211	5	-	-	SYM
ctmj-186	211	6	8	8	NUM
ctmj-186	211	7	.	.	PUNCT
ctmj-186	211	8	11	11	NUM
ctmj-186	211	9	.	.	PUNCT
ctmj-186	212	1	wang	wang	PROPN
ctmj-186	212	2	c	c	PROPN
ctmj-186	212	3	,	,	PUNCT
ctmj-186	212	4	chi	chi	PROPN
ctmj-186	212	5	c	c	PROPN
ctmj-186	212	6	,	,	PUNCT
ctmj-186	212	7	guo	guo	PROPN
ctmj-186	212	8	l	l	PROPN
ctmj-186	212	9	,	,	PUNCT
ctmj-186	212	10	wang	wang	PROPN
ctmj-186	212	11	x	x	PROPN
ctmj-186	212	12	,	,	PUNCT
ctmj-186	212	13	guo	guo	PROPN
ctmj-186	212	14	l	l	PROPN
ctmj-186	212	15	,	,	PUNCT
ctmj-186	212	16	sun	sun	PROPN
ctmj-186	212	17	j	j	PROPN
ctmj-186	212	18	,	,	PUNCT
ctmj-186	212	19	et	et	PROPN
ctmj-186	212	20	al	al	PROPN
ctmj-186	212	21	.	.	PROPN
ctmj-186	212	22	heparin	heparin	PROPN
ctmj-186	212	23	therapy	therapy	NOUN
ctmj-186	212	24	reduces	reduce	VERB
ctmj-186	212	25	28	28	NUM
ctmj-186	212	26	-	-	PUNCT
ctmj-186	212	27	day	day	NOUN
ctmj-186	212	28	mortality	mortality	NOUN
ctmj-186	212	29	in	in	ADP
ctmj-186	212	30	adult	adult	NOUN
ctmj-186	212	31	severe	severe	ADJ
ctmj-186	212	32	sepsis	sepsis	NOUN
ctmj-186	212	33	patients	patient	NOUN
ctmj-186	212	34	:	:	PUNCT
ctmj-186	212	35	a	a	DET
ctmj-186	212	36	systematic	systematic	ADJ
ctmj-186	212	37	review	review	NOUN
ctmj-186	212	38	and	and	CCONJ
ctmj-186	212	39	meta	meta	ADJ
ctmj-186	212	40	-	-	PUNCT
ctmj-186	212	41	analysis	analysis	NOUN
ctmj-186	212	42	.	.	PUNCT
ctmj-186	213	1	crit	crit	PROPN
ctmj-186	213	2	care	care	NOUN
ctmj-186	213	3	2014;18:563	2014;18:563	NUM
ctmj-186	213	4	.	.	PUNCT
ctmj-186	214	1	12	12	NUM
ctmj-186	214	2	.	.	PUNCT
ctmj-186	215	1	cheng	cheng	PROPN
ctmj-186	215	2	b	b	PROPN
ctmj-186	215	3	,	,	PUNCT
ctmj-186	215	4	li	li	PROPN
ctmj-186	215	5	xy	xy	PROPN
ctmj-186	215	6	,	,	PUNCT
ctmj-186	215	7	liu	liu	PROPN
ctmj-186	215	8	kq	kq	PROPN
ctmj-186	215	9	,	,	PUNCT
ctmj-186	215	10	wang	wang	PROPN
ctmj-186	215	11	l	l	PROPN
ctmj-186	215	12	,	,	PUNCT
ctmj-186	215	13	wu	wu	PROPN
ctmj-186	215	14	wp	wp	PROPN
ctmj-186	215	15	,	,	PUNCT
ctmj-186	215	16	xu	xu	PROPN
ctmj-186	216	1	h	h	PROPN
ctmj-186	216	2	,	,	PUNCT
ctmj-186	216	3	et	et	PROPN
ctmj-186	216	4	al	al	PROPN
ctmj-186	216	5	.	.	PUNCT
ctmj-186	217	1	chinese	chinese	ADJ
ctmj-186	217	2	expert	expert	ADJ
ctmj-186	217	3	advice	advice	NOUN
ctmj-186	217	4	on	on	ADP
ctmj-186	217	5	the	the	DET
ctmj-186	217	6	clinical	clinical	ADJ
ctmj-186	217	7	application	application	NOUN
ctmj-186	217	8	of	of	ADP
ctmj-186	217	9	compound	compound	NOUN
ctmj-186	217	10	danshen	danshen	NOUN
ctmj-186	217	11	dripping	dripping	ADJ
ctmj-186	217	12	pills	pill	NOUN
ctmj-186	217	13	.	.	PUNCT
ctmj-186	218	1	chin	chin	PROPN
ctmj-186	218	2	j	j	PROPN
ctmj-186	218	3	integr	integr	PROPN
ctmj-186	218	4	tradit	tradit	PROPN
ctmj-186	218	5	chin	chin	PROPN
ctmj-186	218	6	west	west	PROPN
ctmj-186	218	7	med	me	VERB
ctmj-186	218	8	2017;37:17	2017;37:17	NUM
ctmj-186	218	9	-	-	SYM
ctmj-186	218	10	22	22	NUM
ctmj-186	218	11	.	.	PUNCT
ctmj-186	219	1	13	13	NUM
ctmj-186	219	2	.	.	PUNCT
ctmj-186	219	3	liao	liao	PROPN
ctmj-186	219	4	w	w	PROPN
ctmj-186	219	5	,	,	PUNCT
ctmj-186	219	6	ma	ma	PROPN
ctmj-186	219	7	x	x	PROPN
ctmj-186	219	8	,	,	PUNCT
ctmj-186	219	9	li	li	PROPN
ctmj-186	219	10	j	j	PROPN
ctmj-186	219	11	,	,	PUNCT
ctmj-186	219	12	li	li	PROPN
ctmj-186	219	13	x	x	PROPN
ctmj-186	219	14	,	,	PUNCT
ctmj-186	219	15	guo	guo	PROPN
ctmj-186	219	16	z	z	PROPN
ctmj-186	219	17	,	,	PUNCT
ctmj-186	219	18	zhou	zhou	PROPN
ctmj-186	219	19	s	s	PROPN
ctmj-186	219	20	,	,	PUNCT
ctmj-186	219	21	et	et	PROPN
ctmj-186	219	22	al	al	PROPN
ctmj-186	219	23	.	.	PUNCT
ctmj-186	220	1	a	a	DET
ctmj-186	220	2	review	review	NOUN
ctmj-186	220	3	of	of	ADP
ctmj-186	220	4	the	the	DET
ctmj-186	220	5	mechanism	mechanism	NOUN
ctmj-186	220	6	of	of	ADP
ctmj-186	220	7	action	action	NOUN
ctmj-186	220	8	of	of	ADP
ctmj-186	220	9	dantonic	dantonic	ADJ
ctmj-186	220	10	(	(	PUNCT
ctmj-186	220	11	®	®	NOUN
ctmj-186	220	12	)	)	PUNCT
ctmj-186	220	13	for	for	ADP
ctmj-186	220	14	the	the	DET
ctmj-186	220	15	treatment	treatment	NOUN
ctmj-186	220	16	of	of	ADP
ctmj-186	220	17	chronic	chronic	ADJ
ctmj-186	220	18	stable	stable	ADJ
ctmj-186	220	19	angina	angina	NOUN
ctmj-186	220	20	.	.	PUNCT
ctmj-186	220	21	biomed	biome	VERB
ctmj-186	220	22	pharmacother	pharmacother	ADJ
ctmj-186	220	23	2019;109:690‑700	2019;109:690‑700	NUM
ctmj-186	220	24	.	.	PUNCT
ctmj-186	221	1	14	14	NUM
ctmj-186	221	2	.	.	PUNCT
ctmj-186	222	1	han	han	PROPN
ctmj-186	222	2	jy	jy	PROPN
ctmj-186	222	3	,	,	PUNCT
ctmj-186	222	4	li	li	PROPN
ctmj-186	222	5	q	q	PROPN
ctmj-186	222	6	,	,	PUNCT
ctmj-186	222	7	pan	pan	PROPN
ctmj-186	222	8	cs	cs	PROPN
ctmj-186	222	9	,	,	PUNCT
ctmj-186	222	10	sun	sun	PROPN
ctmj-186	222	11	k	k	PROPN
ctmj-186	222	12	,	,	PUNCT
ctmj-186	222	13	fan	fan	PROPN
ctmj-186	222	14	jy	jy	PROPN
ctmj-186	222	15	.	.	PUNCT
ctmj-186	222	16	progression	progression	NOUN
ctmj-186	222	17	of	of	ADP
ctmj-186	222	18	the	the	DET
ctmj-186	222	19	wei‑qi‑ying‑xue	wei‑qi‑ying‑xue	NOUN
ctmj-186	222	20	syndrome	syndrome	NOUN
ctmj-186	222	21	,	,	PUNCT
ctmj-186	222	22	microcirculatory	microcirculatory	ADJ
ctmj-186	222	23	disturbances	disturbance	NOUN
ctmj-186	222	24	,	,	PUNCT
ctmj-186	222	25	in	in	ADP
ctmj-186	222	26	infectious	infectious	ADJ
ctmj-186	222	27	diseases	disease	NOUN
ctmj-186	222	28	and	and	CCONJ
ctmj-186	222	29	treatment	treatment	NOUN
ctmj-186	222	30	with	with	ADP
ctmj-186	222	31	traditional	traditional	ADJ
ctmj-186	222	32	chinese	chinese	ADJ
ctmj-186	222	33	medicine	medicine	NOUN
ctmj-186	222	34	.	.	PUNCT
ctmj-186	223	1	world	world	PROPN
ctmj-186	223	2	j	j	PROPN
ctmj-186	223	3	tradit	tradit	PROPN
ctmj-186	223	4	chin	chin	PROPN
ctmj-186	223	5	med	med	PROPN
ctmj-186	223	6	2022;8:169	2022;8:169	PROPN
ctmj-186	223	7	-	-	SYM
ctmj-186	223	8	80	80	NUM
ctmj-186	223	9	.	.	PUNCT
ctmj-186	224	1	15	15	NUM
ctmj-186	224	2	.	.	PUNCT
ctmj-186	225	1	suga	suga	PROPN
ctmj-186	225	2	y	y	PROPN
ctmj-186	225	3	,	,	PUNCT
ctmj-186	225	4	akita	akita	NOUN
ctmj-186	225	5	f	f	PROPN
ctmj-186	225	6	,	,	PUNCT
ctmj-186	225	7	yamada	yamada	PROPN
ctmj-186	225	8	s	s	PROPN
ctmj-186	225	9	,	,	PUNCT
ctmj-186	225	10	morishita	morishita	PROPN
ctmj-186	225	11	e	e	PROPN
ctmj-186	225	12	,	,	PUNCT
ctmj-186	225	13	asakura	asakura	PROPN
ctmj-186	225	14	h.	h.	PROPN
ctmj-186	225	15	recombinant	recombinant	ADJ
ctmj-186	225	16	human	human	ADJ
ctmj-186	225	17	erythropoietin	erythropoietin	NOUN
ctmj-186	225	18	attenuates	attenuate	NOUN
ctmj-186	225	19	hepatic	hepatic	ADJ
ctmj-186	225	20	dysfunction	dysfunction	NOUN
ctmj-186	225	21	by	by	ADP
ctmj-186	225	22	suppressing	suppress	VERB
ctmj-186	225	23	hepatocellular	hepatocellular	ADJ
ctmj-186	225	24	apoptosis	apoptosis	NOUN
ctmj-186	225	25	in	in	ADP
ctmj-186	225	26	lipopolysaccharide	lipopolysaccharide	ADV
ctmj-186	225	27	-	-	PUNCT
ctmj-186	225	28	induced	induce	VERB
ctmj-186	225	29	disseminated	disseminate	VERB
ctmj-186	225	30	intravascular	intravascular	ADJ
ctmj-186	225	31	coagulation	coagulation	NOUN
ctmj-186	225	32	in	in	ADP
ctmj-186	225	33	rats	rat	NOUN
ctmj-186	225	34	.	.	PUNCT
ctmj-186	226	1	biomed	biome	VERB
ctmj-186	226	2	rep	rep	PROPN
ctmj-186	226	3	2022;16:5	2022;16:5	NOUN
ctmj-186	226	4	.	.	PUNCT
ctmj-186	227	1	16	16	NUM
ctmj-186	227	2	.	.	PUNCT
ctmj-186	228	1	asakura	asakura	PROPN
ctmj-186	228	2	h.	h.	PROPN
ctmj-186	228	3	classifying	classify	VERB
ctmj-186	228	4	types	type	NOUN
ctmj-186	228	5	of	of	ADP
ctmj-186	228	6	disseminated	disseminate	VERB
ctmj-186	228	7	intravascular	intravascular	ADJ
ctmj-186	228	8	coagulation	coagulation	NOUN
ctmj-186	228	9	:	:	PUNCT
ctmj-186	228	10	clinical	clinical	ADJ
ctmj-186	228	11	and	and	CCONJ
ctmj-186	228	12	animal	animal	NOUN
ctmj-186	228	13	models	model	NOUN
ctmj-186	228	14	.	.	PUNCT
ctmj-186	229	1	j	j	PROPN
ctmj-186	229	2	intensive	intensive	ADJ
ctmj-186	229	3	care	care	NOUN
ctmj-186	229	4	2014;2:20	2014;2:20	NOUN
ctmj-186	229	5	.	.	PUNCT
ctmj-186	230	1	17	17	NUM
ctmj-186	230	2	.	.	PUNCT
ctmj-186	231	1	huang	huang	PROPN
ctmj-186	231	2	j	j	PROPN
ctmj-186	231	3	,	,	PUNCT
ctmj-186	231	4	yin	yin	PROPN
ctmj-186	231	5	xj	xj	PROPN
ctmj-186	231	6	,	,	PUNCT
ctmj-186	231	7	huang	huang	PROPN
ctmj-186	231	8	f.	f.	PROPN
ctmj-186	231	9	research	research	PROPN
ctmj-186	231	10	progress	progress	NOUN
ctmj-186	231	11	of	of	ADP
ctmj-186	231	12	fibrinogen	fibrinogen	NOUN
ctmj-186	231	13	related	relate	VERB
ctmj-186	231	14	drugs	drug	NOUN
ctmj-186	231	15	.	.	PUNCT
ctmj-186	232	1	pharm	pharm	NOUN
ctmj-186	232	2	res	re	NOUN
ctmj-186	232	3	2019;38:167‑71	2019;38:167‑71	NUM
ctmj-186	232	4	.	.	PUNCT
ctmj-186	233	1	18	18	NUM
ctmj-186	233	2	.	.	PUNCT
ctmj-186	234	1	rostami	rostami	PROPN
ctmj-186	234	2	m	m	PROPN
ctmj-186	234	3	,	,	PUNCT
ctmj-186	234	4	khoshnegah	khoshnegah	PROPN
ctmj-186	234	5	z	z	NOUN
ctmj-186	234	6	,	,	PUNCT
ctmj-186	234	7	mansouritorghabeh	mansouritorghabeh	PROPN
ctmj-186	234	8	h.	h.	PROPN
ctmj-186	234	9	hemostatic	hemostatic	ADJ
ctmj-186	234	10	system	system	NOUN
ctmj-186	234	11	(	(	PUNCT
ctmj-186	234	12	fibrinogen	fibrinogen	NOUN
ctmj-186	234	13	level	level	NOUN
ctmj-186	234	14	,	,	PUNCT
ctmj-186	234	15	d‑dimer	d‑dim	ADJ
ctmj-186	234	16	,	,	PUNCT
ctmj-186	234	17	and	and	CCONJ
ctmj-186	234	18	fdp	fdp	X
ctmj-186	234	19	)	)	PUNCT
ctmj-186	234	20	in	in	ADP
ctmj-186	234	21	severe	severe	ADJ
ctmj-186	234	22	and	and	CCONJ
ctmj-186	234	23	non‑severe	non‑severe	ADV
ctmj-186	234	24	patients	patient	NOUN
ctmj-186	234	25	with	with	ADP
ctmj-186	234	26	covid-19	covid-19	PROPN
ctmj-186	234	27	:	:	PUNCT
ctmj-186	234	28	a	a	DET
ctmj-186	234	29	systematic	systematic	ADJ
ctmj-186	234	30	review	review	NOUN
ctmj-186	234	31	and	and	CCONJ
ctmj-186	234	32	meta	meta	ADJ
ctmj-186	234	33	-	-	PUNCT
ctmj-186	234	34	analysis	analysis	NOUN
ctmj-186	234	35	.	.	PUNCT
ctmj-186	235	1	clin	clin	PROPN
ctmj-186	235	2	appl	appl	PROPN
ctmj-186	235	3	thromb	thromb	PROPN
ctmj-186	235	4	hemost	hemost	VERB
ctmj-186	235	5	2021;27:2710760296211010973	2021;27:2710760296211010973	NUM
ctmj-186	235	6	.	.	PROPN
ctmj-186	236	1	19	19	NUM
ctmj-186	236	2	.	.	PUNCT
ctmj-186	237	1	zhou	zhou	PROPN
ctmj-186	237	2	b	b	PROPN
ctmj-186	237	3	,	,	PUNCT
ctmj-186	237	4	liu	liu	PROPN
ctmj-186	237	5	j	j	PROPN
ctmj-186	237	6	,	,	PUNCT
ctmj-186	237	7	zeng	zeng	PROPN
ctmj-186	237	8	l	l	PROPN
ctmj-186	237	9	,	,	PUNCT
ctmj-186	237	10	zhu	zhu	PROPN
ctmj-186	237	11	s	s	PART
ctmj-186	237	12	,	,	PUNCT
ctmj-186	237	13	wang	wang	PROPN
ctmj-186	237	14	h	h	PROPN
ctmj-186	237	15	,	,	PUNCT
ctmj-186	237	16	billiar	billiar	PROPN
ctmj-186	237	17	tr	tr	VERB
ctmj-186	237	18	,	,	PUNCT
ctmj-186	237	19	et	et	PROPN
ctmj-186	237	20	al	al	PROPN
ctmj-186	237	21	.	.	PROPN
ctmj-186	237	22	extracellular	extracellular	PROPN
ctmj-186	237	23	sqstm1	sqstm1	PROPN
ctmj-186	237	24	mediates	mediate	VERB
ctmj-186	237	25	bacterial	bacterial	ADJ
ctmj-186	237	26	septic	septic	ADJ
ctmj-186	237	27	death	death	NOUN
ctmj-186	237	28	in	in	ADP
ctmj-186	237	29	mice	mouse	NOUN
ctmj-186	237	30	through	through	ADP
ctmj-186	237	31	insulin	insulin	NOUN
ctmj-186	237	32	receptor	receptor	NOUN
ctmj-186	237	33	signalling	signal	VERB
ctmj-186	237	34	.	.	PUNCT
ctmj-186	238	1	nat	nat	PROPN
ctmj-186	238	2	microbiol	microbiol	PROPN
ctmj-186	238	3	2020;5:1576‑87	2020;5:1576‑87	PROPN
ctmj-186	238	4	.	.	PUNCT
ctmj-186	239	1	20	20	NUM
ctmj-186	239	2	.	.	PUNCT
ctmj-186	240	1	papurica	papurica	PROPN
ctmj-186	240	2	m	m	PROPN
ctmj-186	240	3	,	,	PUNCT
ctmj-186	240	4	rogobete	rogobete	PROPN
ctmj-186	240	5	af	af	PROPN
ctmj-186	240	6	,	,	PUNCT
ctmj-186	240	7	sandesc	sandesc	NOUN
ctmj-186	240	8	d	d	PROPN
ctmj-186	240	9	,	,	PUNCT
ctmj-186	240	10	cradigati	cradigati	NOUN
ctmj-186	240	11	ca	ca	PROPN
ctmj-186	240	12	,	,	PUNCT
ctmj-186	240	13	sarandan	sarandan	PROPN
ctmj-186	240	14	m	m	PROPN
ctmj-186	240	15	,	,	PUNCT
ctmj-186	240	16	crisan	crisan	ADJ
ctmj-186	240	17	dc	dc	PROPN
ctmj-186	240	18	,	,	PUNCT
ctmj-186	240	19	et	et	PROPN
ctmj-186	240	20	al	al	PROPN
ctmj-186	240	21	.	.	PUNCT
ctmj-186	241	1	the	the	DET
ctmj-186	241	2	expression	expression	NOUN
ctmj-186	241	3	of	of	ADP
ctmj-186	241	4	nuclear	nuclear	ADJ
ctmj-186	241	5	transcription	transcription	NOUN
ctmj-186	241	6	factor	factor	NOUN
ctmj-186	241	7	kappa	kappa	PROPN
ctmj-186	241	8	b	b	PROPN
ctmj-186	241	9	(	(	PUNCT
ctmj-186	241	10	nf‑b	nf‑b	PROPN
ctmj-186	241	11	)	)	PUNCT
ctmj-186	241	12	in	in	ADP
ctmj-186	241	13	the	the	DET
ctmj-186	241	14	case	case	NOUN
ctmj-186	241	15	of	of	ADP
ctmj-186	241	16	critically	critically	ADV
ctmj-186	241	17	ill	ill	ADJ
ctmj-186	241	18	polytrauma	polytrauma	NOUN
ctmj-186	241	19	patients	patient	NOUN
ctmj-186	241	20	with	with	ADP
ctmj-186	241	21	sepsis	sepsis	NOUN
ctmj-186	241	22	and	and	CCONJ
ctmj-186	241	23	its	its	PRON
ctmj-186	241	24	interactions	interaction	NOUN
ctmj-186	241	25	with	with	ADP
ctmj-186	241	26	micrornas	microrna	NOUN
ctmj-186	241	27	.	.	PUNCT
ctmj-186	242	1	biochem	biochem	PROPN
ctmj-186	242	2	genet	genet	PROPN
ctmj-186	242	3	2016;54:337‑47	2016;54:337‑47	NUM
ctmj-186	242	4	.	.	PUNCT
ctmj-186	243	1	21	21	NUM
ctmj-186	243	2	.	.	PUNCT
ctmj-186	244	1	zhang	zhang	PROPN
ctmj-186	244	2	s	s	PROPN
ctmj-186	244	3	,	,	PUNCT
ctmj-186	244	4	wang	wang	PROPN
ctmj-186	244	5	j	j	PROPN
ctmj-186	244	6	,	,	PUNCT
ctmj-186	244	7	chen	chen	PROPN
ctmj-186	244	8	s	s	PROPN
ctmj-186	244	9	,	,	PUNCT
ctmj-186	244	10	yin	yin	PROPN
ctmj-186	244	11	j	j	PROPN
ctmj-186	244	12	,	,	PUNCT
ctmj-186	244	13	pan	pan	PROPN
ctmj-186	244	14	z	z	PROPN
ctmj-186	244	15	,	,	PUNCT
ctmj-186	244	16	liu	liu	PROPN
ctmj-186	244	17	k	k	PROPN
ctmj-186	244	18	,	,	PUNCT
ctmj-186	244	19	et	et	PROPN
ctmj-186	244	20	al	al	PROPN
ctmj-186	244	21	.	.	PUNCT
ctmj-186	244	22	effects	effect	NOUN
ctmj-186	244	23	of	of	ADP
ctmj-186	244	24	suilysin	suilysin	NOUN
ctmj-186	244	25	on	on	ADP
ctmj-186	244	26	streptococcus	streptococcus	NOUN
ctmj-186	244	27	suis	suis	ADV
ctmj-186	244	28	-	-	PUNCT
ctmj-186	244	29	induced	induced	ADJ
ctmj-186	244	30	platelet	platelet	NOUN
ctmj-186	244	31	aggregation	aggregation	NOUN
ctmj-186	244	32	.	.	PUNCT
ctmj-186	245	1	front	front	ADJ
ctmj-186	245	2	cell	cell	NOUN
ctmj-186	245	3	infect	infect	VERB
ctmj-186	245	4	microbiol	microbiol	PROPN
ctmj-186	245	5	2016;6:128	2016;6:128	NUM
ctmj-186	245	6	.	.	PUNCT
ctmj-186	246	1	22	22	NUM
ctmj-186	246	2	.	.	PUNCT
ctmj-186	247	1	feghhi	feghhi	PROPN
ctmj-186	247	2	s	s	PROPN
ctmj-186	247	3	,	,	PUNCT
ctmj-186	247	4	tooley	tooley	PROPN
ctmj-186	247	5	ww	ww	PROPN
ctmj-186	247	6	,	,	PUNCT
ctmj-186	247	7	sniadecki	sniadecki	PROPN
ctmj-186	247	8	nj	nj	PROPN
ctmj-186	247	9	.	.	PUNCT
ctmj-186	248	1	nonmuscle	nonmuscle	PROPN
ctmj-186	248	2	myosin	myosin	PROPN
ctmj-186	248	3	iia	iia	PROPN
ctmj-186	248	4	regulates	regulate	VERB
ctmj-186	248	5	platelet	platelet	NOUN
ctmj-186	248	6	contractile	contractile	NOUN
ctmj-186	248	7	forces	force	NOUN
ctmj-186	248	8	through	through	ADP
ctmj-186	248	9	rho	rho	ADJ
ctmj-186	248	10	kinase	kinase	PROPN
ctmj-186	248	11	and	and	CCONJ
ctmj-186	248	12	myosin	myosin	PROPN
ctmj-186	248	13	light	light	PROPN
ctmj-186	248	14	-	-	PUNCT
ctmj-186	248	15	chain	chain	NOUN
ctmj-186	248	16	kinase	kinase	NOUN
ctmj-186	248	17	.	.	PUNCT
ctmj-186	249	1	j	j	PROPN
ctmj-186	249	2	biomech	biomech	PROPN
ctmj-186	249	3	eng	eng	PROPN
ctmj-186	249	4	2016;138:1045061–1045064	2016;138:1045061–1045064	PROPN
ctmj-186	249	5	.	.	PROPN
ctmj-186	249	6	23	23	NUM
ctmj-186	249	7	.	.	X
ctmj-186	249	8	di	di	PROPN
ctmj-186	249	9	yq	yq	PROPN
ctmj-186	249	10	,	,	PUNCT
ctmj-186	249	11	han	han	PROPN
ctmj-186	249	12	xl	xl	PROPN
ctmj-186	249	13	,	,	PUNCT
ctmj-186	249	14	kang	kang	PROPN
ctmj-186	249	15	xl	xl	PROPN
ctmj-186	249	16	,	,	PUNCT
ctmj-186	249	17	wang	wang	PROPN
ctmj-186	249	18	d	d	PROPN
ctmj-186	249	19	,	,	PUNCT
ctmj-186	249	20	chen	chen	PROPN
ctmj-186	249	21	ch	ch	PROPN
ctmj-186	249	22	,	,	PUNCT
ctmj-186	249	23	wang	wang	PROPN
ctmj-186	249	24	jx	jx	PROPN
ctmj-186	249	25	,	,	PUNCT
ctmj-186	249	26	et	et	PROPN
ctmj-186	249	27	al	al	PROPN
ctmj-186	249	28	.	.	PROPN
ctmj-186	250	1	autophagy	autophagy	PROPN
ctmj-186	250	2	triggers	trigger	NOUN
ctmj-186	250	3	ctsd	ctsd	VERB
ctmj-186	250	4	(	(	PUNCT
ctmj-186	250	5	cathepsin	cathepsin	NOUN
ctmj-186	250	6	d	d	NOUN
ctmj-186	250	7	)	)	PUNCT
ctmj-186	250	8	maturation	maturation	NOUN
ctmj-186	250	9	and	and	CCONJ
ctmj-186	250	10	localization	localization	NOUN
ctmj-186	250	11	inside	inside	ADP
ctmj-186	250	12	cells	cell	NOUN
ctmj-186	250	13	to	to	PART
ctmj-186	250	14	promote	promote	VERB
ctmj-186	250	15	apoptosis	apoptosis	NOUN
ctmj-186	250	16	.	.	PUNCT
ctmj-186	251	1	autophagy	autophagy	VERB
ctmj-186	251	2	2021;17:1170	2021;17:1170	NUM
ctmj-186	251	3	-	-	SYM
ctmj-186	251	4	92	92	NUM
ctmj-186	251	5	.	.	PUNCT